"contig.name";"ssr.no";"ssr.type";"ssr.seq";"ssr.size";"ssr.start";"ssr.end";"MatchID";"contig.length";"geneID";"goTerm";"cellular.components";"biological.processes";"molecular.functions";"keywords"
"AgU000001_v1.1";"1";"p2";"(CA)5";"10";1586;1595;"AgU000001";8457;"VWF_CANLF";"GO:0005783 // GO:0031012 // GO:0005576 // GO:0005578 // GO:0033093 // GO:0051087 // GO:0005518 // GO:0001948 // GO:0019865 // GO:0005178 // GO:0002020 // GO:0042803 // GO:0047485 // GO:0007596 // GO:0007155 // GO:0031589 // GO:0007599 // GO:0030168 // GO:0051260";"blood coagulation (GO:0007596);cell adhesion (GO:0007155);cell-substrate adhesion (GO:0031589);hemostasis (GO:0007599);platelet activation (GO:0030168);protein homooligomerization (GO:0051260);";"chaperone binding (GO:0051087);collagen binding (GO:0005518);glycoprotein binding (GO:0001948);immunoglobulin binding (GO:0019865);integrin binding (GO:0005178);protease binding (GO:0002020);protein homodimerization activity (GO:0042803);protein N-terminus binding (GO:0047485);";"endoplasmic reticulum (GO:0005783);extracellular matrix (GO:0031012);extracellular region (GO:0005576);proteinaceous extracellular matrix (GO:0005578);Weibel-Palade body (GO:0033093);";"Blood coagulation;Cell adhesion;Cleavage on pair of basic residues;Complete proteome;Disulfide bond;Extracellular matrix;Glycoprotein;Hemostasis;Reference proteome;Repeat;Secreted;Signal.;"
"AgU000018_v1.1";"1";"p2";"(AC)5";"10";4757;4766;"AgU000018";5608;"AGRF5_HUMAN";"GO:0009986 // GO:0031410 // GO:0016021 // GO:0005886 // GO:0004930 // GO:0007166 // GO:0006112 // GO:0045444 // GO:0007186 // GO:0042593 // GO:0019216 // GO:0043129";"cell surface receptor signaling pathway (GO:0007166);energy reserve metabolic process (GO:0006112);fat cell differentiation (GO:0045444);G-protein coupled receptor signaling pathway (GO:0007186);glucose homeostasis (GO:0042593);regulation of lipid metabolic process (GO:0019216);surfactant homeostasis (GO:0043129);";"G-protein coupled receptor activity (GO:0004930);";"cell surface (GO:0009986);cytoplasmic vesicle (GO:0031410);integral component of membrane (GO:0016021);plasma membrane (GO:0005886);";"Alternative splicing;Cell membrane;Complete proteome;Disulfide bond;G-protein coupled receptor;Glycoprotein;Immunoglobulin domain;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transducer;Transmembrane;Transmembrane helix.;"
"AgU000018_v1.1";"2";"p2";"(TG)5";"10";5364;5373;"AgU000018";5608;"AGRF5_HUMAN";"GO:0009986 // GO:0031410 // GO:0016021 // GO:0005886 // GO:0004930 // GO:0007166 // GO:0006112 // GO:0045444 // GO:0007186 // GO:0042593 // GO:0019216 // GO:0043129";"cell surface receptor signaling pathway (GO:0007166);energy reserve metabolic process (GO:0006112);fat cell differentiation (GO:0045444);G-protein coupled receptor signaling pathway (GO:0007186);glucose homeostasis (GO:0042593);regulation of lipid metabolic process (GO:0019216);surfactant homeostasis (GO:0043129);";"G-protein coupled receptor activity (GO:0004930);";"cell surface (GO:0009986);cytoplasmic vesicle (GO:0031410);integral component of membrane (GO:0016021);plasma membrane (GO:0005886);";"Alternative splicing;Cell membrane;Complete proteome;Disulfide bond;G-protein coupled receptor;Glycoprotein;Immunoglobulin domain;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transducer;Transmembrane;Transmembrane helix.;"
"AgU000026_v1.1";"1";"p2";"(GT)5";"10";3260;3269;"AgU000026";5316;"BMR1A_HUMAN";"GO:0030425 // GO:0009897 // GO:1990712 // GO:0016021 // GO:0043025 // GO:0005886 // GO:0005524 // GO:0001948 // GO:0046872 // GO:0042803 // GO:0004674 // GO:0004702 // GO:0000981 // GO:0046332 // GO:0004675 // GO:0030509 // GO:0071773 // GO:0002062 // GO:0048589 // GO:0009950 // GO:0007398 // GO:0042733 // GO:0048568 // GO:0003272 // GO:0060914 // GO:0035137 // GO:0006955 // GO:0001701 // GO:0048368 // GO:0030324 // GO:0048382 // GO:0001707 // GO:0001880 // GO:0050768 // GO:0014032 // GO:0021998 // GO:0042475 // GO:0060021 // GO:0048352 // GO:0021983 // GO:0030501 // GO:0050679 // GO:0002053 // GO:0045669 // GO:0010862 // GO:0060391 // GO:0045944 // GO:0006468 // GO:2000772 // GO:0048378 // GO:0001756 // GO:0019827 // GO:0007179";"BMP signaling pathway (GO:0030509);cellular response to BMP stimulus (GO:0071773);chondrocyte differentiation (GO:0002062);developmental growth (GO:0048589);dorsal/ventral axis specification (GO:0009950);ectoderm development (GO:0007398);embryonic digit morphogenesis (GO:0042733);embryonic organ development (GO:0048568);endocardial cushion formation (GO:0003272);heart formation (GO:0060914);hindlimb morphogenesis (GO:0035137);immune response (GO:0006955);in utero embryonic development (GO:0001701);lateral mesoderm development (GO:0048368);lung development (GO:0030324);mesendoderm development (GO:0048382);mesoderm formation (GO:0001707);Mullerian duct regression (GO:0001880);negative regulation of neurogenesis (GO:0050768);neural crest cell development (GO:0014032);neural plate mediolateral regionalization (GO:0021998);odontogenesis of dentin-containing tooth (GO:0042475);palate development (GO:0060021);paraxial mesoderm structural organization (GO:0048352);pituitary gland development (GO:0021983);positive regulation of bone mineralization (GO:0030501);positive regulation of epithelial cell proliferation (GO:0050679);positive regulation of mesenchymal cell proliferation (GO:0002053);positive regulation of osteoblast differentiation (GO:0045669);positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862);positive regulation of SMAD protein import into nucleus (GO:0060391);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);protein phosphorylation (GO:0006468);regulation of cellular senescence (GO:2000772);regulation of lateral mesodermal cell fate specification (GO:0048378);somitogenesis (GO:0001756);stem cell population maintenance (GO:0019827);transforming growth factor beta receptor signaling pathway (GO:0007179);";"ATP binding (GO:0005524);glycoprotein binding (GO:0001948);metal ion binding (GO:0046872);protein homodimerization activity (GO:0042803);protein serine/threonine kinase activity (GO:0004674);receptor signaling protein serine/threonine kinase activity (GO:0004702);RNA polymerase II transcription factor activity, sequence-specific DNA binding (GO:0000981);SMAD binding (GO:0046332);transmembrane receptor protein serine/threonine kinase activity (GO:0004675);";"dendrite (GO:0030425);external side of plasma membrane (GO:0009897);HFE-transferrin receptor complex (GO:1990712);integral component of membrane (GO:0016021);neuronal cell body (GO:0043025);plasma membrane (GO:0005886);";"3D-structure;ATP-binding;Complete proteome;Disease mutation;Disulfide bond;Glycoprotein;Kinase;Magnesium;Manganese;Membrane;Metal-binding;Nucleotide-binding;Polymorphism;Receptor;Reference proteome;Serine/threonine-protein kinase;Signal;Transferase;Transmembrane;Transmembrane helix.;"
"AgU000026_v1.1";"2";"p2";"(CA)5";"10";3970;3979;"AgU000026";5316;"BMR1A_HUMAN";"GO:0030425 // GO:0009897 // GO:1990712 // GO:0016021 // GO:0043025 // GO:0005886 // GO:0005524 // GO:0001948 // GO:0046872 // GO:0042803 // GO:0004674 // GO:0004702 // GO:0000981 // GO:0046332 // GO:0004675 // GO:0030509 // GO:0071773 // GO:0002062 // GO:0048589 // GO:0009950 // GO:0007398 // GO:0042733 // GO:0048568 // GO:0003272 // GO:0060914 // GO:0035137 // GO:0006955 // GO:0001701 // GO:0048368 // GO:0030324 // GO:0048382 // GO:0001707 // GO:0001880 // GO:0050768 // GO:0014032 // GO:0021998 // GO:0042475 // GO:0060021 // GO:0048352 // GO:0021983 // GO:0030501 // GO:0050679 // GO:0002053 // GO:0045669 // GO:0010862 // GO:0060391 // GO:0045944 // GO:0006468 // GO:2000772 // GO:0048378 // GO:0001756 // GO:0019827 // GO:0007179";"BMP signaling pathway (GO:0030509);cellular response to BMP stimulus (GO:0071773);chondrocyte differentiation (GO:0002062);developmental growth (GO:0048589);dorsal/ventral axis specification (GO:0009950);ectoderm development (GO:0007398);embryonic digit morphogenesis (GO:0042733);embryonic organ development (GO:0048568);endocardial cushion formation (GO:0003272);heart formation (GO:0060914);hindlimb morphogenesis (GO:0035137);immune response (GO:0006955);in utero embryonic development (GO:0001701);lateral mesoderm development (GO:0048368);lung development (GO:0030324);mesendoderm development (GO:0048382);mesoderm formation (GO:0001707);Mullerian duct regression (GO:0001880);negative regulation of neurogenesis (GO:0050768);neural crest cell development (GO:0014032);neural plate mediolateral regionalization (GO:0021998);odontogenesis of dentin-containing tooth (GO:0042475);palate development (GO:0060021);paraxial mesoderm structural organization (GO:0048352);pituitary gland development (GO:0021983);positive regulation of bone mineralization (GO:0030501);positive regulation of epithelial cell proliferation (GO:0050679);positive regulation of mesenchymal cell proliferation (GO:0002053);positive regulation of osteoblast differentiation (GO:0045669);positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862);positive regulation of SMAD protein import into nucleus (GO:0060391);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);protein phosphorylation (GO:0006468);regulation of cellular senescence (GO:2000772);regulation of lateral mesodermal cell fate specification (GO:0048378);somitogenesis (GO:0001756);stem cell population maintenance (GO:0019827);transforming growth factor beta receptor signaling pathway (GO:0007179);";"ATP binding (GO:0005524);glycoprotein binding (GO:0001948);metal ion binding (GO:0046872);protein homodimerization activity (GO:0042803);protein serine/threonine kinase activity (GO:0004674);receptor signaling protein serine/threonine kinase activity (GO:0004702);RNA polymerase II transcription factor activity, sequence-specific DNA binding (GO:0000981);SMAD binding (GO:0046332);transmembrane receptor protein serine/threonine kinase activity (GO:0004675);";"dendrite (GO:0030425);external side of plasma membrane (GO:0009897);HFE-transferrin receptor complex (GO:1990712);integral component of membrane (GO:0016021);neuronal cell body (GO:0043025);plasma membrane (GO:0005886);";"3D-structure;ATP-binding;Complete proteome;Disease mutation;Disulfide bond;Glycoprotein;Kinase;Magnesium;Manganese;Membrane;Metal-binding;Nucleotide-binding;Polymorphism;Receptor;Reference proteome;Serine/threonine-protein kinase;Signal;Transferase;Transmembrane;Transmembrane helix.;"
"AgU000033_v1.1";"3";"p2";"(CT)5";"10";1804;1813;"AgU000033";5228;"RORA_MOUSE";"GO:0005654 // GO:0005634 // GO:0008013 // GO:0001046 // GO:0003677 // GO:0008142 // GO:0000977 // GO:0004879 // GO:0043565 // GO:0003707 // GO:0001223 // GO:0001222 // GO:0098531 // GO:0003700 // GO:0008134 // GO:0008270 // GO:0001525 // GO:0071456 // GO:0071347 // GO:0036315 // GO:0071356 // GO:0021930 // GO:0021702 // GO:0046068 // GO:0032922 // GO:0007623 // GO:0030522 // GO:0042692 // GO:0045599 // GO:0043124 // GO:0050728 // GO:0006809 // GO:0042753 // GO:0045944 // GO:0045893 // GO:0010575 // GO:2000188 // GO:0042752 // GO:0010906 // GO:0043030 // GO:0008589 // GO:0019218 // GO:0060850 // GO:0006355 // GO:0072539 // GO:0006351 // GO:0070328 // GO:0006805";"angiogenesis (GO:0001525);cellular response to hypoxia (GO:0071456);cellular response to interleukin-1 (GO:0071347);cellular response to sterol (GO:0036315);cellular response to tumor necrosis factor (GO:0071356);cerebellar granule cell precursor proliferation (GO:0021930);cerebellar Purkinje cell differentiation (GO:0021702);cGMP metabolic process (GO:0046068);circadian regulation of gene expression (GO:0032922);circadian rhythm (GO:0007623);intracellular receptor signaling pathway (GO:0030522);muscle cell differentiation (GO:0042692);negative regulation of fat cell differentiation (GO:0045599);negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124);negative regulation of inflammatory response (GO:0050728);nitric oxide biosynthetic process (GO:0006809);positive regulation of circadian rhythm (GO:0042753);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of transcription, DNA-templated (GO:0045893);positive regulation of vascular endothelial growth factor production (GO:0010575);regulation of cholesterol homeostasis (GO:2000188);regulation of circadian rhythm (GO:0042752);regulation of glucose metabolic process (GO:0010906);regulation of macrophage activation (GO:0043030);regulation of smoothened signaling pathway (GO:0008589);regulation of steroid metabolic process (GO:0019218);regulation of transcription involved in cell fate commitment (GO:0060850);regulation of transcription, DNA-templated (GO:0006355);T-helper 17 cell differentiation (GO:0072539);transcription, DNA-templated (GO:0006351);triglyceride homeostasis (GO:0070328);xenobiotic metabolic process (GO:0006805);";"beta-catenin binding (GO:0008013);core promoter sequence-specific DNA binding (GO:0001046);DNA binding (GO:0003677);oxysterol binding (GO:0008142);RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977);RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding (GO:0004879);sequence-specific DNA binding (GO:0043565);steroid hormone receptor activity (GO:0003707);transcription coactivator binding (GO:0001223);transcription corepressor binding (GO:0001222);transcription factor activity, direct ligand regulated sequence-specific DNA binding (GO:0098531);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription factor binding (GO:0008134);zinc ion binding (GO:0008270);";"nucleoplasm (GO:0005654);nucleus (GO:0005634);";"Activator;Alternative promoter usage;Biological rhythms;Complete proteome;Direct protein sequencing;Disease mutation;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Receptor;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger.;"
"AgU000033_v1.1";"4";"p3";"(AAT)5";"15";3514;3528;"AgU000033";5228;"RORA_MOUSE";"GO:0005654 // GO:0005634 // GO:0008013 // GO:0001046 // GO:0003677 // GO:0008142 // GO:0000977 // GO:0004879 // GO:0043565 // GO:0003707 // GO:0001223 // GO:0001222 // GO:0098531 // GO:0003700 // GO:0008134 // GO:0008270 // GO:0001525 // GO:0071456 // GO:0071347 // GO:0036315 // GO:0071356 // GO:0021930 // GO:0021702 // GO:0046068 // GO:0032922 // GO:0007623 // GO:0030522 // GO:0042692 // GO:0045599 // GO:0043124 // GO:0050728 // GO:0006809 // GO:0042753 // GO:0045944 // GO:0045893 // GO:0010575 // GO:2000188 // GO:0042752 // GO:0010906 // GO:0043030 // GO:0008589 // GO:0019218 // GO:0060850 // GO:0006355 // GO:0072539 // GO:0006351 // GO:0070328 // GO:0006805";"angiogenesis (GO:0001525);cellular response to hypoxia (GO:0071456);cellular response to interleukin-1 (GO:0071347);cellular response to sterol (GO:0036315);cellular response to tumor necrosis factor (GO:0071356);cerebellar granule cell precursor proliferation (GO:0021930);cerebellar Purkinje cell differentiation (GO:0021702);cGMP metabolic process (GO:0046068);circadian regulation of gene expression (GO:0032922);circadian rhythm (GO:0007623);intracellular receptor signaling pathway (GO:0030522);muscle cell differentiation (GO:0042692);negative regulation of fat cell differentiation (GO:0045599);negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124);negative regulation of inflammatory response (GO:0050728);nitric oxide biosynthetic process (GO:0006809);positive regulation of circadian rhythm (GO:0042753);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of transcription, DNA-templated (GO:0045893);positive regulation of vascular endothelial growth factor production (GO:0010575);regulation of cholesterol homeostasis (GO:2000188);regulation of circadian rhythm (GO:0042752);regulation of glucose metabolic process (GO:0010906);regulation of macrophage activation (GO:0043030);regulation of smoothened signaling pathway (GO:0008589);regulation of steroid metabolic process (GO:0019218);regulation of transcription involved in cell fate commitment (GO:0060850);regulation of transcription, DNA-templated (GO:0006355);T-helper 17 cell differentiation (GO:0072539);transcription, DNA-templated (GO:0006351);triglyceride homeostasis (GO:0070328);xenobiotic metabolic process (GO:0006805);";"beta-catenin binding (GO:0008013);core promoter sequence-specific DNA binding (GO:0001046);DNA binding (GO:0003677);oxysterol binding (GO:0008142);RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977);RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding (GO:0004879);sequence-specific DNA binding (GO:0043565);steroid hormone receptor activity (GO:0003707);transcription coactivator binding (GO:0001223);transcription corepressor binding (GO:0001222);transcription factor activity, direct ligand regulated sequence-specific DNA binding (GO:0098531);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription factor binding (GO:0008134);zinc ion binding (GO:0008270);";"nucleoplasm (GO:0005654);nucleus (GO:0005634);";"Activator;Alternative promoter usage;Biological rhythms;Complete proteome;Direct protein sequencing;Disease mutation;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Receptor;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger.;"
"AgU000038_v1.1";"1";"p2";"(TA)5";"10";3523;3532;"AgU000038";5044;"IL6RB_HUMAN";"GO:0070110 // GO:0030425 // GO:0009897 // GO:0070062 // GO:0005576 // GO:0005615 // GO:0005896 // GO:0016020 // GO:0043025 // GO:0005900 // GO:0005886 // GO:0004897 // GO:0005127 // GO:0019838 // GO:0004921 // GO:0045509 // GO:0042803 // GO:0070120 // GO:0019221 // GO:0005977 // GO:0070106 // GO:0070102 // GO:0048861 // GO:0043066 // GO:0070104 // GO:0038165 // GO:0002675 // GO:0002821 // GO:0048711 // GO:0010613 // GO:0008284 // GO:0045669 // GO:0042102 // GO:0042511 // GO:0042517 // GO:0010575 // GO:0008593 // GO:0034097 // GO:0016032";"ciliary neurotrophic factor-mediated signaling pathway (GO:0070120);cytokine-mediated signaling pathway (GO:0019221);glycogen metabolic process (GO:0005977);interleukin-27-mediated signaling pathway (GO:0070106);interleukin-6-mediated signaling pathway (GO:0070102);leukemia inhibitory factor signaling pathway (GO:0048861);negative regulation of apoptotic process (GO:0043066);negative regulation of interleukin-6-mediated signaling pathway (GO:0070104);oncostatin-M-mediated signaling pathway (GO:0038165);positive regulation of acute inflammatory response (GO:0002675);positive regulation of adaptive immune response (GO:0002821);positive regulation of astrocyte differentiation (GO:0048711);positive regulation of cardiac muscle hypertrophy (GO:0010613);positive regulation of cell proliferation (GO:0008284);positive regulation of osteoblast differentiation (GO:0045669);positive regulation of T cell proliferation (GO:0042102);positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511);positive regulation of tyrosine phosphorylation of Stat3 protein (GO:0042517);positive regulation of vascular endothelial growth factor production (GO:0010575);regulation of Notch signaling pathway (GO:0008593);response to cytokine (GO:0034097);viral process (GO:0016032);";"ciliary neurotrophic factor receptor activity (GO:0004897);ciliary neurotrophic factor receptor binding (GO:0005127);growth factor binding (GO:0019838);interleukin-11 receptor activity (GO:0004921);interleukin-27 receptor activity (GO:0045509);protein homodimerization activity (GO:0042803);";"ciliary neurotrophic factor receptor complex (GO:0070110);dendrite (GO:0030425);external side of plasma membrane (GO:0009897);extracellular exosome (GO:0070062);extracellular region (GO:0005576);extracellular space (GO:0005615);interleukin-6 receptor complex (GO:0005896);membrane (GO:0016020);neuronal cell body (GO:0043025);oncostatin-M receptor complex (GO:0005900);plasma membrane (GO:0005886);";"3D-structure;Alternative splicing;Cell membrane;Complete proteome;Direct protein sequencing;Disulfide bond;Glycoprotein;Host-virus interaction;Immunoglobulin domain;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix.;"
"AgU000053_v1.1";"1";"p2";"(AG)6";"12";3638;3649;"AgU000053";4743;"AKAP9_HUMAN";"GO:0005813 // GO:0036064 // GO:0005801 // GO:0005856 // GO:0005829 // GO:0005794 // GO:0005795 // GO:0043231 // GO:0000242 // GO:0008076 // GO:0044325 // GO:0015459 // GO:0032947 // GO:0034237 // GO:0005102 // GO:0000186 // GO:0007411 // GO:0071320 // GO:0007173 // GO:0038095 // GO:0008543 // GO:0000086 // GO:0045087 // GO:0008286 // GO:0000165 // GO:0007020 // GO:0000278 // GO:0048011 // GO:0006996 // GO:0033138 // GO:1901018 // GO:0007265 // GO:0086091 // GO:0060306 // GO:0060307 // GO:0060009 // GO:0007165 // GO:0007264 // GO:0007283 // GO:0007268 // GO:0006810 // GO:0048010";"activation of MAPKK activity (GO:0000186);axon guidance (GO:0007411);cellular response to cAMP (GO:0071320);epidermal growth factor receptor signaling pathway (GO:0007173);Fc-epsilon receptor signaling pathway (GO:0038095);fibroblast growth factor receptor signaling pathway (GO:0008543);G2/M transition of mitotic cell cycle (GO:0000086);innate immune response (GO:0045087);insulin receptor signaling pathway (GO:0008286);MAPK cascade (GO:0000165);microtubule nucleation (GO:0007020);mitotic cell cycle (GO:0000278);neurotrophin TRK receptor signaling pathway (GO:0048011);organelle organization (GO:0006996);positive regulation of peptidyl-serine phosphorylation (GO:0033138);positive regulation of potassium ion transmembrane transporter activity (GO:1901018);Ras protein signal transduction (GO:0007265);regulation of heart rate by cardiac conduction (GO:0086091);regulation of membrane repolarization (GO:0060306);regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307);Sertoli cell development (GO:0060009);signal transduction (GO:0007165);small GTPase mediated signal transduction (GO:0007264);spermatogenesis (GO:0007283);synaptic transmission (GO:0007268);transport (GO:0006810);vascular endothelial growth factor receptor signaling pathway (GO:0048010);";"ion channel binding (GO:0044325);potassium channel regulator activity (GO:0015459);protein complex scaffold (GO:0032947);protein kinase A regulatory subunit binding (GO:0034237);receptor binding (GO:0005102);";"centrosome (GO:0005813);ciliary basal body (GO:0036064);cis-Golgi network (GO:0005801);cytoskeleton (GO:0005856);cytosol (GO:0005829);Golgi apparatus (GO:0005794);Golgi stack (GO:0005795);intracellular membrane-bounded organelle (GO:0043231);pericentriolar material (GO:0000242);voltage-gated potassium channel complex (GO:0008076);";"Alternative splicing;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Golgi apparatus;Long QT syndrome;Phosphoprotein;Polymorphism;Reference proteome.;"
"AgU000073_v1.1";"1";"p2";"(TA)6";"12";2171;2182;"AgU000073";4373;"TGFR2_HUMAN";"GO:0005901 // GO:0005829 // GO:0009897 // GO:0016021 // GO:0005886 // GO:0043235 // GO:0070022 // GO:0005524 // GO:0005539 // GO:0046872 // GO:0004702 // GO:0046332 // GO:0050431 // GO:0005026 // GO:0005024 // GO:0004675 // GO:0034713 // GO:0034714 // GO:0032147 // GO:0006915 // GO:0001568 // GO:0007420 // GO:0048701 // GO:0035162 // GO:0007507 // GO:0043011 // GO:0030512 // GO:0060021 // GO:0060389 // GO:0001569 // GO:0018105 // GO:0018107 // GO:0002663 // GO:0008284 // GO:0002053 // GO:0051138 // GO:2000379 // GO:0002666 // GO:0002651 // GO:0006468 // GO:0042127 // GO:0040008 // GO:0070723 // GO:0042493 // GO:0007179 // GO:0001570";"activation of protein kinase activity (GO:0032147);apoptotic process (GO:0006915);blood vessel development (GO:0001568);brain development (GO:0007420);embryonic cranial skeleton morphogenesis (GO:0048701);embryonic hemopoiesis (GO:0035162);heart development (GO:0007507);myeloid dendritic cell differentiation (GO:0043011);negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512);palate development (GO:0060021);pathway-restricted SMAD protein phosphorylation (GO:0060389);patterning of blood vessels (GO:0001569);peptidyl-serine phosphorylation (GO:0018105);peptidyl-threonine phosphorylation (GO:0018107);positive regulation of B cell tolerance induction (GO:0002663);positive regulation of cell proliferation (GO:0008284);positive regulation of mesenchymal cell proliferation (GO:0002053);positive regulation of NK T cell differentiation (GO:0051138);positive regulation of reactive oxygen species metabolic process (GO:2000379);positive regulation of T cell tolerance induction (GO:0002666);positive regulation of tolerance induction to self antigen (GO:0002651);protein phosphorylation (GO:0006468);regulation of cell proliferation (GO:0042127);regulation of growth (GO:0040008);response to cholesterol (GO:0070723);response to drug (GO:0042493);transforming growth factor beta receptor signaling pathway (GO:0007179);vasculogenesis (GO:0001570);";"ATP binding (GO:0005524);glycosaminoglycan binding (GO:0005539);metal ion binding (GO:0046872);receptor signaling protein serine/threonine kinase activity (GO:0004702);SMAD binding (GO:0046332);transforming growth factor beta binding (GO:0050431);transforming growth factor beta receptor activity, type II (GO:0005026);transforming growth factor beta-activated receptor activity (GO:0005024);transmembrane receptor protein serine/threonine kinase activity (GO:0004675);type I transforming growth factor beta receptor binding (GO:0034713);type III transforming growth factor beta receptor binding (GO:0034714);";"caveola (GO:0005901);cytosol (GO:0005829);external side of plasma membrane (GO:0009897);integral component of membrane (GO:0016021);plasma membrane (GO:0005886);receptor complex (GO:0043235);transforming growth factor beta receptor homodimeric complex (GO:0070022);";"3D-structure;Alternative splicing;Aortic aneurysm;Apoptosis;ATP-binding;Cell membrane;Complete proteome;Differentiation;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Growth regulation;Hereditary nonpolyposis colorectal cancer;Kinase;Magnesium;Manganese;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Serine/threonine-protein kinase;Signal;Transferase;Transmembrane;Transmembrane helix.;"
"AgU000074_v1.1";"1";"p2";"(AC)8";"16";4025;4040;"AgU000074";4371;"CD302_PIG";"GO:0005938 // GO:0030175 // GO:0016021 // GO:0030246";"No_GOBP";"carbohydrate binding (GO:0030246);";"cell cortex (GO:0005938);filopodium (GO:0030175);integral component of membrane (GO:0016021);";"Cell projection;Complete proteome;Cytoplasm;Disulfide bond;Glycoprotein;Lectin;Membrane;Receptor;Reference proteome;Signal;Transmembrane;Transmembrane helix.;"
"AgU000087_v1.1";"1";"p3";"(ATT)6";"18";3163;3180;"AgU000087";4270;"ITAV_BOVIN";"GO:0008305 // GO:0046872 // GO:0001618 // GO:0001568 // GO:0007155 // GO:0007229";"blood vessel development (GO:0001568);cell adhesion (GO:0007155);integrin-mediated signaling pathway (GO:0007229);";"metal ion binding (GO:0046872);virus receptor activity (GO:0001618);";"integrin complex (GO:0008305);";"Calcium;Cell adhesion;Cleavage on pair of basic residues;Complete proteome;Direct protein sequencing;Disulfide bond;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Integrin;Membrane;Metal-binding;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix.;"
"AgU000123_v1.1";"1";"p2";"(CT)5";"10";511;520;"AgU000123";3948;"NCKP1_HUMAN";"GO:0005829 // GO:0070062 // GO:0005925 // GO:0016021 // GO:0031258 // GO:0031209 // GO:0032403 // GO:0045176 // GO:0006915 // GO:0045175 // GO:0042074 // GO:0007417 // GO:0010172 // GO:0048617 // GO:0035050 // GO:0007492 // GO:0030950 // GO:0038096 // GO:0001701 // GO:0045087 // GO:0030032 // GO:0008078 // GO:0001843 // GO:0048570 // GO:0048340 // GO:2000601 // GO:0010592 // GO:0050821 // GO:0016601 // GO:0032880 // GO:0007264 // GO:0001756 // GO:0048010 // GO:0016032 // GO:0007354";"apical protein localization (GO:0045176);apoptotic process (GO:0006915);basal protein localization (GO:0045175);cell migration involved in gastrulation (GO:0042074);central nervous system development (GO:0007417);embryonic body morphogenesis (GO:0010172);embryonic foregut morphogenesis (GO:0048617);embryonic heart tube development (GO:0035050);endoderm development (GO:0007492);establishment or maintenance of actin cytoskeleton polarity (GO:0030950);Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096);in utero embryonic development (GO:0001701);innate immune response (GO:0045087);lamellipodium assembly (GO:0030032);mesodermal cell migration (GO:0008078);neural tube closure (GO:0001843);notochord morphogenesis (GO:0048570);paraxial mesoderm morphogenesis (GO:0048340);positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601);positive regulation of lamellipodium assembly (GO:0010592);protein stabilization (GO:0050821);Rac protein signal transduction (GO:0016601);regulation of protein localization (GO:0032880);small GTPase mediated signal transduction (GO:0007264);somitogenesis (GO:0001756);vascular endothelial growth factor receptor signaling pathway (GO:0048010);viral process (GO:0016032);zygotic determination of anterior/posterior axis, embryo (GO:0007354);";"protein complex binding (GO:0032403);";"cytosol (GO:0005829);extracellular exosome (GO:0070062);focal adhesion (GO:0005925);integral component of membrane (GO:0016021);lamellipodium membrane (GO:0031258);SCAR complex (GO:0031209);";"3D-structure;Acetylation;Alternative splicing;Cell membrane;Cell projection;Complete proteome;Host-virus interaction;Membrane;Reference proteome;Transmembrane;Transmembrane helix.;"
"AgU000160_v1.1";"1";"p2";"(TC)6";"12";2967;2978;"AgU000160";3730;"EMP2_BOVIN";"GO:0045177 // GO:0016324 // GO:0009986 // GO:0005737 // GO:0005794 // GO:0000139 // GO:0016021 // GO:0045121 // GO:0005634 // GO:0005886 // GO:0007015 // GO:0070252 // GO:0032147 // GO:0032060 // GO:0043534 // GO:0007155 // GO:0008219 // GO:0016477 // GO:0007160 // GO:0045022 // GO:0007566 // GO:0001765 // GO:0008284 // GO:0034394 // GO:0072659 // GO:0045765 // GO:0010594 // GO:0003093 // GO:0043549 // GO:2001212 // GO:0001913";"actin filament organization (GO:0007015);actin-mediated cell contraction (GO:0070252);activation of protein kinase activity (GO:0032147);bleb assembly (GO:0032060);blood vessel endothelial cell migration (GO:0043534);cell adhesion (GO:0007155);cell death (GO:0008219);cell migration (GO:0016477);cell-matrix adhesion (GO:0007160);early endosome to late endosome transport (GO:0045022);embryo implantation (GO:0007566);membrane raft assembly (GO:0001765);positive regulation of cell proliferation (GO:0008284);protein localization to cell surface (GO:0034394);protein localization to plasma membrane (GO:0072659);regulation of angiogenesis (GO:0045765);regulation of endothelial cell migration (GO:0010594);regulation of glomerular filtration (GO:0003093);regulation of kinase activity (GO:0043549);regulation of vasculogenesis (GO:2001212);T cell mediated cytotoxicity (GO:0001913);";"No_GOMF";"apical part of cell (GO:0045177);apical plasma membrane (GO:0016324);cell surface (GO:0009986);cytoplasm (GO:0005737);Golgi apparatus (GO:0005794);Golgi membrane (GO:0000139);integral component of membrane (GO:0016021);membrane raft (GO:0045121);nucleus (GO:0005634);plasma membrane (GO:0005886);";"Cell membrane;Complete proteome;Cytoplasm;Glycoprotein;Golgi apparatus;Membrane;Nucleus;Reference proteome;Transmembrane;Transmembrane helix.;"
"AgU000254_v1.1";"1";"p2";"(TC)13";"26";1338;1363;"AgU000254";3395;"CD44_CANLF";"GO:0016021 // GO:0005886 // GO:0005540 // GO:0007155";"cell adhesion (GO:0007155);";"hyaluronic acid binding (GO:0005540);";"integral component of membrane (GO:0016021);plasma membrane (GO:0005886);";"Cell adhesion;Cell membrane;Complete proteome;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Proteoglycan;Receptor;Reference proteome;Signal;Transmembrane;Transmembrane helix.;"
"AgU000356_v1.1";"1";"p2";"(GA)5";"10";1841;1850;"AgU000356";3166;"IL3RB_HUMAN";"GO:0030526 // GO:0005887 // GO:0005622 // GO:0005886 // GO:0004896 // GO:0004872 // GO:0000186 // GO:0007411 // GO:0044267 // GO:0036016 // GO:0007173 // GO:0038095 // GO:0008543 // GO:0045087 // GO:0008286 // GO:0038156 // GO:0038043 // GO:0000165 // GO:0048011 // GO:0007265 // GO:0007585 // GO:0007165 // GO:0007264 // GO:0048010";"activation of MAPKK activity (GO:0000186);axon guidance (GO:0007411);cellular protein metabolic process (GO:0044267);cellular response to interleukin-3 (GO:0036016);epidermal growth factor receptor signaling pathway (GO:0007173);Fc-epsilon receptor signaling pathway (GO:0038095);fibroblast growth factor receptor signaling pathway (GO:0008543);innate immune response (GO:0045087);insulin receptor signaling pathway (GO:0008286);interleukin-3-mediated signaling pathway (GO:0038156);interleukin-5-mediated signaling pathway (GO:0038043);MAPK cascade (GO:0000165);neurotrophin TRK receptor signaling pathway (GO:0048011);Ras protein signal transduction (GO:0007265);respiratory gaseous exchange (GO:0007585);signal transduction (GO:0007165);small GTPase mediated signal transduction (GO:0007264);vascular endothelial growth factor receptor signaling pathway (GO:0048010);";"cytokine receptor activity (GO:0004896);receptor activity (GO:0004872);";"granulocyte macrophage colony-stimulating factor receptor complex (GO:0030526);integral component of plasma membrane (GO:0005887);intracellular (GO:0005622);plasma membrane (GO:0005886);";"3D-structure;Alternative splicing;Complete proteome;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix.;"
"AgU000367_v1.1";"1";"p2";"(AC)5";"10";2501;2510;"AgU000367";3130;"PSA_HUMAN";"GO:0005829 // GO:0070062 // GO:0005634 // GO:0004177 // GO:0070006 // GO:0042277 // GO:0008270 // GO:0002474 // GO:0071456 // GO:0043171 // GO:1903955 // GO:0000209 // GO:0006508";"antigen processing and presentation of peptide antigen via MHC class I (GO:0002474);cellular response to hypoxia (GO:0071456);peptide catabolic process (GO:0043171);positive regulation of protein targeting to mitochondrion (GO:1903955);protein polyubiquitination (GO:0000209);proteolysis (GO:0006508);";"aminopeptidase activity (GO:0004177);metalloaminopeptidase activity (GO:0070006);peptide binding (GO:0042277);zinc ion binding (GO:0008270);";"cytosol (GO:0005829);extracellular exosome (GO:0070062);nucleus (GO:0005634);";"Alternative splicing;Aminopeptidase;Complete proteome;Cytoplasm;Direct protein sequencing;Hydrolase;Metal-binding;Metalloprotease;Nitration;Nucleus;Protease;Reference proteome;Zinc.;"
"AgU000376_v1.1";"2";"p3";"(CAG)5";"15";458;472;"AgU000376";3122;"EGR1_HUMAN";"GO:0005737 // GO:0005654 // GO:0005634 // GO:0003677 // GO:0035035 // GO:0046872 // GO:0000979 // GO:0000977 // GO:0043565 // GO:0003700 // GO:0000976 // GO:0001077 // GO:0030509 // GO:0071236 // GO:0071320 // GO:0035690 // GO:0071372 // GO:0071480 // GO:0071371 // GO:0071504 // GO:0071455 // GO:0032869 // GO:0071317 // GO:0071260 // GO:0071506 // GO:0071383 // GO:0007623 // GO:0019221 // GO:0072110 // GO:0070498 // GO:0007611 // GO:0060291 // GO:0043066 // GO:0090090 // GO:0000122 // GO:0048709 // GO:0072303 // GO:0043525 // GO:0045944 // GO:0045893 // GO:0048169 // GO:0033233 // GO:0061418 // GO:0001975 // GO:0034465 // GO:0042220 // GO:0051602 // GO:0045471 // GO:0009749 // GO:0071873 // GO:0031667 // GO:0035914 // GO:0030217 // GO:0006366 // GO:0060337";"BMP signaling pathway (GO:0030509);cellular response to antibiotic (GO:0071236);cellular response to cAMP (GO:0071320);cellular response to drug (GO:0035690);cellular response to follicle-stimulating hormone stimulus (GO:0071372);cellular response to gamma radiation (GO:0071480);cellular response to gonadotropin stimulus (GO:0071371);cellular response to heparin (GO:0071504);cellular response to hyperoxia (GO:0071455);cellular response to insulin stimulus (GO:0032869);cellular response to isoquinoline alkaloid (GO:0071317);cellular response to mechanical stimulus (GO:0071260);cellular response to mycophenolic acid (GO:0071506);cellular response to steroid hormone stimulus (GO:0071383);circadian rhythm (GO:0007623);cytokine-mediated signaling pathway (GO:0019221);glomerular mesangial cell proliferation (GO:0072110);interleukin-1-mediated signaling pathway (GO:0070498);learning or memory (GO:0007611);long-term synaptic potentiation (GO:0060291);negative regulation of apoptotic process (GO:0043066);negative regulation of canonical Wnt signaling pathway (GO:0090090);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);oligodendrocyte differentiation (GO:0048709);positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303);positive regulation of neuron apoptotic process (GO:0043525);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of transcription, DNA-templated (GO:0045893);regulation of long-term neuronal synaptic plasticity (GO:0048169);regulation of protein sumoylation (GO:0033233);regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418);response to amphetamine (GO:0001975);response to carbon monoxide (GO:0034465);response to cocaine (GO:0042220);response to electrical stimulus (GO:0051602);response to ethanol (GO:0045471);response to glucose (GO:0009749);response to norepinephrine (GO:0071873);response to nutrient levels (GO:0031667);skeletal muscle cell differentiation (GO:0035914);T cell differentiation (GO:0030217);transcription from RNA polymerase II promoter (GO:0006366);type I interferon signaling pathway (GO:0060337);";"DNA binding (GO:0003677);histone acetyltransferase binding (GO:0035035);metal ion binding (GO:0046872);RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979);RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977);sequence-specific DNA binding (GO:0043565);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription regulatory region sequence-specific DNA binding (GO:0000976);transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001077);";"cytoplasm (GO:0005737);nucleoplasm (GO:0005654);nucleus (GO:0005634);";"3D-structure;Activator;Complete proteome;DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger.;"
"AgU000376_v1.1";"3";"p3";"(CCT)5";"15";805;819;"AgU000376";3122;"EGR1_HUMAN";"GO:0005737 // GO:0005654 // GO:0005634 // GO:0003677 // GO:0035035 // GO:0046872 // GO:0000979 // GO:0000977 // GO:0043565 // GO:0003700 // GO:0000976 // GO:0001077 // GO:0030509 // GO:0071236 // GO:0071320 // GO:0035690 // GO:0071372 // GO:0071480 // GO:0071371 // GO:0071504 // GO:0071455 // GO:0032869 // GO:0071317 // GO:0071260 // GO:0071506 // GO:0071383 // GO:0007623 // GO:0019221 // GO:0072110 // GO:0070498 // GO:0007611 // GO:0060291 // GO:0043066 // GO:0090090 // GO:0000122 // GO:0048709 // GO:0072303 // GO:0043525 // GO:0045944 // GO:0045893 // GO:0048169 // GO:0033233 // GO:0061418 // GO:0001975 // GO:0034465 // GO:0042220 // GO:0051602 // GO:0045471 // GO:0009749 // GO:0071873 // GO:0031667 // GO:0035914 // GO:0030217 // GO:0006366 // GO:0060337";"BMP signaling pathway (GO:0030509);cellular response to antibiotic (GO:0071236);cellular response to cAMP (GO:0071320);cellular response to drug (GO:0035690);cellular response to follicle-stimulating hormone stimulus (GO:0071372);cellular response to gamma radiation (GO:0071480);cellular response to gonadotropin stimulus (GO:0071371);cellular response to heparin (GO:0071504);cellular response to hyperoxia (GO:0071455);cellular response to insulin stimulus (GO:0032869);cellular response to isoquinoline alkaloid (GO:0071317);cellular response to mechanical stimulus (GO:0071260);cellular response to mycophenolic acid (GO:0071506);cellular response to steroid hormone stimulus (GO:0071383);circadian rhythm (GO:0007623);cytokine-mediated signaling pathway (GO:0019221);glomerular mesangial cell proliferation (GO:0072110);interleukin-1-mediated signaling pathway (GO:0070498);learning or memory (GO:0007611);long-term synaptic potentiation (GO:0060291);negative regulation of apoptotic process (GO:0043066);negative regulation of canonical Wnt signaling pathway (GO:0090090);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);oligodendrocyte differentiation (GO:0048709);positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303);positive regulation of neuron apoptotic process (GO:0043525);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of transcription, DNA-templated (GO:0045893);regulation of long-term neuronal synaptic plasticity (GO:0048169);regulation of protein sumoylation (GO:0033233);regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418);response to amphetamine (GO:0001975);response to carbon monoxide (GO:0034465);response to cocaine (GO:0042220);response to electrical stimulus (GO:0051602);response to ethanol (GO:0045471);response to glucose (GO:0009749);response to norepinephrine (GO:0071873);response to nutrient levels (GO:0031667);skeletal muscle cell differentiation (GO:0035914);T cell differentiation (GO:0030217);transcription from RNA polymerase II promoter (GO:0006366);type I interferon signaling pathway (GO:0060337);";"DNA binding (GO:0003677);histone acetyltransferase binding (GO:0035035);metal ion binding (GO:0046872);RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979);RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977);sequence-specific DNA binding (GO:0043565);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription regulatory region sequence-specific DNA binding (GO:0000976);transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001077);";"cytoplasm (GO:0005737);nucleoplasm (GO:0005654);nucleus (GO:0005634);";"3D-structure;Activator;Complete proteome;DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger.;"
"AgU000386_v1.1";"1";"p2";"(TC)5";"10";1928;1937;"AgU000386";3093;"EZRI_HUMAN";"GO:0015629 // GO:0005884 // GO:0045177 // GO:0016324 // GO:0097449 // GO:0016323 // GO:0005903 // GO:0044297 // GO:0071944 // GO:0042995 // GO:0051286 // GO:0036064 // GO:0030863 // GO:0005737 // GO:0098592 // GO:0005829 // GO:0005768 // GO:0070062 // GO:0005615 // GO:0019898 // GO:0030175 // GO:0005925 // GO:0001772 // GO:0016020 // GO:0044393 // GO:0005902 // GO:0031528 // GO:0043209 // GO:0005730 // GO:0048471 // GO:0005886 // GO:0044853 // GO:0001726 // GO:0032587 // GO:0097454 // GO:0030315 // GO:0001931 // GO:0031982 // GO:0003779 // GO:0051015 // GO:0051117 // GO:0050839 // GO:0008017 // GO:0044822 // GO:0019904 // GO:0034236 // GO:0034237 // GO:0044548 // GO:0031532 // GO:0051017 // GO:0030953 // GO:0007411 // GO:0034629 // GO:0071320 // GO:0043622 // GO:0007016 // GO:0051660 // GO:0061028 // GO:0090002 // GO:0035088 // GO:0046847 // GO:0001951 // GO:0007159 // GO:0022614 // GO:0030033 // GO:0070373 // GO:1900041 // GO:1903753 // GO:0050860 // GO:0000122 // GO:0048015 // GO:1903364 // GO:2000643 // GO:0090004 // GO:0010628 // GO:0040018 // GO:1902966 // GO:0050714 // GO:0010737 // GO:0072697 // GO:0031623 // GO:0008360 // GO:0032532 // GO:1902115 // GO:0003376 // GO:1902896";"actin cytoskeleton reorganization (GO:0031532);actin filament bundle assembly (GO:0051017);astral microtubule organization (GO:0030953);axon guidance (GO:0007411);cellular protein complex localization (GO:0034629);cellular response to cAMP (GO:0071320);cortical microtubule organization (GO:0043622);cytoskeletal anchoring at plasma membrane (GO:0007016);establishment of centrosome localization (GO:0051660);establishment of endothelial barrier (GO:0061028);establishment of protein localization to plasma membrane (GO:0090002);establishment or maintenance of apical/basal cell polarity (GO:0035088);filopodium assembly (GO:0046847);intestinal D-glucose absorption (GO:0001951);leukocyte cell-cell adhesion (GO:0007159);membrane to membrane docking (GO:0022614);microvillus assembly (GO:0030033);negative regulation of ERK1 and ERK2 cascade (GO:0070373);negative regulation of interleukin-2 secretion (GO:1900041);negative regulation of p38MAPK cascade (GO:1903753);negative regulation of T cell receptor signaling pathway (GO:0050860);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);phosphatidylinositol-mediated signaling (GO:0048015);positive regulation of cellular protein catabolic process (GO:1903364);positive regulation of early endosome to late endosome transport (GO:2000643);positive regulation of establishment of protein localization to plasma membrane (GO:0090004);positive regulation of gene expression (GO:0010628);positive regulation of multicellular organism growth (GO:0040018);positive regulation of protein localization to early endosome (GO:1902966);positive regulation of protein secretion (GO:0050714);protein kinase A signaling (GO:0010737);protein localization to cell cortex (GO:0072697);receptor internalization (GO:0031623);regulation of cell shape (GO:0008360);regulation of microvillus length (GO:0032532);regulation of organelle assembly (GO:1902115);sphingosine-1-phosphate signaling pathway (GO:0003376);terminal web assembly (GO:1902896);";"actin binding (GO:0003779);actin filament binding (GO:0051015);ATPase binding (GO:0051117);cell adhesion molecule binding (GO:0050839);microtubule binding (GO:0008017);poly(A) RNA binding (GO:0044822);protein domain specific binding (GO:0019904);protein kinase A catalytic subunit binding (GO:0034236);protein kinase A regulatory subunit binding (GO:0034237);S100 protein binding (GO:0044548);";"actin cytoskeleton (GO:0015629);actin filament (GO:0005884);apical part of cell (GO:0045177);apical plasma membrane (GO:0016324);astrocyte projection (GO:0097449);basolateral plasma membrane (GO:0016323);brush border (GO:0005903);cell body (GO:0044297);cell periphery (GO:0071944);cell projection (GO:0042995);cell tip (GO:0051286);ciliary basal body (GO:0036064);cortical cytoskeleton (GO:0030863);cytoplasm (GO:0005737);cytoplasmic side of apical plasma membrane (GO:0098592);cytosol (GO:0005829);endosome (GO:0005768);extracellular exosome (GO:0070062);extracellular space (GO:0005615);extrinsic component of membrane (GO:0019898);filopodium (GO:0030175);focal adhesion (GO:0005925);immunological synapse (GO:0001772);membrane (GO:0016020);microspike (GO:0044393);microvillus (GO:0005902);microvillus membrane (GO:0031528);myelin sheath (GO:0043209);nucleolus (GO:0005730);perinuclear region of cytoplasm (GO:0048471);plasma membrane (GO:0005886);plasma membrane raft (GO:0044853);ruffle (GO:0001726);ruffle membrane (GO:0032587);Schwann cell microvillus (GO:0097454);T-tubule (GO:0030315);uropod (GO:0001931);vesicle (GO:0031982);";"3D-structure;Acetylation;Cell membrane;Cell projection;Cell shape;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Membrane;Phosphoprotein;Polymorphism;Reference proteome;S-nitrosylation.;"
"AgU000395_v1.1";"1";"p3";"(CAG)5";"15";593;607;"AgU000395";3088;"TISD_HUMAN";"GO:0005737 // GO:0005634 // GO:0017091 // GO:0003677 // GO:0046872 // GO:0035925 // GO:0044822 // GO:0003700 // GO:0008283 // GO:0060216 // GO:0030097 // GO:0006402 // GO:2000737 // GO:0000288 // GO:1900153 // GO:0043488 // GO:0006355 // GO:0048103 // GO:0035019 // GO:0033077";"cell proliferation (GO:0008283);definitive hemopoiesis (GO:0060216);hemopoiesis (GO:0030097);mRNA catabolic process (GO:0006402);negative regulation of stem cell differentiation (GO:2000737);nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288);positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153);regulation of mRNA stability (GO:0043488);regulation of transcription, DNA-templated (GO:0006355);somatic stem cell division (GO:0048103);somatic stem cell population maintenance (GO:0035019);T cell differentiation in thymus (GO:0033077);";"AU-rich element binding (GO:0017091);DNA binding (GO:0003677);metal ion binding (GO:0046872);mRNA 3'-UTR AU-rich region binding (GO:0035925);poly(A) RNA binding (GO:0044822);transcription factor activity, sequence-specific DNA binding (GO:0003700);";"cytoplasm (GO:0005737);nucleus (GO:0005634);";"3D-structure;Complete proteome;Cytoplasm;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;RNA-binding;Zinc;Zinc-finger.;"
"AgU000395_v1.1";"2";"p3";"(CGC)5";"15";1044;1058;"AgU000395";3088;"TISD_HUMAN";"GO:0005737 // GO:0005634 // GO:0017091 // GO:0003677 // GO:0046872 // GO:0035925 // GO:0044822 // GO:0003700 // GO:0008283 // GO:0060216 // GO:0030097 // GO:0006402 // GO:2000737 // GO:0000288 // GO:1900153 // GO:0043488 // GO:0006355 // GO:0048103 // GO:0035019 // GO:0033077";"cell proliferation (GO:0008283);definitive hemopoiesis (GO:0060216);hemopoiesis (GO:0030097);mRNA catabolic process (GO:0006402);negative regulation of stem cell differentiation (GO:2000737);nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288);positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153);regulation of mRNA stability (GO:0043488);regulation of transcription, DNA-templated (GO:0006355);somatic stem cell division (GO:0048103);somatic stem cell population maintenance (GO:0035019);T cell differentiation in thymus (GO:0033077);";"AU-rich element binding (GO:0017091);DNA binding (GO:0003677);metal ion binding (GO:0046872);mRNA 3'-UTR AU-rich region binding (GO:0035925);poly(A) RNA binding (GO:0044822);transcription factor activity, sequence-specific DNA binding (GO:0003700);";"cytoplasm (GO:0005737);nucleus (GO:0005634);";"3D-structure;Complete proteome;Cytoplasm;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;RNA-binding;Zinc;Zinc-finger.;"
"AgU000395_v1.1";"3";"p3";"(AAC)5";"15";2333;2347;"AgU000395";3088;"TISD_HUMAN";"GO:0005737 // GO:0005634 // GO:0017091 // GO:0003677 // GO:0046872 // GO:0035925 // GO:0044822 // GO:0003700 // GO:0008283 // GO:0060216 // GO:0030097 // GO:0006402 // GO:2000737 // GO:0000288 // GO:1900153 // GO:0043488 // GO:0006355 // GO:0048103 // GO:0035019 // GO:0033077";"cell proliferation (GO:0008283);definitive hemopoiesis (GO:0060216);hemopoiesis (GO:0030097);mRNA catabolic process (GO:0006402);negative regulation of stem cell differentiation (GO:2000737);nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288);positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153);regulation of mRNA stability (GO:0043488);regulation of transcription, DNA-templated (GO:0006355);somatic stem cell division (GO:0048103);somatic stem cell population maintenance (GO:0035019);T cell differentiation in thymus (GO:0033077);";"AU-rich element binding (GO:0017091);DNA binding (GO:0003677);metal ion binding (GO:0046872);mRNA 3'-UTR AU-rich region binding (GO:0035925);poly(A) RNA binding (GO:0044822);transcription factor activity, sequence-specific DNA binding (GO:0003700);";"cytoplasm (GO:0005737);nucleus (GO:0005634);";"3D-structure;Complete proteome;Cytoplasm;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;RNA-binding;Zinc;Zinc-finger.;"
"AgU000416_v1.1";"1";"p2";"(AC)5";"10";2494;2503;"AgU000416";3034;"RAB5B_PONAB";"GO:0031901 // GO:0030139 // GO:0070062 // GO:0042470 // GO:0005886 // GO:0019003 // GO:0005525 // GO:0019882 // GO:0007032 // GO:0048227 // GO:0015031 // GO:0030100 // GO:0007264";"antigen processing and presentation (GO:0019882);endosome organization (GO:0007032);plasma membrane to endosome transport (GO:0048227);protein transport (GO:0015031);regulation of endocytosis (GO:0030100);small GTPase mediated signal transduction (GO:0007264);";"GDP binding (GO:0019003);GTP binding (GO:0005525);";"early endosome membrane (GO:0031901);endocytic vesicle (GO:0030139);extracellular exosome (GO:0070062);melanosome (GO:0042470);plasma membrane (GO:0005886);";"Acetylation;Cell membrane;Complete proteome;Endosome;GTP-binding;Lipoprotein;Membrane;Nucleotide-binding;Prenylation;Protein transport;Reference proteome;Transport.;"
"AgU000523_v1.1";"1";"p3";"(GCG)7";"21";2676;2696;"AgU000523";2865;"MAPK2_HUMAN";"GO:0005813 // GO:0005737 // GO:0005829 // GO:0070062 // GO:0005654 // GO:0005634 // GO:0005524 // GO:0009931 // GO:0005516 // GO:0004683 // GO:0051019 // GO:0004672 // GO:0004674 // GO:0004871 // GO:0070935 // GO:0000187 // GO:0019369 // GO:0006974 // GO:0034605 // GO:0035924 // GO:0031572 // GO:0010467 // GO:0006954 // GO:0045087 // GO:0048839 // GO:0006691 // GO:0044351 // GO:0000165 // GO:0002755 // GO:0002756 // GO:0048011 // GO:0038066 // GO:0018105 // GO:0042535 // GO:0046777 // GO:0006468 // GO:0007265 // GO:1900034 // GO:0032675 // GO:0043488 // GO:0032680 // GO:0034097 // GO:0032496 // GO:0006950 // GO:0044281 // GO:0051403 // GO:0034166 // GO:0034134 // GO:0034138 // GO:0034142 // GO:0034146 // GO:0034162 // GO:0002224 // GO:0038123 // GO:0038124 // GO:0035666 // GO:0048010";"3'-UTR-mediated mRNA stabilization (GO:0070935);activation of MAPK activity (GO:0000187);arachidonic acid metabolic process (GO:0019369);cellular response to DNA damage stimulus (GO:0006974);cellular response to heat (GO:0034605);cellular response to vascular endothelial growth factor stimulus (GO:0035924);G2 DNA damage checkpoint (GO:0031572);gene expression (GO:0010467);inflammatory response (GO:0006954);innate immune response (GO:0045087);inner ear development (GO:0048839);leukotriene metabolic process (GO:0006691);macropinocytosis (GO:0044351);MAPK cascade (GO:0000165);MyD88-dependent toll-like receptor signaling pathway (GO:0002755);MyD88-independent toll-like receptor signaling pathway (GO:0002756);neurotrophin TRK receptor signaling pathway (GO:0048011);p38MAPK cascade (GO:0038066);peptidyl-serine phosphorylation (GO:0018105);positive regulation of tumor necrosis factor biosynthetic process (GO:0042535);protein autophosphorylation (GO:0046777);protein phosphorylation (GO:0006468);Ras protein signal transduction (GO:0007265);regulation of cellular response to heat (GO:1900034);regulation of interleukin-6 production (GO:0032675);regulation of mRNA stability (GO:0043488);regulation of tumor necrosis factor production (GO:0032680);response to cytokine (GO:0034097);response to lipopolysaccharide (GO:0032496);response to stress (GO:0006950);small molecule metabolic process (GO:0044281);stress-activated MAPK cascade (GO:0051403);toll-like receptor 10 signaling pathway (GO:0034166);toll-like receptor 2 signaling pathway (GO:0034134);toll-like receptor 3 signaling pathway (GO:0034138);toll-like receptor 4 signaling pathway (GO:0034142);toll-like receptor 5 signaling pathway (GO:0034146);toll-like receptor 9 signaling pathway (GO:0034162);toll-like receptor signaling pathway (GO:0002224);toll-like receptor TLR1 (GO:0038123);toll-like receptor TLR6 (GO:0038124);TRIF-dependent toll-like receptor signaling pathway (GO:0035666);vascular endothelial growth factor receptor signaling pathway (GO:0048010);";"ATP binding (GO:0005524);calcium-dependent protein serine/threonine kinase activity (GO:0009931);calmodulin binding (GO:0005516);calmodulin-dependent protein kinase activity (GO:0004683);mitogen-activated protein kinase binding (GO:0051019);protein kinase activity (GO:0004672);protein serine/threonine kinase activity (GO:0004674);signal transducer activity (GO:0004871);";"centrosome (GO:0005813);cytoplasm (GO:0005737);cytosol (GO:0005829);extracellular exosome (GO:0070062);nucleoplasm (GO:0005654);nucleus (GO:0005634);";"3D-structure;Alternative splicing;ATP-binding;Complete proteome;Cytoplasm;DNA damage;Isopeptide bond;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation.;"
"AgU000542_v1.1";"1";"p2";"(AG)5";"10";662;671;"AgU000542";2846;"ERBB3_HUMAN";"GO:0016324 // GO:0016323 // GO:0005615 // GO:0005887 // GO:0005622 // GO:0016328 // GO:0005886 // GO:0043235 // GO:0005524 // GO:0019838 // GO:0042802 // GO:0046982 // GO:0042803 // GO:0004672 // GO:0030296 // GO:0004888 // GO:0000186 // GO:0007411 // GO:0021545 // GO:0003197 // GO:0007173 // GO:0097192 // GO:0038095 // GO:0008543 // GO:0007507 // GO:0045087 // GO:0008286 // GO:0000165 // GO:0007162 // GO:0043524 // GO:0051048 // GO:0009968 // GO:0051402 // GO:0048011 // GO:0007422 // GO:0014065 // GO:0048015 // GO:0070886 // GO:0014068 // GO:0061098 // GO:0007265 // GO:0042127 // GO:0014037 // GO:0007165 // GO:0007264 // GO:0007169 // GO:0048010 // GO:0042060";"activation of MAPKK activity (GO:0000186);axon guidance (GO:0007411);cranial nerve development (GO:0021545);endocardial cushion development (GO:0003197);epidermal growth factor receptor signaling pathway (GO:0007173);extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192);Fc-epsilon receptor signaling pathway (GO:0038095);fibroblast growth factor receptor signaling pathway (GO:0008543);heart development (GO:0007507);innate immune response (GO:0045087);insulin receptor signaling pathway (GO:0008286);MAPK cascade (GO:0000165);negative regulation of cell adhesion (GO:0007162);negative regulation of neuron apoptotic process (GO:0043524);negative regulation of secretion (GO:0051048);negative regulation of signal transduction (GO:0009968);neuron apoptotic process (GO:0051402);neurotrophin TRK receptor signaling pathway (GO:0048011);peripheral nervous system development (GO:0007422);phosphatidylinositol 3-kinase signaling (GO:0014065);phosphatidylinositol-mediated signaling (GO:0048015);positive regulation of calcineurin-NFAT signaling cascade (GO:0070886);positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068);positive regulation of protein tyrosine kinase activity (GO:0061098);Ras protein signal transduction (GO:0007265);regulation of cell proliferation (GO:0042127);Schwann cell differentiation (GO:0014037);signal transduction (GO:0007165);small GTPase mediated signal transduction (GO:0007264);transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169);vascular endothelial growth factor receptor signaling pathway (GO:0048010);wound healing (GO:0042060);";"ATP binding (GO:0005524);growth factor binding (GO:0019838);identical protein binding (GO:0042802);protein heterodimerization activity (GO:0046982);protein homodimerization activity (GO:0042803);protein kinase activity (GO:0004672);protein tyrosine kinase activator activity (GO:0030296);transmembrane signaling receptor activity (GO:0004888);";"apical plasma membrane (GO:0016324);basolateral plasma membrane (GO:0016323);extracellular space (GO:0005615);integral component of plasma membrane (GO:0005887);intracellular (GO:0005622);lateral plasma membrane (GO:0016328);plasma membrane (GO:0005886);receptor complex (GO:0043235);";"3D-structure;Alternative splicing;ATP-binding;Cell membrane;Complete proteome;Disulfide bond;Glycoprotein;Kinase;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Secreted;Signal;Transferase;Transmembrane;Transmembrane helix;Tyrosine-protein kinase.;"
"AgU000543_v1.1";"1";"p2";"(TG)7";"14";1250;1263;"AgU000543";2838;"G9L1E5_MUSPF";"GO:0016020 // GO:0005730 // GO:0005654 // GO:0003682 // GO:0001047 // GO:0004872 // GO:0000981 // GO:0030375 // GO:0006702 // GO:0030521 // GO:0001525 // GO:0007420 // GO:0000902 // GO:0071364 // GO:0035729 // GO:0071383 // GO:0097067 // GO:0035050 // GO:0035162 // GO:0035116 // GO:0001892 // GO:0048822 // GO:0060750 // GO:0070371 // GO:0045444 // GO:0030216 // GO:0007595 // GO:0002088 // GO:0001889 // GO:0060745 // GO:0060744 // GO:0035855 // GO:0030224 // GO:0042789 // GO:0043066 // GO:0010839 // GO:0045665 // GO:0000122 // GO:0031100 // GO:0035357 // GO:0045648 // GO:0070318 // GO:2000347 // GO:0060335 // GO:0033148 // GO:0045618 // GO:0033601 // GO:0033160 // GO:0045944 // GO:0006356 // GO:0070562 // GO:0003406 // GO:0006590 // GO:0002154 // GO:0006367 // GO:0003222";"androgen biosynthetic process (GO:0006702);androgen receptor signaling pathway (GO:0030521);angiogenesis (GO:0001525);brain development (GO:0007420);cell morphogenesis (GO:0000902);cellular response to epidermal growth factor stimulus (GO:0071364);cellular response to hepatocyte growth factor stimulus (GO:0035729);cellular response to steroid hormone stimulus (GO:0071383);cellular response to thyroid hormone stimulus (GO:0097067);embryonic heart tube development (GO:0035050);embryonic hemopoiesis (GO:0035162);embryonic hindlimb morphogenesis (GO:0035116);embryonic placenta development (GO:0001892);enucleate erythrocyte development (GO:0048822);epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750);ERK1 and ERK2 cascade (GO:0070371);fat cell differentiation (GO:0045444);keratinocyte differentiation (GO:0030216);lactation (GO:0007595);lens development in camera-type eye (GO:0002088);liver development (GO:0001889);mammary gland branching involved in pregnancy (GO:0060745);mammary gland branching involved in thelarche (GO:0060744);megakaryocyte development (GO:0035855);monocyte differentiation (GO:0030224);mRNA transcription from RNA polymerase II promoter (GO:0042789);negative regulation of apoptotic process (GO:0043066);negative regulation of keratinocyte proliferation (GO:0010839);negative regulation of neuron differentiation (GO:0045665);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);organ regeneration (GO:0031100);peroxisome proliferator activated receptor signaling pathway (GO:0035357);positive regulation of erythrocyte differentiation (GO:0045648);positive regulation of G0 to G1 transition (GO:0070318);positive regulation of hepatocyte proliferation (GO:2000347);positive regulation of interferon-gamma-mediated signaling pathway (GO:0060335);positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148);positive regulation of keratinocyte differentiation (GO:0045618);positive regulation of mammary gland epithelial cell proliferation (GO:0033601);positive regulation of protein import into nucleus, translocation (GO:0033160);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);regulation of transcription from RNA polymerase I promoter (GO:0006356);regulation of vitamin D receptor signaling pathway (GO:0070562);retinal pigment epithelium development (GO:0003406);thyroid hormone generation (GO:0006590);thyroid hormone mediated signaling pathway (GO:0002154);transcription initiation from RNA polymerase II promoter (GO:0006367);ventricular trabecula myocardium morphogenesis (GO:0003222);";"chromatin binding (GO:0003682);core promoter binding (GO:0001047);receptor activity (GO:0004872);RNA polymerase II transcription factor activity, sequence-specific DNA binding (GO:0000981);thyroid hormone receptor coactivator activity (GO:0030375);";"membrane (GO:0016020);nucleolus (GO:0005730);nucleoplasm (GO:0005654);";"Receptor {ECO:0000313|EMBL:AES10974.1}.;"
"AgU000568_v1.1";"1";"p2";"(CT)7";"14";1660;1673;"AgU000568";2812;"IL33_CANLF";"GO:0005694 // GO:0005615 // GO:0005634 // GO:0030133 // GO:0006351";"transcription, DNA-templated (GO:0006351);";"No_GOMF";"chromosome (GO:0005694);extracellular space (GO:0005615);nucleus (GO:0005634);transport vesicle (GO:0030133);";"Chromosome;Complete proteome;Cytokine;Cytoplasmic vesicle;Nucleus;Reference proteome;Secreted;Transcription.;"
"AgU000696_v1.1";"1";"p2";"(CG)5";"10";2544;2553;"AgU000696";2674;"SOCS3_HUMAN";"GO:0005737 // GO:0005829 // GO:0004860 // GO:0007568 // GO:0060670 // GO:0019221 // GO:0060333 // GO:0007259 // GO:0060397 // GO:0043066 // GO:1904030 // GO:0050728 // GO:0046627 // GO:0046426 // GO:0031100 // GO:0060674 // GO:0045597 // GO:0016567 // GO:0040008 // GO:0060334 // GO:0060338 // GO:0042493 // GO:0032355 // GO:0032094 // GO:0010332 // GO:0051384 // GO:0009408 // GO:0001666 // GO:0032868 // GO:0032496 // GO:0032570 // GO:0060708 // GO:0060707 // GO:0060337";"aging (GO:0007568);branching involved in labyrinthine layer morphogenesis (GO:0060670);cytokine-mediated signaling pathway (GO:0019221);interferon-gamma-mediated signaling pathway (GO:0060333);JAK-STAT cascade (GO:0007259);JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397);negative regulation of apoptotic process (GO:0043066);negative regulation of cyclin-dependent protein kinase activity (GO:1904030);negative regulation of inflammatory response (GO:0050728);negative regulation of insulin receptor signaling pathway (GO:0046627);negative regulation of JAK-STAT cascade (GO:0046426);organ regeneration (GO:0031100);placenta blood vessel development (GO:0060674);positive regulation of cell differentiation (GO:0045597);protein ubiquitination (GO:0016567);regulation of growth (GO:0040008);regulation of interferon-gamma-mediated signaling pathway (GO:0060334);regulation of type I interferon-mediated signaling pathway (GO:0060338);response to drug (GO:0042493);response to estradiol (GO:0032355);response to food (GO:0032094);response to gamma radiation (GO:0010332);response to glucocorticoid (GO:0051384);response to heat (GO:0009408);response to hypoxia (GO:0001666);response to insulin (GO:0032868);response to lipopolysaccharide (GO:0032496);response to progesterone (GO:0032570);spongiotrophoblast differentiation (GO:0060708);trophoblast giant cell differentiation (GO:0060707);type I interferon signaling pathway (GO:0060337);";"protein kinase inhibitor activity (GO:0004860);";"cytoplasm (GO:0005737);cytosol (GO:0005829);";"Complete proteome;Growth regulation;Pharmaceutical;Phosphoprotein;Polymorphism;Reference proteome;SH2 domain;Signal transduction inhibitor;Ubl conjugation pathway.;"
"AgU000706_v1.1";"1";"p2";"(GT)15";"30";1718;1747;"AgU000706";2654;"PTPRJ_HUMAN";"GO:0009986 // GO:0005911 // GO:0070062 // GO:0001772 // GO:0005887 // GO:0005886 // GO:0032587 // GO:0008013 // GO:0070097 // GO:0045295 // GO:0051019 // GO:0016791 // GO:0005161 // GO:0019901 // GO:0004725 // GO:0060242 // GO:0007507 // GO:0030308 // GO:0030336 // GO:0008285 // GO:0042059 // GO:0043407 // GO:0010642 // GO:0051898 // GO:0050860 // GO:0043116 // GO:0048709 // GO:0035335 // GO:0048008 // GO:0050918 // GO:0045785 // GO:0051894 // GO:0051897 // GO:0030155 // GO:0050852 // GO:0001570";"contact inhibition (GO:0060242);heart development (GO:0007507);negative regulation of cell growth (GO:0030308);negative regulation of cell migration (GO:0030336);negative regulation of cell proliferation (GO:0008285);negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059);negative regulation of MAP kinase activity (GO:0043407);negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642);negative regulation of protein kinase B signaling (GO:0051898);negative regulation of T cell receptor signaling pathway (GO:0050860);negative regulation of vascular permeability (GO:0043116);oligodendrocyte differentiation (GO:0048709);peptidyl-tyrosine dephosphorylation (GO:0035335);platelet-derived growth factor receptor signaling pathway (GO:0048008);positive chemotaxis (GO:0050918);positive regulation of cell adhesion (GO:0045785);positive regulation of focal adhesion assembly (GO:0051894);positive regulation of protein kinase B signaling (GO:0051897);regulation of cell adhesion (GO:0030155);T cell receptor signaling pathway (GO:0050852);vasculogenesis (GO:0001570);";"beta-catenin binding (GO:0008013);delta-catenin binding (GO:0070097);gamma-catenin binding (GO:0045295);mitogen-activated protein kinase binding (GO:0051019);phosphatase activity (GO:0016791);platelet-derived growth factor receptor binding (GO:0005161);protein kinase binding (GO:0019901);protein tyrosine phosphatase activity (GO:0004725);";"cell surface (GO:0009986);cell-cell junction (GO:0005911);extracellular exosome (GO:0070062);immunological synapse (GO:0001772);integral component of plasma membrane (GO:0005887);plasma membrane (GO:0005886);ruffle membrane (GO:0032587);";"3D-structure;Alternative splicing;Cell junction;Cell membrane;Cell projection;Complete proteome;Direct protein sequencing;Glycoprotein;Hydrolase;Membrane;Polymorphism;Protein phosphatase;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix.;"
"AgU000706_v1.1";"2";"p2";"(TA)6";"12";1865;1876;"AgU000706";2654;"PTPRJ_HUMAN";"GO:0009986 // GO:0005911 // GO:0070062 // GO:0001772 // GO:0005887 // GO:0005886 // GO:0032587 // GO:0008013 // GO:0070097 // GO:0045295 // GO:0051019 // GO:0016791 // GO:0005161 // GO:0019901 // GO:0004725 // GO:0060242 // GO:0007507 // GO:0030308 // GO:0030336 // GO:0008285 // GO:0042059 // GO:0043407 // GO:0010642 // GO:0051898 // GO:0050860 // GO:0043116 // GO:0048709 // GO:0035335 // GO:0048008 // GO:0050918 // GO:0045785 // GO:0051894 // GO:0051897 // GO:0030155 // GO:0050852 // GO:0001570";"contact inhibition (GO:0060242);heart development (GO:0007507);negative regulation of cell growth (GO:0030308);negative regulation of cell migration (GO:0030336);negative regulation of cell proliferation (GO:0008285);negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059);negative regulation of MAP kinase activity (GO:0043407);negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642);negative regulation of protein kinase B signaling (GO:0051898);negative regulation of T cell receptor signaling pathway (GO:0050860);negative regulation of vascular permeability (GO:0043116);oligodendrocyte differentiation (GO:0048709);peptidyl-tyrosine dephosphorylation (GO:0035335);platelet-derived growth factor receptor signaling pathway (GO:0048008);positive chemotaxis (GO:0050918);positive regulation of cell adhesion (GO:0045785);positive regulation of focal adhesion assembly (GO:0051894);positive regulation of protein kinase B signaling (GO:0051897);regulation of cell adhesion (GO:0030155);T cell receptor signaling pathway (GO:0050852);vasculogenesis (GO:0001570);";"beta-catenin binding (GO:0008013);delta-catenin binding (GO:0070097);gamma-catenin binding (GO:0045295);mitogen-activated protein kinase binding (GO:0051019);phosphatase activity (GO:0016791);platelet-derived growth factor receptor binding (GO:0005161);protein kinase binding (GO:0019901);protein tyrosine phosphatase activity (GO:0004725);";"cell surface (GO:0009986);cell-cell junction (GO:0005911);extracellular exosome (GO:0070062);immunological synapse (GO:0001772);integral component of plasma membrane (GO:0005887);plasma membrane (GO:0005886);ruffle membrane (GO:0032587);";"3D-structure;Alternative splicing;Cell junction;Cell membrane;Cell projection;Complete proteome;Direct protein sequencing;Glycoprotein;Hydrolase;Membrane;Polymorphism;Protein phosphatase;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix.;"
"AgU000892_v1.1";"1";"p2";"(CA)6";"12";1013;1024;"AgU000892";2472;"SDCB1_HUMAN";"GO:0005912 // GO:0072562 // GO:0005737 // GO:0005856 // GO:0005829 // GO:0005789 // GO:0070062 // GO:0005615 // GO:1903561 // GO:0005925 // GO:0005895 // GO:0042470 // GO:0016020 // GO:0005634 // GO:0005886 // GO:0008093 // GO:0005109 // GO:0042802 // GO:0005137 // GO:0046982 // GO:0047485 // GO:0045545 // GO:0030036 // GO:0007411 // GO:0048013 // GO:0035556 // GO:1903543 // GO:1903553 // GO:0046330 // GO:0042327 // GO:0006612 // GO:0007265 // GO:0006930 // GO:0007268";"actin cytoskeleton organization (GO:0030036);axon guidance (GO:0007411);ephrin receptor signaling pathway (GO:0048013);intracellular signal transduction (GO:0035556);positive regulation of exosomal secretion (GO:1903543);positive regulation of extracellular exosome assembly (GO:1903553);positive regulation of JNK cascade (GO:0046330);positive regulation of phosphorylation (GO:0042327);protein targeting to membrane (GO:0006612);Ras protein signal transduction (GO:0007265);substrate-dependent cell migration, cell extension (GO:0006930);synaptic transmission (GO:0007268);";"cytoskeletal adaptor activity (GO:0008093);frizzled binding (GO:0005109);identical protein binding (GO:0042802);interleukin-5 receptor binding (GO:0005137);protein heterodimerization activity (GO:0046982);protein N-terminus binding (GO:0047485);syndecan binding (GO:0045545);";"adherens junction (GO:0005912);blood microparticle (GO:0072562);cytoplasm (GO:0005737);cytoskeleton (GO:0005856);cytosol (GO:0005829);endoplasmic reticulum membrane (GO:0005789);extracellular exosome (GO:0070062);extracellular space (GO:0005615);extracellular vesicle (GO:1903561);focal adhesion (GO:0005925);interleukin-5 receptor complex (GO:0005895);melanosome (GO:0042470);membrane (GO:0016020);nucleus (GO:0005634);plasma membrane (GO:0005886);";"3D-structure;Acetylation;Alternative splicing;Cell junction;Cell membrane;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Endoplasmic reticulum;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat.;"
"AgU000895_v1.1";"1";"p3";"(GAT)5";"15";1865;1879;"AgU000895";2467;"VAMP7_HUMAN";"GO:0035577 // GO:0030054 // GO:0005737 // GO:0005789 // GO:0070062 // GO:0016021 // GO:0043231 // GO:0030027 // GO:0031902 // GO:0005765 // GO:0016020 // GO:0043005 // GO:0045335 // GO:0030670 // GO:0005886 // GO:0031091 // GO:0031143 // GO:0030141 // GO:0030667 // GO:0031201 // GO:0045202 // GO:0005802 // GO:0030658 // GO:0005484 // GO:0000149 // GO:0017156 // GO:0008333 // GO:0043308 // GO:0006888 // GO:0061024 // GO:0043320 // GO:0043312 // GO:0006911 // GO:1903595 // GO:0006892 // GO:0015031 // GO:0006906 // GO:0016192";"calcium ion-dependent exocytosis (GO:0017156);endosome to lysosome transport (GO:0008333);eosinophil degranulation (GO:0043308);ER to Golgi vesicle-mediated transport (GO:0006888);membrane organization (GO:0061024);natural killer cell degranulation (GO:0043320);neutrophil degranulation (GO:0043312);phagocytosis, engulfment (GO:0006911);positive regulation of histamine secretion by mast cell (GO:1903595);post-Golgi vesicle-mediated transport (GO:0006892);protein transport (GO:0015031);vesicle fusion (GO:0006906);vesicle-mediated transport (GO:0016192);";"SNAP receptor activity (GO:0005484);SNARE binding (GO:0000149);";"azurophil granule membrane (GO:0035577);cell junction (GO:0030054);cytoplasm (GO:0005737);endoplasmic reticulum membrane (GO:0005789);extracellular exosome (GO:0070062);integral component of membrane (GO:0016021);intracellular membrane-bounded organelle (GO:0043231);lamellipodium (GO:0030027);late endosome membrane (GO:0031902);lysosomal membrane (GO:0005765);membrane (GO:0016020);neuron projection (GO:0043005);phagocytic vesicle (GO:0045335);phagocytic vesicle membrane (GO:0030670);plasma membrane (GO:0005886);platelet alpha granule (GO:0031091);pseudopodium (GO:0031143);secretory granule (GO:0030141);secretory granule membrane (GO:0030667);SNARE complex (GO:0031201);synapse (GO:0045202);trans-Golgi network (GO:0005802);transport vesicle membrane (GO:0030658);";"3D-structure;Acetylation;Alternative splicing;Cell junction;Coiled coil;Complete proteome;Cytoplasmic vesicle;Direct protein sequencing;Endoplasmic reticulum;Endosome;Exocytosis;Golgi apparatus;Lysosome;Membrane;Phosphoprotein;Protein transport;Reference proteome;Signal-anchor;Synapse;Synaptosome;Transmembrane;Transmembrane helix;Transport.;"
"AgU000982_v1.1";"1";"p2";"(CT)6";"12";1390;1401;"AgU000982";2403;"ERRFI_HUMAN";"GO:0005737 // GO:0005829 // GO:0031234 // GO:0005634 // GO:0005096 // GO:0019901 // GO:0071474 // GO:0071549 // GO:0071364 // GO:0032869 // GO:0036120 // GO:0048286 // GO:0060428 // GO:0060426 // GO:1903243 // GO:0032966 // GO:0007175 // GO:0070373 // GO:0032691 // GO:0031953 // GO:0042536 // GO:0043547 // GO:0045616 // GO:0061469 // GO:0006950 // GO:0043589";"cellular hyperosmotic response (GO:0071474);cellular response to dexamethasone stimulus (GO:0071549);cellular response to epidermal growth factor stimulus (GO:0071364);cellular response to insulin stimulus (GO:0032869);cellular response to platelet-derived growth factor stimulus (GO:0036120);lung alveolus development (GO:0048286);lung epithelium development (GO:0060428);lung vasculature development (GO:0060426);negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243);negative regulation of collagen biosynthetic process (GO:0032966);negative regulation of epidermal growth factor-activated receptor activity (GO:0007175);negative regulation of ERK1 and ERK2 cascade (GO:0070373);negative regulation of interleukin-1 beta production (GO:0032691);negative regulation of protein autophosphorylation (GO:0031953);negative regulation of tumor necrosis factor biosynthetic process (GO:0042536);positive regulation of GTPase activity (GO:0043547);regulation of keratinocyte differentiation (GO:0045616);regulation of type B pancreatic cell proliferation (GO:0061469);response to stress (GO:0006950);skin morphogenesis (GO:0043589);";"GTPase activator activity (GO:0005096);protein kinase binding (GO:0019901);";"cytoplasm (GO:0005737);cytosol (GO:0005829);extrinsic component of cytoplasmic side of plasma membrane (GO:0031234);nucleus (GO:0005634);";"3D-structure;Acetylation;Cell membrane;Complete proteome;Cytoplasm;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Tumor suppressor.;"
"AgU001017_v1.1";"1";"p3";"(TCC)5";"15";1891;1905;"AgU001017";2370;"MSH6_HUMAN";"GO:0005737 // GO:0005794 // GO:0043231 // GO:0032301 // GO:0000790 // GO:0000228 // GO:0005654 // GO:0005886 // GO:0005524 // GO:0003682 // GO:0003684 // GO:0008094 // GO:0032137 // GO:0035064 // GO:0030983 // GO:0008340 // GO:0006281 // GO:0097193 // GO:0008630 // GO:0045190 // GO:0000710 // GO:0006298 // GO:0045910 // GO:0051096 // GO:0045830 // GO:0007131 // GO:0009411 // GO:0016446 // GO:0016447 // GO:0016032";"determination of adult lifespan (GO:0008340);DNA repair (GO:0006281);intrinsic apoptotic signaling pathway (GO:0097193);intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630);isotype switching (GO:0045190);meiotic mismatch repair (GO:0000710);mismatch repair (GO:0006298);negative regulation of DNA recombination (GO:0045910);positive regulation of helicase activity (GO:0051096);positive regulation of isotype switching (GO:0045830);reciprocal meiotic recombination (GO:0007131);response to UV (GO:0009411);somatic hypermutation of immunoglobulin genes (GO:0016446);somatic recombination of immunoglobulin gene segments (GO:0016447);viral process (GO:0016032);";"ATP binding (GO:0005524);chromatin binding (GO:0003682);damaged DNA binding (GO:0003684);DNA-dependent ATPase activity (GO:0008094);guanine/thymine mispair binding (GO:0032137);methylated histone binding (GO:0035064);mismatched DNA binding (GO:0030983);";"cytoplasm (GO:0005737);Golgi apparatus (GO:0005794);intracellular membrane-bounded organelle (GO:0043231);MutSalpha complex (GO:0032301);nuclear chromatin (GO:0000790);nuclear chromosome (GO:0000228);nucleoplasm (GO:0005654);plasma membrane (GO:0005886);";"3D-structure;Acetylation;Alternative splicing;ATP-binding;Chromosome;Complete proteome;Direct protein sequencing;Disease mutation;DNA damage;DNA repair;DNA-binding;Hereditary nonpolyposis colorectal cancer;Host-virus interaction;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome.;"
"AgU001054_v1.1";"1";"p2";"(TC)5";"10";964;973;"AgU001054";2350;"SDF1_HUMAN";"GO:0009897 // GO:0070062 // GO:0005576 // GO:0005615 // GO:0042056 // GO:0008009 // GO:0042379 // GO:0045236 // GO:0005102 // GO:0008344 // GO:0001667 // GO:0007411 // GO:0008015 // GO:0007155 // GO:0060326 // GO:0006874 // GO:0070098 // GO:0006935 // GO:0007186 // GO:0007281 // GO:0008354 // GO:0006955 // GO:0050930 // GO:0008045 // GO:1902230 // GO:2000107 // GO:1903237 // GO:0001764 // GO:0031100 // GO:0001569 // GO:0050918 // GO:0048842 // GO:0090280 // GO:0045785 // GO:0033603 // GO:0001938 // GO:0090026 // GO:1901741 // GO:2000406 // GO:0008064 // GO:0009408 // GO:0001666 // GO:0009612 // GO:0043434 // GO:0009314 // GO:0009615 // GO:0007165 // GO:0042098 // GO:0022029";"adult locomotory behavior (GO:0008344);ameboidal-type cell migration (GO:0001667);axon guidance (GO:0007411);blood circulation (GO:0008015);cell adhesion (GO:0007155);cell chemotaxis (GO:0060326);cellular calcium ion homeostasis (GO:0006874);chemokine-mediated signaling pathway (GO:0070098);chemotaxis (GO:0006935);G-protein coupled receptor signaling pathway (GO:0007186);germ cell development (GO:0007281);germ cell migration (GO:0008354);immune response (GO:0006955);induction of positive chemotaxis (GO:0050930);motor neuron axon guidance (GO:0008045);negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230);negative regulation of leukocyte apoptotic process (GO:2000107);negative regulation of leukocyte tethering or rolling (GO:1903237);neuron migration (GO:0001764);organ regeneration (GO:0031100);patterning of blood vessels (GO:0001569);positive chemotaxis (GO:0050918);positive regulation of axon extension involved in axon guidance (GO:0048842);positive regulation of calcium ion import (GO:0090280);positive regulation of cell adhesion (GO:0045785);positive regulation of dopamine secretion (GO:0033603);positive regulation of endothelial cell proliferation (GO:0001938);positive regulation of monocyte chemotaxis (GO:0090026);positive regulation of myoblast fusion (GO:1901741);positive regulation of T cell migration (GO:2000406);regulation of actin polymerization or depolymerization (GO:0008064);response to heat (GO:0009408);response to hypoxia (GO:0001666);response to mechanical stimulus (GO:0009612);response to peptide hormone (GO:0043434);response to radiation (GO:0009314);response to virus (GO:0009615);signal transduction (GO:0007165);T cell proliferation (GO:0042098);telencephalon cell migration (GO:0022029);";"chemoattractant activity (GO:0042056);chemokine activity (GO:0008009);chemokine receptor binding (GO:0042379);CXCR chemokine receptor binding (GO:0045236);receptor binding (GO:0005102);";"external side of plasma membrane (GO:0009897);extracellular exosome (GO:0070062);extracellular region (GO:0005576);extracellular space (GO:0005615);";"3D-structure;Alternative splicing;Chemotaxis;Complete proteome;Cytokine;Disulfide bond;Growth factor;Reference proteome;Secreted;Signal.;"
"AgU001075_v1.1";"1";"p2";"(AC)6";"12";1677;1688;"AgU001075";2343;"SIN3A_HUMAN";"GO:0000785 // GO:0005737 // GO:0045171 // GO:0000776 // GO:0005730 // GO:0005654 // GO:0005634 // GO:0016580 // GO:0005667 // GO:0017053 // GO:0003682 // GO:0033558 // GO:0001102 // GO:0001106 // GO:0003700 // GO:0000976 // GO:0002218 // GO:0007596 // GO:0044255 // GO:0034613 // GO:0071333 // GO:0006260 // GO:0010467 // GO:0002244 // GO:0016575 // GO:0001701 // GO:0043066 // GO:0042754 // GO:0045814 // GO:1901675 // GO:1900181 // GO:0000122 // GO:2000678 // GO:0045892 // GO:0031937 // GO:0002230 // GO:0010971 // GO:0045944 // GO:0006476 // GO:0040029 // GO:0051595 // GO:0048511 // GO:0044281 // GO:0006351";"activation of innate immune response (GO:0002218);blood coagulation (GO:0007596);cellular lipid metabolic process (GO:0044255);cellular protein localization (GO:0034613);cellular response to glucose stimulus (GO:0071333);DNA replication (GO:0006260);gene expression (GO:0010467);hematopoietic progenitor cell differentiation (GO:0002244);histone deacetylation (GO:0016575);in utero embryonic development (GO:0001701);negative regulation of apoptotic process (GO:0043066);negative regulation of circadian rhythm (GO:0042754);negative regulation of gene expression, epigenetic (GO:0045814);negative regulation of histone H3-K27 acetylation (GO:1901675);negative regulation of protein localization to nucleus (GO:1900181);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);negative regulation of transcription regulatory region DNA binding (GO:2000678);negative regulation of transcription, DNA-templated (GO:0045892);positive regulation of chromatin silencing (GO:0031937);positive regulation of defense response to virus by host (GO:0002230);positive regulation of G2/M transition of mitotic cell cycle (GO:0010971);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);protein deacetylation (GO:0006476);regulation of gene expression, epigenetic (GO:0040029);response to methylglyoxal (GO:0051595);rhythmic process (GO:0048511);small molecule metabolic process (GO:0044281);transcription, DNA-templated (GO:0006351);";"chromatin binding (GO:0003682);protein deacetylase activity (GO:0033558);RNA polymerase II activating transcription factor binding (GO:0001102);RNA polymerase II transcription corepressor activity (GO:0001106);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription regulatory region sequence-specific DNA binding (GO:0000976);";"chromatin (GO:0000785);cytoplasm (GO:0005737);intercellular bridge (GO:0045171);kinetochore (GO:0000776);nucleolus (GO:0005730);nucleoplasm (GO:0005654);nucleus (GO:0005634);Sin3 complex (GO:0016580);transcription factor complex (GO:0005667);transcriptional repressor complex (GO:0017053);";"3D-structure;Acetylation;Biological rhythms;Coiled coil;Complete proteome;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation.;"
"AgU001075_v1.1";"2";"p2";"(TC)6";"12";2012;2023;"AgU001075";2343;"SIN3A_HUMAN";"GO:0000785 // GO:0005737 // GO:0045171 // GO:0000776 // GO:0005730 // GO:0005654 // GO:0005634 // GO:0016580 // GO:0005667 // GO:0017053 // GO:0003682 // GO:0033558 // GO:0001102 // GO:0001106 // GO:0003700 // GO:0000976 // GO:0002218 // GO:0007596 // GO:0044255 // GO:0034613 // GO:0071333 // GO:0006260 // GO:0010467 // GO:0002244 // GO:0016575 // GO:0001701 // GO:0043066 // GO:0042754 // GO:0045814 // GO:1901675 // GO:1900181 // GO:0000122 // GO:2000678 // GO:0045892 // GO:0031937 // GO:0002230 // GO:0010971 // GO:0045944 // GO:0006476 // GO:0040029 // GO:0051595 // GO:0048511 // GO:0044281 // GO:0006351";"activation of innate immune response (GO:0002218);blood coagulation (GO:0007596);cellular lipid metabolic process (GO:0044255);cellular protein localization (GO:0034613);cellular response to glucose stimulus (GO:0071333);DNA replication (GO:0006260);gene expression (GO:0010467);hematopoietic progenitor cell differentiation (GO:0002244);histone deacetylation (GO:0016575);in utero embryonic development (GO:0001701);negative regulation of apoptotic process (GO:0043066);negative regulation of circadian rhythm (GO:0042754);negative regulation of gene expression, epigenetic (GO:0045814);negative regulation of histone H3-K27 acetylation (GO:1901675);negative regulation of protein localization to nucleus (GO:1900181);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);negative regulation of transcription regulatory region DNA binding (GO:2000678);negative regulation of transcription, DNA-templated (GO:0045892);positive regulation of chromatin silencing (GO:0031937);positive regulation of defense response to virus by host (GO:0002230);positive regulation of G2/M transition of mitotic cell cycle (GO:0010971);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);protein deacetylation (GO:0006476);regulation of gene expression, epigenetic (GO:0040029);response to methylglyoxal (GO:0051595);rhythmic process (GO:0048511);small molecule metabolic process (GO:0044281);transcription, DNA-templated (GO:0006351);";"chromatin binding (GO:0003682);protein deacetylase activity (GO:0033558);RNA polymerase II activating transcription factor binding (GO:0001102);RNA polymerase II transcription corepressor activity (GO:0001106);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription regulatory region sequence-specific DNA binding (GO:0000976);";"chromatin (GO:0000785);cytoplasm (GO:0005737);intercellular bridge (GO:0045171);kinetochore (GO:0000776);nucleolus (GO:0005730);nucleoplasm (GO:0005654);nucleus (GO:0005634);Sin3 complex (GO:0016580);transcription factor complex (GO:0005667);transcriptional repressor complex (GO:0017053);";"3D-structure;Acetylation;Biological rhythms;Coiled coil;Complete proteome;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation.;"
"AgU001116_v1.1";"1";"p2";"(GT)5";"10";1753;1762;"AgU001116";2304;"MYLK_SHEEP";"GO:0032154 // GO:0005737 // GO:0005856 // GO:0030027 // GO:0005524 // GO:0046872 // GO:0004687";"No_GOBP";"ATP binding (GO:0005524);metal ion binding (GO:0046872);myosin light chain kinase activity (GO:0004687);";"cleavage furrow (GO:0032154);cytoplasm (GO:0005737);cytoskeleton (GO:0005856);lamellipodium (GO:0030027);";"Actin-binding;Alternative initiation;ATP-binding;Calcium;Calmodulin-binding;Cell projection;Complete proteome;Cytoplasm;Cytoskeleton;Disulfide bond;Immunoglobulin domain;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase.;"
"AgU001116_v1.1";"2";"p2";"(GT)5";"10";2153;2162;"AgU001116";2304;"MYLK_SHEEP";"GO:0032154 // GO:0005737 // GO:0005856 // GO:0030027 // GO:0005524 // GO:0046872 // GO:0004687";"No_GOBP";"ATP binding (GO:0005524);metal ion binding (GO:0046872);myosin light chain kinase activity (GO:0004687);";"cleavage furrow (GO:0032154);cytoplasm (GO:0005737);cytoskeleton (GO:0005856);lamellipodium (GO:0030027);";"Actin-binding;Alternative initiation;ATP-binding;Calcium;Calmodulin-binding;Cell projection;Complete proteome;Cytoplasm;Cytoskeleton;Disulfide bond;Immunoglobulin domain;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase.;"
"AgU001227_v1.1";"1";"p2";"(GA)6";"12";1585;1596;"AgU001227";2240;"UBA3_HUMAN";"GO:0005829 // GO:0005634 // GO:0016881 // GO:0005524 // GO:0019781 // GO:0046982 // GO:0006464 // GO:0007113 // GO:0045087 // GO:0045892 // GO:0038061 // GO:0045116 // GO:0006508 // GO:0051726 // GO:0002223 // GO:0033209";"cellular protein modification process (GO:0006464);endomitotic cell cycle (GO:0007113);innate immune response (GO:0045087);negative regulation of transcription, DNA-templated (GO:0045892);NIK/NF-kappaB signaling (GO:0038061);protein neddylation (GO:0045116);proteolysis (GO:0006508);regulation of cell cycle (GO:0051726);stimulatory C-type lectin receptor signaling pathway (GO:0002223);tumor necrosis factor-mediated signaling pathway (GO:0033209);";"acid-amino acid ligase activity (GO:0016881);ATP binding (GO:0005524);NEDD8 activating enzyme activity (GO:0019781);protein heterodimerization activity (GO:0046982);";"cytosol (GO:0005829);nucleus (GO:0005634);";"3D-structure;Acetylation;Alternative splicing;ATP-binding;Cell cycle;Complete proteome;Ligase;Nucleotide-binding;Polymorphism;Reference proteome;Ubl conjugation pathway.;"
"AgU001338_v1.1";"1";"p3";"(GAT)7";"21";1822;1842;"AgU001338";2178;"VAMP3_HUMAN";"GO:0016324 // GO:0030054 // GO:0009986 // GO:0030136 // GO:0030665 // GO:0005829 // GO:0016021 // GO:0005622 // GO:0043231 // GO:0043005 // GO:0005886 // GO:0055037 // GO:0030141 // GO:0031201 // GO:0008021 // GO:0005484 // GO:0000149 // GO:0017156 // GO:0006887 // GO:0043001 // GO:0061025 // GO:1903531 // GO:0001921 // GO:0006461 // GO:0042147 // GO:0035493 // GO:0034446 // GO:0006904 // GO:0006906 // GO:0016192";"calcium ion-dependent exocytosis (GO:0017156);exocytosis (GO:0006887);Golgi to plasma membrane protein transport (GO:0043001);membrane fusion (GO:0061025);negative regulation of secretion by cell (GO:1903531);positive regulation of receptor recycling (GO:0001921);protein complex assembly (GO:0006461);retrograde transport, endosome to Golgi (GO:0042147);SNARE complex assembly (GO:0035493);substrate adhesion-dependent cell spreading (GO:0034446);vesicle docking involved in exocytosis (GO:0006904);vesicle fusion (GO:0006906);vesicle-mediated transport (GO:0016192);";"SNAP receptor activity (GO:0005484);SNARE binding (GO:0000149);";"apical plasma membrane (GO:0016324);cell junction (GO:0030054);cell surface (GO:0009986);clathrin-coated vesicle (GO:0030136);clathrin-coated vesicle membrane (GO:0030665);cytosol (GO:0005829);integral component of membrane (GO:0016021);intracellular (GO:0005622);intracellular membrane-bounded organelle (GO:0043231);neuron projection (GO:0043005);plasma membrane (GO:0005886);recycling endosome (GO:0055037);secretory granule (GO:0030141);SNARE complex (GO:0031201);synaptic vesicle (GO:0008021);";"Acetylation;Cell junction;Coiled coil;Complete proteome;Direct protein sequencing;Membrane;Protein transport;Reference proteome;Synapse;Synaptosome;Transmembrane;Transmembrane helix;Transport.;"
"AgU001432_v1.1";"2";"p2";"(AT)8";"16";1652;1667;"AgU001432";2125;"FOXC1_HUMAN";"GO:0005737 // GO:0005720 // GO:0005654 // GO:0005634 // GO:0003677 // GO:0008301 // GO:0000977 // GO:0000981 // GO:0043565 // GO:0003705 // GO:0003700 // GO:0008134 // GO:0044212 // GO:0001228 // GO:0048844 // GO:0001974 // GO:0007420 // GO:0043010 // GO:0060038 // GO:0030154 // GO:0016477 // GO:0008283 // GO:0030199 // GO:0035050 // GO:0001654 // GO:0008354 // GO:0030203 // GO:0007507 // GO:0001701 // GO:0032808 // GO:0001945 // GO:0036438 // GO:0014031 // GO:0016525 // GO:1902257 // GO:1901491 // GO:0045930 // GO:0014032 // GO:0007219 // GO:0042475 // GO:0001503 // GO:0001541 // GO:0048341 // GO:1901534 // GO:1902038 // GO:0045944 // GO:0045893 // GO:0050880 // GO:0046620 // GO:0006355 // GO:0001501 // GO:0001756 // GO:0006366 // GO:0001657 // GO:0048010 // GO:0038084 // GO:0055010";"artery morphogenesis (GO:0048844);blood vessel remodeling (GO:0001974);brain development (GO:0007420);camera-type eye development (GO:0043010);cardiac muscle cell proliferation (GO:0060038);cell differentiation (GO:0030154);cell migration (GO:0016477);cell proliferation (GO:0008283);collagen fibril organization (GO:0030199);embryonic heart tube development (GO:0035050);eye development (GO:0001654);germ cell migration (GO:0008354);glycosaminoglycan metabolic process (GO:0030203);heart development (GO:0007507);in utero embryonic development (GO:0001701);lacrimal gland development (GO:0032808);lymph vessel development (GO:0001945);maintenance of lens transparency (GO:0036438);mesenchymal cell development (GO:0014031);negative regulation of angiogenesis (GO:0016525);negative regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902257);negative regulation of lymphangiogenesis (GO:1901491);negative regulation of mitotic cell cycle (GO:0045930);neural crest cell development (GO:0014032);Notch signaling pathway (GO:0007219);odontogenesis of dentin-containing tooth (GO:0042475);ossification (GO:0001503);ovarian follicle development (GO:0001541);paraxial mesoderm formation (GO:0048341);positive regulation of hematopoietic progenitor cell differentiation (GO:1901534);positive regulation of hematopoietic stem cell differentiation (GO:1902038);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of transcription, DNA-templated (GO:0045893);regulation of blood vessel size (GO:0050880);regulation of organ growth (GO:0046620);regulation of transcription, DNA-templated (GO:0006355);skeletal system development (GO:0001501);somitogenesis (GO:0001756);transcription from RNA polymerase II promoter (GO:0006366);ureteric bud development (GO:0001657);vascular endothelial growth factor receptor signaling pathway (GO:0048010);vascular endothelial growth factor signaling pathway (GO:0038084);ventricular cardiac muscle tissue morphogenesis (GO:0055010);";"DNA binding (GO:0003677);DNA binding, bending (GO:0008301);RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977);RNA polymerase II transcription factor activity, sequence-specific DNA binding (GO:0000981);sequence-specific DNA binding (GO:0043565);transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding (GO:0003705);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription factor binding (GO:0008134);transcription regulatory region DNA binding (GO:0044212);transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding (GO:0001228);";"cytoplasm (GO:0005737);nuclear heterochromatin (GO:0005720);nucleoplasm (GO:0005654);nucleus (GO:0005634);";"Complete proteome;Deafness;Disease mutation;DNA-binding;Nucleus;Peters anomaly;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation.;"
"AgU001679_v1.1";"1";"p2";"(GA)5";"10";1766;1775;"AgU001679";2031;"TOPRS_HUMAN";"GO:0005814 // GO:0036064 // GO:0000930 // GO:0030496 // GO:0016607 // GO:0005634 // GO:0032391 // GO:0016605 // GO:0000922 // GO:0000151 // GO:0003823 // GO:0003677 // GO:0044547 // GO:0016874 // GO:0019789 // GO:0061630 // GO:0004842 // GO:0008270 // GO:0006974 // GO:0008630 // GO:0042771 // GO:0051457 // GO:0043066 // GO:0035845 // GO:0045893 // GO:0051443 // GO:0043161 // GO:0070936 // GO:0034504 // GO:0006513 // GO:0016925 // GO:0042127 // GO:0010842 // GO:0046549 // GO:0046548 // GO:0006351 // GO:0006511";"cellular response to DNA damage stimulus (GO:0006974);intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630);intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771);maintenance of protein location in nucleus (GO:0051457);negative regulation of apoptotic process (GO:0043066);photoreceptor cell outer segment organization (GO:0035845);positive regulation of transcription, DNA-templated (GO:0045893);positive regulation of ubiquitin-protein transferase activity (GO:0051443);proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161);protein K48-linked ubiquitination (GO:0070936);protein localization to nucleus (GO:0034504);protein monoubiquitination (GO:0006513);protein sumoylation (GO:0016925);regulation of cell proliferation (GO:0042127);retina layer formation (GO:0010842);retinal cone cell development (GO:0046549);retinal rod cell development (GO:0046548);transcription, DNA-templated (GO:0006351);ubiquitin-dependent protein catabolic process (GO:0006511);";"antigen binding (GO:0003823);DNA binding (GO:0003677);DNA topoisomerase binding (GO:0044547);ligase activity (GO:0016874);SUMO transferase activity (GO:0019789);ubiquitin protein ligase activity (GO:0061630);ubiquitin-protein transferase activity (GO:0004842);zinc ion binding (GO:0008270);";"centriole (GO:0005814);ciliary basal body (GO:0036064);gamma-tubulin complex (GO:0000930);midbody (GO:0030496);nuclear speck (GO:0016607);nucleus (GO:0005634);photoreceptor connecting cilium (GO:0032391);PML body (GO:0016605);spindle pole (GO:0000922);ubiquitin ligase complex (GO:0000151);";"Alternative splicing;Complete proteome;DNA damage;Isopeptide bond;Ligase;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Retinitis pigmentosa;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger.;"
"AgU001875_v1.1";"1";"p2";"(TA)10";"20";1659;1678;"AgU001875";1959;"ACKR3_CANLF";"GO:0009986 // GO:0005905 // GO:0005769 // GO:0005768 // GO:0016021 // GO:0048471 // GO:0005886 // GO:0055037 // GO:0019958 // GO:0016494 // GO:0015026 // GO:0005044 // GO:0001525 // GO:0007155 // GO:0006935 // GO:1902230 // GO:0002230 // GO:0070374 // GO:0031623 // GO:0001570";"angiogenesis (GO:0001525);cell adhesion (GO:0007155);chemotaxis (GO:0006935);negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230);positive regulation of defense response to virus by host (GO:0002230);positive regulation of ERK1 and ERK2 cascade (GO:0070374);receptor internalization (GO:0031623);vasculogenesis (GO:0001570);";"C-X-C chemokine binding (GO:0019958);C-X-C chemokine receptor activity (GO:0016494);coreceptor activity (GO:0015026);scavenger receptor activity (GO:0005044);";"cell surface (GO:0009986);coated pit (GO:0005905);early endosome (GO:0005769);endosome (GO:0005768);integral component of membrane (GO:0016021);perinuclear region of cytoplasm (GO:0048471);plasma membrane (GO:0005886);recycling endosome (GO:0055037);";"Cell adhesion;Cell membrane;Complete proteome;Cytoplasm;Developmental protein;Disulfide bond;Endosome;G-protein coupled receptor;Glycoprotein;Membrane;Phosphoprotein;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix;Ubl conjugation.;"
"AgU001893_v1.1";"1";"p2";"(AG)5";"10";504;513;"AgU001893";1955;"PDPK1_HUMAN";"GO:0042995 // GO:0005737 // GO:0016023 // GO:0005829 // GO:0005925 // GO:0097481 // GO:0005654 // GO:0005886 // GO:0004676 // GO:0005524 // GO:0016004 // GO:0043274 // GO:0004674 // GO:0030036 // GO:0032148 // GO:0007596 // GO:0019722 // GO:0016477 // GO:0071364 // GO:0032869 // GO:0007173 // GO:0097191 // GO:0038095 // GO:0008543 // GO:0048041 // GO:0006972 // GO:0045087 // GO:0008286 // GO:0035556 // GO:0010667 // GO:0006469 // GO:0034122 // GO:0030512 // GO:0048011 // GO:0018107 // GO:0048015 // GO:0030168 // GO:0090004 // GO:0010518 // GO:0051281 // GO:0046777 // GO:0006468 // GO:0010594 // GO:0043122 // GO:0043304 // GO:0006355 // GO:0007264 // GO:0002223 // GO:0007268 // GO:0031295 // GO:0050852 // GO:0006351 // GO:0003323 // GO:0048010";"actin cytoskeleton organization (GO:0030036);activation of protein kinase B activity (GO:0032148);blood coagulation (GO:0007596);calcium-mediated signaling (GO:0019722);cell migration (GO:0016477);cellular response to epidermal growth factor stimulus (GO:0071364);cellular response to insulin stimulus (GO:0032869);epidermal growth factor receptor signaling pathway (GO:0007173);extrinsic apoptotic signaling pathway (GO:0097191);Fc-epsilon receptor signaling pathway (GO:0038095);fibroblast growth factor receptor signaling pathway (GO:0008543);focal adhesion assembly (GO:0048041);hyperosmotic response (GO:0006972);innate immune response (GO:0045087);insulin receptor signaling pathway (GO:0008286);intracellular signal transduction (GO:0035556);negative regulation of cardiac muscle cell apoptotic process (GO:0010667);negative regulation of protein kinase activity (GO:0006469);negative regulation of toll-like receptor signaling pathway (GO:0034122);negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512);neurotrophin TRK receptor signaling pathway (GO:0048011);peptidyl-threonine phosphorylation (GO:0018107);phosphatidylinositol-mediated signaling (GO:0048015);platelet activation (GO:0030168);positive regulation of establishment of protein localization to plasma membrane (GO:0090004);positive regulation of phospholipase activity (GO:0010518);positive regulation of release of sequestered calcium ion into cytosol (GO:0051281);protein autophosphorylation (GO:0046777);protein phosphorylation (GO:0006468);regulation of endothelial cell migration (GO:0010594);regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122);regulation of mast cell degranulation (GO:0043304);regulation of transcription, DNA-templated (GO:0006355);small GTPase mediated signal transduction (GO:0007264);stimulatory C-type lectin receptor signaling pathway (GO:0002223);synaptic transmission (GO:0007268);T cell costimulation (GO:0031295);T cell receptor signaling pathway (GO:0050852);transcription, DNA-templated (GO:0006351);type B pancreatic cell development (GO:0003323);vascular endothelial growth factor receptor signaling pathway (GO:0048010);";"3-phosphoinositide-dependent protein kinase activity (GO:0004676);ATP binding (GO:0005524);phospholipase activator activity (GO:0016004);phospholipase binding (GO:0043274);protein serine/threonine kinase activity (GO:0004674);";"cell projection (GO:0042995);cytoplasm (GO:0005737);cytoplasmic membrane-bounded vesicle (GO:0016023);cytosol (GO:0005829);focal adhesion (GO:0005925);neuronal postsynaptic density (GO:0097481);nucleoplasm (GO:0005654);plasma membrane (GO:0005886);";"3D-structure;Acetylation;Activator;Alternative splicing;ATP-binding;Cell junction;Cell membrane;Complete proteome;Cytoplasm;Direct protein sequencing;Kinase;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Ubl conjugation.;"
"AgU002020_v1.1";"1";"p2";"(TC)5";"10";1366;1375;"AgU002020";1917;"TF65_MOUSE";"GO:0005737 // GO:0005829 // GO:0033256 // GO:0071159 // GO:0005654 // GO:0005634 // GO:0005667 // GO:0042805 // GO:0033613 // GO:0071532 // GO:0003682 // GO:0031490 // GO:0003677 // GO:0019899 // GO:0042826 // GO:0042802 // GO:0051059 // GO:0042301 // GO:0046982 // GO:0042803 // GO:0019901 // GO:0047485 // GO:0070491 // GO:0000978 // GO:0000980 // GO:0000977 // GO:0043565 // GO:0003705 // GO:0003700 // GO:0008134 // GO:0044212 // GO:0001077 // GO:0001205 // GO:0001078 // GO:0031625 // GO:0006117 // GO:0007568 // GO:0070301 // GO:0071347 // GO:0071354 // GO:0071222 // GO:0071316 // GO:0071375 // GO:0071356 // GO:0019221 // GO:0006952 // GO:0001942 // GO:0007249 // GO:0006954 // GO:0045087 // GO:0001889 // GO:0043066 // GO:2001237 // GO:0046627 // GO:1901223 // GO:0042177 // GO:0000122 // GO:0045892 // GO:0038061 // GO:0070431 // GO:0009887 // GO:0008284 // GO:0032332 // GO:0043123 // GO:0045084 // GO:2000630 // GO:0051092 // GO:0014040 // GO:0045944 // GO:0045893 // GO:0050727 // GO:0043200 // GO:0009617 // GO:0051591 // GO:0033590 // GO:0034097 // GO:0042493 // GO:0032868 // GO:0070555 // GO:0043278 // GO:0032495 // GO:0035994 // GO:0010033 // GO:0032570 // GO:0010224 // GO:0006366";"acetaldehyde metabolic process (GO:0006117);aging (GO:0007568);cellular response to hydrogen peroxide (GO:0070301);cellular response to interleukin-1 (GO:0071347);cellular response to interleukin-6 (GO:0071354);cellular response to lipopolysaccharide (GO:0071222);cellular response to nicotine (GO:0071316);cellular response to peptide hormone stimulus (GO:0071375);cellular response to tumor necrosis factor (GO:0071356);cytokine-mediated signaling pathway (GO:0019221);defense response (GO:0006952);hair follicle development (GO:0001942);I-kappaB kinase/NF-kappaB signaling (GO:0007249);inflammatory response (GO:0006954);innate immune response (GO:0045087);liver development (GO:0001889);negative regulation of apoptotic process (GO:0043066);negative regulation of extrinsic apoptotic signaling pathway (GO:2001237);negative regulation of insulin receptor signaling pathway (GO:0046627);negative regulation of NIK/NF-kappaB signaling (GO:1901223);negative regulation of protein catabolic process (GO:0042177);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);negative regulation of transcription, DNA-templated (GO:0045892);NIK/NF-kappaB signaling (GO:0038061);nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431);organ morphogenesis (GO:0009887);positive regulation of cell proliferation (GO:0008284);positive regulation of chondrocyte differentiation (GO:0032332);positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123);positive regulation of interleukin-12 biosynthetic process (GO:0045084);positive regulation of miRNA metabolic process (GO:2000630);positive regulation of NF-kappaB transcription factor activity (GO:0051092);positive regulation of Schwann cell differentiation (GO:0014040);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of transcription, DNA-templated (GO:0045893);regulation of inflammatory response (GO:0050727);response to amino acid (GO:0043200);response to bacterium (GO:0009617);response to cAMP (GO:0051591);response to cobalamin (GO:0033590);response to cytokine (GO:0034097);response to drug (GO:0042493);response to insulin (GO:0032868);response to interleukin-1 (GO:0070555);response to morphine (GO:0043278);response to muramyl dipeptide (GO:0032495);response to muscle stretch (GO:0035994);response to organic substance (GO:0010033);response to progesterone (GO:0032570);response to UV-B (GO:0010224);transcription from RNA polymerase II promoter (GO:0006366);";"actinin binding (GO:0042805);activating transcription factor binding (GO:0033613);ankyrin repeat binding (GO:0071532);chromatin binding (GO:0003682);chromatin DNA binding (GO:0031490);DNA binding (GO:0003677);enzyme binding (GO:0019899);histone deacetylase binding (GO:0042826);identical protein binding (GO:0042802);NF-kappaB binding (GO:0051059);phosphate ion binding (GO:0042301);protein heterodimerization activity (GO:0046982);protein homodimerization activity (GO:0042803);protein kinase binding (GO:0019901);protein N-terminus binding (GO:0047485);repressing transcription factor binding (GO:0070491);RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978);RNA polymerase II distal enhancer sequence-specific DNA binding (GO:0000980);RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977);sequence-specific DNA binding (GO:0043565);transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding (GO:0003705);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription factor binding (GO:0008134);transcription regulatory region DNA binding (GO:0044212);transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001077);transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding (GO:0001205);transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001078);ubiquitin protein ligase binding (GO:0031625);";"cytoplasm (GO:0005737);cytosol (GO:0005829);I-kappaB/NF-kappaB complex (GO:0033256);NF-kappaB complex (GO:0071159);nucleoplasm (GO:0005654);nucleus (GO:0005634);transcription factor complex (GO:0005667);";"3D-structure;Acetylation;Activator;Alternative splicing;Complete proteome;Cytoplasm;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;S-nitrosylation;Transcription;Transcription regulation;Ubl conjugation.;"
"AgU002096_v1.1";"1";"p3";"(CTG)5";"15";676;690;"AgU002096";1889;"M3YA16_MUSPF";"GO:0016021";"No_GOBP";"No_GOMF";"integral component of membrane (GO:0016021);";"Complete proteome {ECO:0000313|Proteomes:UP000000715};Immunoglobulin domain {ECO:0000256|RuleBase:RU003326,;ECO:0000256|SAAS:SAAS00290237};Membrane {ECO:0000256|SAM:Phobius};Reference proteome {ECO:0000313|Proteomes:UP000000715};Signal {ECO:0000256|SAM:SignalP};Transmembrane {ECO:0000256|SAM:Phobius};Transmembrane helix {ECO:0000256|SAM:Phobius}.;"
"AgU002096_v1.1";"2";"p2";"(GA)5";"10";1309;1318;"AgU002096";1889;"M3YA16_MUSPF";"GO:0016021";"No_GOBP";"No_GOMF";"integral component of membrane (GO:0016021);";"Complete proteome {ECO:0000313|Proteomes:UP000000715};Immunoglobulin domain {ECO:0000256|RuleBase:RU003326,;ECO:0000256|SAAS:SAAS00290237};Membrane {ECO:0000256|SAM:Phobius};Reference proteome {ECO:0000313|Proteomes:UP000000715};Signal {ECO:0000256|SAM:SignalP};Transmembrane {ECO:0000256|SAM:Phobius};Transmembrane helix {ECO:0000256|SAM:Phobius}.;"
"AgU002160_v1.1";"1";"p3";"(AAG)6";"18";1065;1082;"AgU002160";1868;"PK3CB_MOUSE";"GO:0031526 // GO:0005737 // GO:0005634 // GO:0005942 // GO:0005886 // GO:0016303 // GO:0035005 // GO:0005524 // GO:0043560 // GO:0046934 // GO:0002250 // GO:0060055 // GO:0006914 // GO:0060326 // GO:0006874 // GO:0040016 // GO:0006897 // GO:0001935 // GO:0007156 // GO:0006954 // GO:0045087 // GO:0014065 // GO:0036092 // GO:0030168 // GO:0010628 // GO:0006468 // GO:0001952 // GO:0009611";"adaptive immune response (GO:0002250);angiogenesis involved in wound healing (GO:0060055);autophagy (GO:0006914);cell chemotaxis (GO:0060326);cellular calcium ion homeostasis (GO:0006874);embryonic cleavage (GO:0040016);endocytosis (GO:0006897);endothelial cell proliferation (GO:0001935);homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156);inflammatory response (GO:0006954);innate immune response (GO:0045087);phosphatidylinositol 3-kinase signaling (GO:0014065);phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092);platelet activation (GO:0030168);positive regulation of gene expression (GO:0010628);protein phosphorylation (GO:0006468);regulation of cell-matrix adhesion (GO:0001952);response to wounding (GO:0009611);";"1-phosphatidylinositol-3-kinase activity (GO:0016303);1-phosphatidylinositol-4-phosphate 3-kinase activity (GO:0035005);ATP binding (GO:0005524);insulin receptor substrate binding (GO:0043560);phosphatidylinositol-4,5-bisphosphate 3-kinase activity (GO:0046934);";"brush border membrane (GO:0031526);cytoplasm (GO:0005737);nucleus (GO:0005634);phosphatidylinositol 3-kinase complex (GO:0005942);plasma membrane (GO:0005886);";"3D-structure;ATP-binding;Autophagy;Cell adhesion;Complete proteome;Cytoplasm;Endocytosis;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase.;"
"AgU002268_v1.1";"1";"p3";"(GCG)5";"15";1137;1151;"AgU002268";1833;"CEBPB_HUMAN";"GO:0036488 // GO:0000779 // GO:0005737 // GO:0000790 // GO:0016363 // GO:0005654 // GO:0005634 // GO:0003682 // GO:0003677 // GO:0046982 // GO:0042803 // GO:0000978 // GO:0000977 // GO:0003705 // GO:0003700 // GO:0001077 // GO:0006953 // GO:0050873 // GO:0071230 // GO:0042742 // GO:0001892 // GO:0002432 // GO:0072574 // GO:0006955 // GO:0006954 // GO:0070059 // GO:0097421 // GO:0060644 // GO:0033598 // GO:0043524 // GO:0042130 // GO:0045892 // GO:0030182 // GO:0001541 // GO:0045600 // GO:0032753 // GO:0045669 // GO:0045944 // GO:1990440 // GO:0045408 // GO:0045670 // GO:0060850 // GO:0006355 // GO:0034976 // GO:0032496 // GO:0035711 // GO:0006366";"acute-phase response (GO:0006953);brown fat cell differentiation (GO:0050873);cellular response to amino acid stimulus (GO:0071230);defense response to bacterium (GO:0042742);embryonic placenta development (GO:0001892);granuloma formation (GO:0002432);hepatocyte proliferation (GO:0072574);immune response (GO:0006955);inflammatory response (GO:0006954);intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059);liver regeneration (GO:0097421);mammary gland epithelial cell differentiation (GO:0060644);mammary gland epithelial cell proliferation (GO:0033598);negative regulation of neuron apoptotic process (GO:0043524);negative regulation of T cell proliferation (GO:0042130);negative regulation of transcription, DNA-templated (GO:0045892);neuron differentiation (GO:0030182);ovarian follicle development (GO:0001541);positive regulation of fat cell differentiation (GO:0045600);positive regulation of interleukin-4 production (GO:0032753);positive regulation of osteoblast differentiation (GO:0045669);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440);regulation of interleukin-6 biosynthetic process (GO:0045408);regulation of osteoclast differentiation (GO:0045670);regulation of transcription involved in cell fate commitment (GO:0060850);regulation of transcription, DNA-templated (GO:0006355);response to endoplasmic reticulum stress (GO:0034976);response to lipopolysaccharide (GO:0032496);T-helper 1 cell activation (GO:0035711);transcription from RNA polymerase II promoter (GO:0006366);";"chromatin binding (GO:0003682);DNA binding (GO:0003677);protein heterodimerization activity (GO:0046982);protein homodimerization activity (GO:0042803);RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978);RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977);transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding (GO:0003705);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001077);";"CHOP-C/EBP complex (GO:0036488);condensed chromosome, centromeric region (GO:0000779);cytoplasm (GO:0005737);nuclear chromatin (GO:0000790);nuclear matrix (GO:0016363);nucleoplasm (GO:0005654);nucleus (GO:0005634);";"3D-structure;Acetylation;Activator;Alternative initiation;Complete proteome;Cytoplasm;Differentiation;DNA-binding;Glycoprotein;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation.;"
"AgU002404_v1.1";"1";"p2";"(GC)5";"10";1363;1372;"AgU002404";1796;"NFKB2_HUMAN";"GO:0033257 // GO:0005737 // GO:0005829 // GO:0005654 // GO:0005634 // GO:0003682 // GO:0000978 // GO:0003713 // GO:0003700 // GO:0001077 // GO:0007568 // GO:0030198 // GO:0002268 // GO:0002467 // GO:0007249 // GO:0006954 // GO:0045087 // GO:0002755 // GO:0002756 // GO:0000122 // GO:0038061 // GO:0051092 // GO:0045944 // GO:0032481 // GO:0006355 // GO:0034097 // GO:0032496 // GO:0048511 // GO:0048536 // GO:0002223 // GO:0034166 // GO:0034134 // GO:0034138 // GO:0034142 // GO:0034146 // GO:0034162 // GO:0002224 // GO:0038123 // GO:0038124 // GO:0006366 // GO:0035666 // GO:0033209";"aging (GO:0007568);extracellular matrix organization (GO:0030198);follicular dendritic cell differentiation (GO:0002268);germinal center formation (GO:0002467);I-kappaB kinase/NF-kappaB signaling (GO:0007249);inflammatory response (GO:0006954);innate immune response (GO:0045087);MyD88-dependent toll-like receptor signaling pathway (GO:0002755);MyD88-independent toll-like receptor signaling pathway (GO:0002756);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);NIK/NF-kappaB signaling (GO:0038061);positive regulation of NF-kappaB transcription factor activity (GO:0051092);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of type I interferon production (GO:0032481);regulation of transcription, DNA-templated (GO:0006355);response to cytokine (GO:0034097);response to lipopolysaccharide (GO:0032496);rhythmic process (GO:0048511);spleen development (GO:0048536);stimulatory C-type lectin receptor signaling pathway (GO:0002223);toll-like receptor 10 signaling pathway (GO:0034166);toll-like receptor 2 signaling pathway (GO:0034134);toll-like receptor 3 signaling pathway (GO:0034138);toll-like receptor 4 signaling pathway (GO:0034142);toll-like receptor 5 signaling pathway (GO:0034146);toll-like receptor 9 signaling pathway (GO:0034162);toll-like receptor signaling pathway (GO:0002224);toll-like receptor TLR1 (GO:0038123);toll-like receptor TLR6 (GO:0038124);transcription from RNA polymerase II promoter (GO:0006366);TRIF-dependent toll-like receptor signaling pathway (GO:0035666);tumor necrosis factor-mediated signaling pathway (GO:0033209);";"chromatin binding (GO:0003682);RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978);transcription coactivator activity (GO:0003713);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001077);";"Bcl3/NF-kappaB2 complex (GO:0033257);cytoplasm (GO:0005737);cytosol (GO:0005829);nucleoplasm (GO:0005654);nucleus (GO:0005634);";"3D-structure;Activator;Alternative splicing;ANK repeat;Biological rhythms;Chromosomal rearrangement;Complete proteome;Cytoplasm;Direct protein sequencing;Disease mutation;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation.;"
"AgU002472_v1.1";"1";"p4";"(TAAA)5";"20";539;558;"AgU002472";1773;"ANKR1_HUMAN";"GO:0005737 // GO:0005829 // GO:0031674 // GO:0005730 // GO:0005654 // GO:0005634 // GO:0030017 // GO:0005667 // GO:0003677 // GO:0042826 // GO:0002039 // GO:0070412 // GO:0001105 // GO:0001085 // GO:0031432 // GO:0003714 // GO:0055008 // GO:0044255 // GO:0035690 // GO:0071456 // GO:0071347 // GO:0071222 // GO:0071260 // GO:0071407 // GO:0071560 // GO:0071356 // GO:2000279 // GO:0043065 // GO:0043517 // GO:0010976 // GO:0050714 // GO:0045944 // GO:0035994 // GO:0045214 // GO:0035914 // GO:0044281";"cardiac muscle tissue morphogenesis (GO:0055008);cellular lipid metabolic process (GO:0044255);cellular response to drug (GO:0035690);cellular response to hypoxia (GO:0071456);cellular response to interleukin-1 (GO:0071347);cellular response to lipopolysaccharide (GO:0071222);cellular response to mechanical stimulus (GO:0071260);cellular response to organic cyclic compound (GO:0071407);cellular response to transforming growth factor beta stimulus (GO:0071560);cellular response to tumor necrosis factor (GO:0071356);negative regulation of DNA biosynthetic process (GO:2000279);positive regulation of apoptotic process (GO:0043065);positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517);positive regulation of neuron projection development (GO:0010976);positive regulation of protein secretion (GO:0050714);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);response to muscle stretch (GO:0035994);sarcomere organization (GO:0045214);skeletal muscle cell differentiation (GO:0035914);small molecule metabolic process (GO:0044281);";"DNA binding (GO:0003677);histone deacetylase binding (GO:0042826);p53 binding (GO:0002039);R-SMAD binding (GO:0070412);RNA polymerase II transcription coactivator activity (GO:0001105);RNA polymerase II transcription factor binding (GO:0001085);titin binding (GO:0031432);transcription corepressor activity (GO:0003714);";"cytoplasm (GO:0005737);cytosol (GO:0005829);I band (GO:0031674);nucleolus (GO:0005730);nucleoplasm (GO:0005654);nucleus (GO:0005634);sarcomere (GO:0030017);transcription factor complex (GO:0005667);";"ANK repeat;Coiled coil;Complete proteome;Disease mutation;Nucleus;Reference proteome;Repeat.;"
"AgU002542_v1.1";"1";"p2";"(AC)8";"16";301;316;"AgU002542";1752;"PAR1_HUMAN";"GO:0005901 // GO:0009986 // GO:0005829 // GO:0005769 // GO:0005576 // GO:0005794 // GO:0005887 // GO:0005770 // GO:0031594 // GO:0005886 // GO:0031094 // GO:0045211 // GO:0001965 // GO:0031681 // GO:0004930 // GO:0005102 // GO:0015057 // GO:0006919 // GO:0000186 // GO:0009653 // GO:0007596 // GO:0002248 // GO:0007529 // GO:0007186 // GO:0048873 // GO:0006954 // GO:0008285 // GO:0003105 // GO:0043524 // GO:1900134 // GO:0007200 // GO:0030168 // GO:0060155 // GO:0030194 // GO:0051928 // GO:0030335 // GO:0008284 // GO:0032967 // GO:0043280 // GO:0007204 // GO:0051482 // GO:0070374 // GO:0043123 // GO:2000778 // GO:2000484 // GO:0046427 // GO:0043410 // GO:0014068 // GO:0051281 // GO:0035025 // GO:0045987 // GO:0045893 // GO:0045907 // GO:0007205 // GO:0030193 // GO:0032651 // GO:0051930 // GO:0051209 // GO:0032496 // GO:0009611 // GO:0007262 // GO:0007260";"activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919);activation of MAPKK activity (GO:0000186);anatomical structure morphogenesis (GO:0009653);blood coagulation (GO:0007596);connective tissue replacement involved in inflammatory response wound healing (GO:0002248);establishment of synaptic specificity at neuromuscular junction (GO:0007529);G-protein coupled receptor signaling pathway (GO:0007186);homeostasis of number of cells within a tissue (GO:0048873);inflammatory response (GO:0006954);negative regulation of cell proliferation (GO:0008285);negative regulation of glomerular filtration (GO:0003105);negative regulation of neuron apoptotic process (GO:0043524);negative regulation of renin secretion into blood stream (GO:1900134);phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200);platelet activation (GO:0030168);platelet dense granule organization (GO:0060155);positive regulation of blood coagulation (GO:0030194);positive regulation of calcium ion transport (GO:0051928);positive regulation of cell migration (GO:0030335);positive regulation of cell proliferation (GO:0008284);positive regulation of collagen biosynthetic process (GO:0032967);positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280);positive regulation of cytosolic calcium ion concentration (GO:0007204);positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway (GO:0051482);positive regulation of ERK1 and ERK2 cascade (GO:0070374);positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123);positive regulation of interleukin-6 secretion (GO:2000778);positive regulation of interleukin-8 secretion (GO:2000484);positive regulation of JAK-STAT cascade (GO:0046427);positive regulation of MAPK cascade (GO:0043410);positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068);positive regulation of release of sequestered calcium ion into cytosol (GO:0051281);positive regulation of Rho protein signal transduction (GO:0035025);positive regulation of smooth muscle contraction (GO:0045987);positive regulation of transcription, DNA-templated (GO:0045893);positive regulation of vasoconstriction (GO:0045907);protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205);regulation of blood coagulation (GO:0030193);regulation of interleukin-1 beta production (GO:0032651);regulation of sensory perception of pain (GO:0051930);release of sequestered calcium ion into cytosol (GO:0051209);response to lipopolysaccharide (GO:0032496);response to wounding (GO:0009611);STAT protein import into nucleus (GO:0007262);tyrosine phosphorylation of STAT protein (GO:0007260);";"G-protein alpha-subunit binding (GO:0001965);G-protein beta-subunit binding (GO:0031681);G-protein coupled receptor activity (GO:0004930);receptor binding (GO:0005102);thrombin receptor activity (GO:0015057);";"caveola (GO:0005901);cell surface (GO:0009986);cytosol (GO:0005829);early endosome (GO:0005769);extracellular region (GO:0005576);Golgi apparatus (GO:0005794);integral component of plasma membrane (GO:0005887);late endosome (GO:0005770);neuromuscular junction (GO:0031594);plasma membrane (GO:0005886);platelet dense tubular network (GO:0031094);postsynaptic membrane (GO:0045211);";"3D-structure;Blood coagulation;Cell membrane;Complete proteome;Disulfide bond;G-protein coupled receptor;Glycoprotein;Hemostasis;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Signal;Transducer;Transmembrane;Transmembrane helix.;"
"AgU002562_v1.1";"1";"p2";"(AT)5";"10";939;948;"AgU002562";1748;"AP1AR_HUMAN";"GO:0005769 // GO:0005794 // GO:0005770 // GO:0030133 // GO:0035650 // GO:0019894 // GO:0034613 // GO:2000146 // GO:0001920 // GO:1900025 // GO:0015031 // GO:0034315 // GO:0048203";"cellular protein localization (GO:0034613);negative regulation of cell motility (GO:2000146);negative regulation of receptor recycling (GO:0001920);negative regulation of substrate adhesion-dependent cell spreading (GO:1900025);protein transport (GO:0015031);regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315);vesicle targeting, trans-Golgi to endosome (GO:0048203);";"AP-1 adaptor complex binding (GO:0035650);kinesin binding (GO:0019894);";"early endosome (GO:0005769);Golgi apparatus (GO:0005794);late endosome (GO:0005770);transport vesicle (GO:0030133);";"Alternative splicing;Coiled coil;Complete proteome;Endosome;Glycoprotein;Golgi apparatus;Lipoprotein;Palmitate;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport.;"
"AgU002579_v1.1";"1";"p2";"(TG)5";"10";1135;1144;"AgU002579";1744;"AP2A1_HUMAN";"GO:0030122 // GO:0016324 // GO:0016323 // GO:0030130 // GO:0030669 // GO:0005829 // GO:0030666 // GO:0036020 // GO:0032433 // GO:0016020 // GO:0005886 // GO:0019901 // GO:0008565 // GO:0019886 // GO:0007411 // GO:0072583 // GO:0006897 // GO:0048013 // GO:0007173 // GO:0006895 // GO:0006886 // GO:0042059 // GO:1900126 // GO:0048011 // GO:0050690 // GO:0007268 // GO:0016032";"antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886);axon guidance (GO:0007411);clathrin-mediated endocytosis (GO:0072583);endocytosis (GO:0006897);ephrin receptor signaling pathway (GO:0048013);epidermal growth factor receptor signaling pathway (GO:0007173);Golgi to endosome transport (GO:0006895);intracellular protein transport (GO:0006886);negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059);negative regulation of hyaluronan biosynthetic process (GO:1900126);neurotrophin TRK receptor signaling pathway (GO:0048011);regulation of defense response to virus by virus (GO:0050690);synaptic transmission (GO:0007268);viral process (GO:0016032);";"protein kinase binding (GO:0019901);protein transporter activity (GO:0008565);";"AP-2 adaptor complex (GO:0030122);apical plasma membrane (GO:0016324);basolateral plasma membrane (GO:0016323);clathrin coat of trans-Golgi network vesicle (GO:0030130);clathrin-coated endocytic vesicle membrane (GO:0030669);cytosol (GO:0005829);endocytic vesicle membrane (GO:0030666);endolysosome membrane (GO:0036020);filopodium tip (GO:0032433);membrane (GO:0016020);plasma membrane (GO:0005886);";"Alternative splicing;Cell membrane;Coated pit;Complete proteome;Endocytosis;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport.;"
"AgU002812_v1.1";"1";"p3";"(CGG)9";"27";163;189;"AgU002812";1685;"TM131_HUMAN";"GO:0016021 // GO:0016020 // GO:0002682";"regulation of immune system process (GO:0002682);";"No_GOMF";"integral component of membrane (GO:0016021);membrane (GO:0016020);";"Complete proteome;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix.;"
"AgU002813_v1.1";"2";"p2";"(TC)5";"10";1011;1020;"AgU002813";1680;"RIPK1_HUMAN";"GO:0005737 // GO:0005829 // GO:0031264 // GO:0045121 // GO:0005739 // GO:0043235 // GO:0097342 // GO:0005524 // GO:0070513 // GO:0005123 // GO:0042802 // GO:0032403 // GO:0004672 // GO:0004674 // GO:0031625 // GO:0006919 // GO:0097296 // GO:0007257 // GO:1990000 // GO:0006915 // GO:0007166 // GO:0044257 // GO:0071363 // GO:0071356 // GO:0071550 // GO:0097191 // GO:0007249 // GO:0045087 // GO:0002756 // GO:0070266 // GO:0097527 // GO:0043154 // GO:2001237 // GO:2001240 // GO:0043124 // GO:0036289 // GO:0043065 // GO:2001238 // GO:0043123 // GO:0032757 // GO:0046330 // GO:0045651 // GO:0060545 // GO:0051092 // GO:0043068 // GO:0001934 // GO:2000379 // GO:0045944 // GO:0032760 // GO:0032481 // GO:0012501 // GO:0097300 // GO:0046777 // GO:0051291 // GO:0051260 // GO:0070926 // GO:1902041 // GO:0010939 // GO:0010803 // GO:0034612 // GO:0097343 // GO:1901026 // GO:0070231 // GO:0034138 // GO:0034142 // GO:0002224 // GO:0035666 // GO:0033209";"activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919);activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296);activation of JUN kinase activity (GO:0007257);amyloid fibril formation (GO:1990000);apoptotic process (GO:0006915);cell surface receptor signaling pathway (GO:0007166);cellular protein catabolic process (GO:0044257);cellular response to growth factor stimulus (GO:0071363);cellular response to tumor necrosis factor (GO:0071356);death-inducing signaling complex assembly (GO:0071550);extrinsic apoptotic signaling pathway (GO:0097191);I-kappaB kinase/NF-kappaB signaling (GO:0007249);innate immune response (GO:0045087);MyD88-independent toll-like receptor signaling pathway (GO:0002756);necroptotic process (GO:0070266);necroptotic signaling pathway (GO:0097527);negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154);negative regulation of extrinsic apoptotic signaling pathway (GO:2001237);negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240);negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124);peptidyl-serine autophosphorylation (GO:0036289);positive regulation of apoptotic process (GO:0043065);positive regulation of extrinsic apoptotic signaling pathway (GO:2001238);positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123);positive regulation of interleukin-8 production (GO:0032757);positive regulation of JNK cascade (GO:0046330);positive regulation of macrophage differentiation (GO:0045651);positive regulation of necroptotic process (GO:0060545);positive regulation of NF-kappaB transcription factor activity (GO:0051092);positive regulation of programmed cell death (GO:0043068);positive regulation of protein phosphorylation (GO:0001934);positive regulation of reactive oxygen species metabolic process (GO:2000379);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of tumor necrosis factor production (GO:0032760);positive regulation of type I interferon production (GO:0032481);programmed cell death (GO:0012501);programmed necrotic cell death (GO:0097300);protein autophosphorylation (GO:0046777);protein heterooligomerization (GO:0051291);protein homooligomerization (GO:0051260);regulation of ATP (GO:0070926);regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041);regulation of necrotic cell death (GO:0010939);regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803);response to tumor necrosis factor (GO:0034612);ripoptosome assembly (GO:0097343);ripoptosome assembly involved in necroptotic process (GO:1901026);T cell apoptotic process (GO:0070231);toll-like receptor 3 signaling pathway (GO:0034138);toll-like receptor 4 signaling pathway (GO:0034142);toll-like receptor signaling pathway (GO:0002224);TRIF-dependent toll-like receptor signaling pathway (GO:0035666);tumor necrosis factor-mediated signaling pathway (GO:0033209);";"ATP binding (GO:0005524);death domain binding (GO:0070513);death receptor binding (GO:0005123);identical protein binding (GO:0042802);protein complex binding (GO:0032403);protein kinase activity (GO:0004672);protein serine/threonine kinase activity (GO:0004674);ubiquitin protein ligase binding (GO:0031625);";"cytoplasm (GO:0005737);cytosol (GO:0005829);death-inducing signaling complex (GO:0031264);membrane raft (GO:0045121);mitochondrion (GO:0005739);receptor complex (GO:0043235);ripoptosome (GO:0097342);";"3D-structure;Alternative splicing;ATP-binding;Cell membrane;Complete proteome;Cytoplasm;Isopeptide bond;Kinase;Membrane;Necrosis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation.;"
"AgU002947_v1.1";"1";"p2";"(CT)5";"10";1509;1518;"AgU002947";1648;"NCK1_HUMAN";"GO:0005911 // GO:0005737 // GO:0005829 // GO:0005783 // GO:0005634 // GO:0005886 // GO:0000164 // GO:0005840 // GO:0012506 // GO:0008093 // GO:0071074 // GO:0030674 // GO:0004860 // GO:0005102 // GO:0030159 // GO:0030971 // GO:0005070 // GO:0007015 // GO:0007411 // GO:0038096 // GO:0045087 // GO:0030032 // GO:0060548 // GO:1904030 // GO:1903912 // GO:0033137 // GO:1903898 // GO:1990441 // GO:0070262 // GO:0030838 // GO:1903676 // GO:1903679 // GO:1902237 // GO:0042102 // GO:0045944 // GO:0036493 // GO:0051707 // GO:0007172 // GO:0007264 // GO:0006930 // GO:0042110 // GO:0050852 // GO:0048010";"actin filament organization (GO:0007015);axon guidance (GO:0007411);Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096);innate immune response (GO:0045087);lamellipodium assembly (GO:0030032);negative regulation of cell death (GO:0060548);negative regulation of cyclin-dependent protein kinase activity (GO:1904030);negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912);negative regulation of peptidyl-serine phosphorylation (GO:0033137);negative regulation of PERK-mediated unfolded protein response (GO:1903898);negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441);peptidyl-serine dephosphorylation (GO:0070262);positive regulation of actin filament polymerization (GO:0030838);positive regulation of cap-dependent translational initiation (GO:1903676);positive regulation of cap-independent translational initiation (GO:1903679);positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237);positive regulation of T cell proliferation (GO:0042102);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of translation in response to endoplasmic reticulum stress (GO:0036493);response to other organism (GO:0051707);signal complex assembly (GO:0007172);small GTPase mediated signal transduction (GO:0007264);substrate-dependent cell migration, cell extension (GO:0006930);T cell activation (GO:0042110);T cell receptor signaling pathway (GO:0050852);vascular endothelial growth factor receptor signaling pathway (GO:0048010);";"cytoskeletal adaptor activity (GO:0008093);eukaryotic initiation factor eIF2 binding (GO:0071074);protein binding, bridging (GO:0030674);protein kinase inhibitor activity (GO:0004860);receptor binding (GO:0005102);receptor signaling complex scaffold activity (GO:0030159);receptor tyrosine kinase binding (GO:0030971);SH3/SH2 adaptor activity (GO:0005070);";"cell-cell junction (GO:0005911);cytoplasm (GO:0005737);cytosol (GO:0005829);endoplasmic reticulum (GO:0005783);nucleus (GO:0005634);plasma membrane (GO:0005886);protein phosphatase type 1 complex (GO:0000164);ribosome (GO:0005840);vesicle membrane (GO:0012506);";"3D-structure;Acetylation;Alternative splicing;Complete proteome;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH2 domain;SH3 domain;Translation regulation.;"
"AgU003069_v1.1";"1";"p2";"(CT)5";"10";688;697;"AgU003069";1622;"NR4A1_BOVIN";"GO:0005737 // GO:0031965 // GO:0005654 // GO:0005667 // GO:0046982 // GO:0004879 // GO:0043565 // GO:0003707 // GO:0001077 // GO:0008270 // GO:0071376 // GO:0045444 // GO:0045786 // GO:0043154 // GO:0043065 // GO:0045944 // GO:0061469 // GO:0035914";"cellular response to corticotropin-releasing hormone stimulus (GO:0071376);fat cell differentiation (GO:0045444);negative regulation of cell cycle (GO:0045786);negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154);positive regulation of apoptotic process (GO:0043065);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);regulation of type B pancreatic cell proliferation (GO:0061469);skeletal muscle cell differentiation (GO:0035914);";"protein heterodimerization activity (GO:0046982);RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding (GO:0004879);sequence-specific DNA binding (GO:0043565);steroid hormone receptor activity (GO:0003707);transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001077);zinc ion binding (GO:0008270);";"cytoplasm (GO:0005737);nuclear membrane (GO:0031965);nucleoplasm (GO:0005654);transcription factor complex (GO:0005667);";"Acetylation;Complete proteome;Cytoplasm;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Receptor;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger.;"
"AgU003233_v1.1";"1";"p2";"(AG)5";"10";429;438;"AgU003233";1586;"KSYK_PIG";"GO:0005829 // GO:0032009 // GO:0005886 // GO:0005524 // GO:0004715 // GO:0002250 // GO:0001525 // GO:0050853 // GO:0048514 // GO:0071226 // GO:0042742 // GO:0045087 // GO:0007229 // GO:0035556 // GO:0002366 // GO:0007159 // GO:0001945 // GO:0002281 // GO:0002283 // GO:0030593 // GO:0018108 // GO:0045780 // GO:0033630 // GO:0006468 // GO:0090237 // GO:0070372 // GO:0043313 // GO:0050764 // GO:0010543 // GO:0090330 // GO:0032928 // GO:0002554";"adaptive immune response (GO:0002250);angiogenesis (GO:0001525);B cell receptor signaling pathway (GO:0050853);blood vessel morphogenesis (GO:0048514);cellular response to molecule of fungal origin (GO:0071226);defense response to bacterium (GO:0042742);innate immune response (GO:0045087);integrin-mediated signaling pathway (GO:0007229);intracellular signal transduction (GO:0035556);leukocyte activation involved in immune response (GO:0002366);leukocyte cell-cell adhesion (GO:0007159);lymph vessel development (GO:0001945);macrophage activation involved in immune response (GO:0002281);neutrophil activation involved in immune response (GO:0002283);neutrophil chemotaxis (GO:0030593);peptidyl-tyrosine phosphorylation (GO:0018108);positive regulation of bone resorption (GO:0045780);positive regulation of cell adhesion mediated by integrin (GO:0033630);protein phosphorylation (GO:0006468);regulation of arachidonic acid secretion (GO:0090237);regulation of ERK1 and ERK2 cascade (GO:0070372);regulation of neutrophil degranulation (GO:0043313);regulation of phagocytosis (GO:0050764);regulation of platelet activation (GO:0010543);regulation of platelet aggregation (GO:0090330);regulation of superoxide anion generation (GO:0032928);serotonin secretion by platelet (GO:0002554);";"ATP binding (GO:0005524);non-membrane spanning protein tyrosine kinase activity (GO:0004715);";"cytosol (GO:0005829);early phagosome (GO:0032009);plasma membrane (GO:0005886);";"Adaptive immunity;Angiogenesis;ATP-binding;Cell membrane;Complete proteome;Cytoplasm;Direct protein sequencing;Immunity;Innate immunity;Kinase;Membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;SH2 domain;Transferase;Tyrosine-protein kinase;Ubl conjugation.;"
"AgU003302_v1.1";"1";"p2";"(GT)5";"10";114;123;"AgU003302";1570;"TNF13_HUMAN";"GO:0005737 // GO:0005829 // GO:0009897 // GO:0070062 // GO:0005576 // GO:0005615 // GO:0005654 // GO:0005102 // GO:0010467 // GO:0002426 // GO:0008284 // GO:0002636 // GO:0048298 // GO:0043488 // GO:0007165 // GO:0033209";"gene expression (GO:0010467);immunoglobulin production in mucosal tissue (GO:0002426);positive regulation of cell proliferation (GO:0008284);positive regulation of germinal center formation (GO:0002636);positive regulation of isotype switching to IgA isotypes (GO:0048298);regulation of mRNA stability (GO:0043488);signal transduction (GO:0007165);tumor necrosis factor-mediated signaling pathway (GO:0033209);";"receptor binding (GO:0005102);";"cytoplasm (GO:0005737);cytosol (GO:0005829);external side of plasma membrane (GO:0009897);extracellular exosome (GO:0070062);extracellular region (GO:0005576);extracellular space (GO:0005615);nucleoplasm (GO:0005654);";"3D-structure;Alternative splicing;Cleavage on pair of basic residues;Complete proteome;Cytokine;Disulfide bond;Glycoprotein;Immunity;Polymorphism;Reference proteome;Secreted.;"
"AgU003381_v1.1";"1";"p3";"(TTC)5";"15";131;145;"AgU003381";1551;"OTU7B_HUMAN";"GO:0005737 // GO:0005634 // GO:0008234 // GO:0003677 // GO:0070530 // GO:1990380 // GO:0004843 // GO:0008270 // GO:0002385 // GO:0043124 // GO:0032717 // GO:1900181 // GO:0000122 // GO:0071947 // GO:0035871 // GO:0071108 // GO:0070536 // GO:0050727 // GO:0045088";"mucosal immune response (GO:0002385);negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124);negative regulation of interleukin-8 production (GO:0032717);negative regulation of protein localization to nucleus (GO:1900181);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947);protein K11-linked deubiquitination (GO:0035871);protein K48-linked deubiquitination (GO:0071108);protein K63-linked deubiquitination (GO:0070536);regulation of inflammatory response (GO:0050727);regulation of innate immune response (GO:0045088);";"cysteine-type peptidase activity (GO:0008234);DNA binding (GO:0003677);K63-linked polyubiquitin binding (GO:0070530);Lys48-specific deubiquitinase activity (GO:1990380);ubiquitin-specific protease activity (GO:0004843);zinc ion binding (GO:0008270);";"cytoplasm (GO:0005737);nucleus (GO:0005634);";"Alternative splicing;Complete proteome;Cytoplasm;Hydrolase;Immunity;Metal-binding;Nucleus;Phosphoprotein;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway;Zinc;Zinc-finger.;"
"AgU003480_v1.1";"1";"p2";"(AC)5";"10";217;226;"AgU003480";1526;"M3K5_HUMAN";"GO:0005829 // GO:1990604 // GO:1902911 // GO:0005524 // GO:0000287 // GO:0004709 // GO:0042803 // GO:0004672 // GO:0019903 // GO:0007257 // GO:0000186 // GO:0097190 // GO:0070301 // GO:1902170 // GO:0045087 // GO:0070059 // GO:0008631 // GO:0007254 // GO:0000165 // GO:0038066 // GO:0043065 // GO:0043280 // GO:0046330 // GO:0043507 // GO:0045663 // GO:1901216 // GO:0097300 // GO:0006468 // GO:0034976 // GO:0002931 // GO:0016032";"activation of JUN kinase activity (GO:0007257);activation of MAPKK activity (GO:0000186);apoptotic signaling pathway (GO:0097190);cellular response to hydrogen peroxide (GO:0070301);cellular response to reactive nitrogen species (GO:1902170);innate immune response (GO:0045087);intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059);intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631);JNK cascade (GO:0007254);MAPK cascade (GO:0000165);p38MAPK cascade (GO:0038066);positive regulation of apoptotic process (GO:0043065);positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280);positive regulation of JNK cascade (GO:0046330);positive regulation of JUN kinase activity (GO:0043507);positive regulation of myoblast differentiation (GO:0045663);positive regulation of neuron death (GO:1901216);programmed necrotic cell death (GO:0097300);protein phosphorylation (GO:0006468);response to endoplasmic reticulum stress (GO:0034976);response to ischemia (GO:0002931);viral process (GO:0016032);";"ATP binding (GO:0005524);magnesium ion binding (GO:0000287);MAP kinase kinase kinase activity (GO:0004709);protein homodimerization activity (GO:0042803);protein kinase activity (GO:0004672);protein phosphatase binding (GO:0019903);";"cytosol (GO:0005829);IRE1-TRAF2-ASK1 complex (GO:1990604);protein kinase complex (GO:1902911);";"3D-structure;Alternative splicing;Apoptosis;ATP-binding;Coiled coil;Complete proteome;Cytoplasm;Endoplasmic reticulum;Host-virus interaction;Immunity;Innate immunity;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Stress response;Transferase;Ubl conjugation.;"
"AgU003551_v1.1";"1";"p3";"(GCA)5";"15";1297;1311;"AgU003551";1519;"CD14_BOVIN";"GO:0031362 // GO:0009897 // GO:0005576 // GO:0046696 // GO:0071222 // GO:0006954 // GO:0045087 // GO:0031663 // GO:0032729 // GO:0032760 // GO:0009617 // GO:0034142";"cellular response to lipopolysaccharide (GO:0071222);inflammatory response (GO:0006954);innate immune response (GO:0045087);lipopolysaccharide-mediated signaling pathway (GO:0031663);positive regulation of interferon-gamma production (GO:0032729);positive regulation of tumor necrosis factor production (GO:0032760);response to bacterium (GO:0009617);toll-like receptor 4 signaling pathway (GO:0034142);";"No_GOMF";"anchored component of external side of plasma membrane (GO:0031362);external side of plasma membrane (GO:0009897);extracellular region (GO:0005576);lipopolysaccharide receptor complex (GO:0046696);";"Cell membrane;Complete proteome;Disulfide bond;Glycoprotein;GPI-anchor;Immunity;Inflammatory response;Innate immunity;Leucine-rich repeat;Lipoprotein;Membrane;Reference proteome;Repeat;Secreted;Signal.;"
"AgU003600_v1.1";"1";"p2";"(AG)5";"10";828;837;"AgU003600";1503;"CY24B_HUMAN";"GO:0005887 // GO:0005739 // GO:0043020 // GO:0030670 // GO:0005886 // GO:0050660 // GO:0020037 // GO:0046872 // GO:0046982 // GO:0016175 // GO:0005244 // GO:0042590 // GO:0002479 // GO:0002474 // GO:0050665 // GO:0006954 // GO:0045087 // GO:0055114 // GO:0090382 // GO:0045730 // GO:0007264 // GO:0042554 // GO:0006801 // GO:0048010";"antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590);antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479);antigen processing and presentation of peptide antigen via MHC class I (GO:0002474);hydrogen peroxide biosynthetic process (GO:0050665);inflammatory response (GO:0006954);innate immune response (GO:0045087);oxidation-reduction process (GO:0055114);phagosome maturation (GO:0090382);respiratory burst (GO:0045730);small GTPase mediated signal transduction (GO:0007264);superoxide anion generation (GO:0042554);superoxide metabolic process (GO:0006801);vascular endothelial growth factor receptor signaling pathway (GO:0048010);";"flavin adenine dinucleotide binding (GO:0050660);heme binding (GO:0020037);metal ion binding (GO:0046872);protein heterodimerization activity (GO:0046982);superoxide-generating NADPH oxidase activity (GO:0016175);voltage-gated ion channel activity (GO:0005244);";"integral component of plasma membrane (GO:0005887);mitochondrion (GO:0005739);NADPH oxidase complex (GO:0043020);phagocytic vesicle membrane (GO:0030670);plasma membrane (GO:0005886);";"3D-structure;Cell membrane;Chronic granulomatous disease;Complete proteome;Direct protein sequencing;Disease mutation;Electron transport;FAD;Flavoprotein;Glycoprotein;Heme;Ion channel;Ion transport;Iron;Membrane;Metal-binding;NADP;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel.;"
"AgU003731_v1.1";"1";"p4";"(TATT)6";"24";1223;1246;"AgU003731";1486;"IL1B_EUMJU";"GO:0005776 // GO:0031410 // GO:0005829 // GO:0070062 // GO:0005615 // GO:0005764 // GO:0001660 // GO:0006955 // GO:0051781";"fever generation (GO:0001660);immune response (GO:0006955);positive regulation of cell division (GO:0051781);";"No_GOMF";"autophagosome (GO:0005776);cytoplasmic vesicle (GO:0031410);cytosol (GO:0005829);extracellular exosome (GO:0070062);extracellular space (GO:0005615);lysosome (GO:0005764);";"Cytokine;Cytoplasm;Cytoplasmic vesicle;Inflammatory response;Lysosome;Mitogen;Pyrogen;Secreted.;"
"AgU003752_v1.1";"1";"p2";"(GA)5";"10";687;696;"AgU003752";1483;"DICER_HUMAN";"GO:0033167 // GO:0030424 // GO:0005737 // GO:0005829 // GO:0030425 // GO:0005793 // GO:0030426 // GO:0035068 // GO:0005634 // GO:0070578 // GO:0005524 // GO:0004530 // GO:0003677 // GO:0003725 // GO:0004521 // GO:0004386 // GO:0046872 // GO:0035198 // GO:0070883 // GO:0019904 // GO:0004525 // GO:0035197 // GO:0001525 // GO:0006309 // GO:0048754 // GO:0055013 // GO:0061309 // GO:0051216 // GO:0021987 // GO:0036404 // GO:0033168 // GO:0051607 // GO:0035116 // GO:0061548 // GO:0010467 // GO:0031047 // GO:0071335 // GO:0031069 // GO:0060119 // GO:0060576 // GO:0030324 // GO:0035280 // GO:0048255 // GO:0035264 // GO:0014835 // GO:0010626 // GO:0000122 // GO:0021675 // GO:0048812 // GO:0021889 // GO:0032290 // GO:0010628 // GO:2000630 // GO:0031643 // GO:0014040 // GO:0009791 // GO:0031054 // GO:0035196 // GO:0030422 // GO:0051726 // GO:0070173 // GO:0010660 // GO:0045664 // GO:0048713 // GO:0045069 // GO:0048608 // GO:0090502 // GO:0035087 // GO:0021522 // GO:0051225 // GO:0048536 // GO:0019827 // GO:0030423 // GO:0010070";"angiogenesis (GO:0001525);apoptotic DNA fragmentation (GO:0006309);branching morphogenesis of an epithelial tube (GO:0048754);cardiac muscle cell development (GO:0055013);cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309);cartilage development (GO:0051216);cerebral cortex development (GO:0021987);conversion of ds siRNA to ss siRNA (GO:0036404);conversion of ds siRNA to ss siRNA involved in RNA interference (GO:0033168);defense response to virus (GO:0051607);embryonic hindlimb morphogenesis (GO:0035116);ganglion development (GO:0061548);gene expression (GO:0010467);gene silencing by RNA (GO:0031047);hair follicle cell proliferation (GO:0071335);hair follicle morphogenesis (GO:0031069);inner ear receptor cell development (GO:0060119);intestinal epithelial cell development (GO:0060576);lung development (GO:0030324);miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280);mRNA stabilization (GO:0048255);multicellular organism growth (GO:0035264);myoblast differentiation involved in skeletal muscle regeneration (GO:0014835);negative regulation of Schwann cell proliferation (GO:0010626);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);nerve development (GO:0021675);neuron projection morphogenesis (GO:0048812);olfactory bulb interneuron differentiation (GO:0021889);peripheral nervous system myelin formation (GO:0032290);positive regulation of gene expression (GO:0010628);positive regulation of miRNA metabolic process (GO:2000630);positive regulation of myelination (GO:0031643);positive regulation of Schwann cell differentiation (GO:0014040);post-embryonic development (GO:0009791);pre-miRNA processing (GO:0031054);production of miRNAs involved in gene silencing by miRNA (GO:0035196);production of siRNA involved in RNA interference (GO:0030422);regulation of cell cycle (GO:0051726);regulation of enamel mineralization (GO:0070173);regulation of muscle cell apoptotic process (GO:0010660);regulation of neuron differentiation (GO:0045664);regulation of oligodendrocyte differentiation (GO:0048713);regulation of viral genome replication (GO:0045069);reproductive structure development (GO:0048608);RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502);siRNA loading onto RISC involved in RNA interference (GO:0035087);spinal cord motor neuron differentiation (GO:0021522);spindle assembly (GO:0051225);spleen development (GO:0048536);stem cell population maintenance (GO:0019827);targeting of mRNA for destruction involved in RNA interference (GO:0030423);zygote asymmetric cell division (GO:0010070);";"ATP binding (GO:0005524);deoxyribonuclease I activity (GO:0004530);DNA binding (GO:0003677);double-stranded RNA binding (GO:0003725);endoribonuclease activity (GO:0004521);helicase activity (GO:0004386);metal ion binding (GO:0046872);miRNA binding (GO:0035198);pre-miRNA binding (GO:0070883);protein domain specific binding (GO:0019904);ribonuclease III activity (GO:0004525);siRNA binding (GO:0035197);";"ARC complex (GO:0033167);axon (GO:0030424);cytoplasm (GO:0005737);cytosol (GO:0005829);dendrite (GO:0030425);endoplasmic reticulum-Golgi intermediate compartment (GO:0005793);growth cone (GO:0030426);micro-ribonucleoprotein complex (GO:0035068);nucleus (GO:0005634);RISC-loading complex (GO:0070578);";"3D-structure;Alternative splicing;ATP-binding;Complete proteome;Cytoplasm;Disease mutation;Endonuclease;Helicase;Hydrolase;Magnesium;Manganese;Metal-binding;Nuclease;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;RNA-binding;RNA-mediated gene silencing.;"
"AgU003880_v1.1";"1";"p2";"(AC)12";"24";504;527;"AgU003880";1458;"SNAI2_MOUSE";"GO:0005737 // GO:0000790 // GO:0005634 // GO:0003682 // GO:0046872 // GO:0043565 // GO:0003705 // GO:0001078 // GO:0060070 // GO:0060536 // GO:0016477 // GO:0003273 // GO:0071364 // GO:0044344 // GO:0071479 // GO:0036120 // GO:0035921 // GO:0001837 // GO:0003198 // GO:0060429 // GO:2000811 // GO:0043066 // GO:0090090 // GO:0035414 // GO:0006933 // GO:1900387 // GO:0032331 // GO:0043518 // GO:2001240 // GO:1902230 // GO:0010839 // GO:2000647 // GO:0000122 // GO:0010957 // GO:0070563 // GO:0014032 // GO:0007219 // GO:0001649 // GO:0060021 // GO:0043473 // GO:0030335 // GO:2001028 // GO:0045600 // GO:0035066 // GO:0042981 // GO:2000810 // GO:0060693 // GO:0032642 // GO:0045667 // GO:0009314 // GO:0007605 // GO:0006351 // GO:0050872 // GO:0044319";"canonical Wnt signaling pathway (GO:0060070);cartilage morphogenesis (GO:0060536);cell migration (GO:0016477);cell migration involved in endocardial cushion formation (GO:0003273);cellular response to epidermal growth factor stimulus (GO:0071364);cellular response to fibroblast growth factor stimulus (GO:0044344);cellular response to ionizing radiation (GO:0071479);cellular response to platelet-derived growth factor stimulus (GO:0036120);desmosome disassembly (GO:0035921);epithelial to mesenchymal transition (GO:0001837);epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198);epithelium development (GO:0060429);negative regulation of anoikis (GO:2000811);negative regulation of apoptotic process (GO:0043066);negative regulation of canonical Wnt signaling pathway (GO:0090090);negative regulation of catenin import into nucleus (GO:0035414);negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933);negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387);negative regulation of chondrocyte differentiation (GO:0032331);negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518);negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240);negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230);negative regulation of keratinocyte proliferation (GO:0010839);negative regulation of stem cell proliferation (GO:2000647);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);negative regulation of vitamin D biosynthetic process (GO:0010957);negative regulation of vitamin D receptor signaling pathway (GO:0070563);neural crest cell development (GO:0014032);Notch signaling pathway (GO:0007219);osteoblast differentiation (GO:0001649);palate development (GO:0060021);pigmentation (GO:0043473);positive regulation of cell migration (GO:0030335);positive regulation of endothelial cell chemotaxis (GO:2001028);positive regulation of fat cell differentiation (GO:0045600);positive regulation of histone acetylation (GO:0035066);regulation of apoptotic process (GO:0042981);regulation of bicellular tight junction assembly (GO:2000810);regulation of branching involved in salivary gland morphogenesis (GO:0060693);regulation of chemokine production (GO:0032642);regulation of osteoblast differentiation (GO:0045667);response to radiation (GO:0009314);sensory perception of sound (GO:0007605);transcription, DNA-templated (GO:0006351);white fat cell differentiation (GO:0050872);wound healing, spreading of cells (GO:0044319);";"chromatin binding (GO:0003682);metal ion binding (GO:0046872);sequence-specific DNA binding (GO:0043565);transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding (GO:0003705);transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001078);";"cytoplasm (GO:0005737);nuclear chromatin (GO:0000790);nucleus (GO:0005634);";"Complete proteome;Cytoplasm;Developmental protein;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger.;"
"AgU004117_v1.1";"1";"p2";"(TA)5";"10";1207;1216;"AgU004117";1410;"I23O1_HUMAN";"GO:0005829 // GO:0030485 // GO:0032421 // GO:0009055 // GO:0020037 // GO:0033754 // GO:0046872 // GO:0004833 // GO:0034641 // GO:0002534 // GO:0007565 // GO:0002376 // GO:0034276 // GO:0033555 // GO:0032693 // GO:0070233 // GO:0042130 // GO:0002678 // GO:0032735 // GO:0070234 // GO:0002666 // GO:0002830 // GO:0032496 // GO:0044281 // GO:0036269 // GO:0006569 // GO:0019441";"cellular nitrogen compound metabolic process (GO:0034641);cytokine production involved in inflammatory response (GO:0002534);female pregnancy (GO:0007565);immune system process (GO:0002376);kynurenic acid biosynthetic process (GO:0034276);multicellular organismal response to stress (GO:0033555);negative regulation of interleukin-10 production (GO:0032693);negative regulation of T cell apoptotic process (GO:0070233);negative regulation of T cell proliferation (GO:0042130);positive regulation of chronic inflammatory response (GO:0002678);positive regulation of interleukin-12 production (GO:0032735);positive regulation of T cell apoptotic process (GO:0070234);positive regulation of T cell tolerance induction (GO:0002666);positive regulation of type 2 immune response (GO:0002830);response to lipopolysaccharide (GO:0032496);small molecule metabolic process (GO:0044281);swimming behavior (GO:0036269);tryptophan catabolic process (GO:0006569);tryptophan catabolic process to kynurenine (GO:0019441);";"electron carrier activity (GO:0009055);heme binding (GO:0020037);indoleamine 2,3-dioxygenase activity (GO:0033754);metal ion binding (GO:0046872);tryptophan 2,3-dioxygenase activity (GO:0004833);";"cytosol (GO:0005829);smooth muscle contractile fiber (GO:0030485);stereocilium bundle (GO:0032421);";"3D-structure;Complete proteome;Cytoplasm;Dioxygenase;Direct protein sequencing;Heme;Immunity;Iron;Metal-binding;Oxidoreductase;Polymorphism;Reference proteome;Tryptophan catabolism.;"
"AgU004295_v1.1";"1";"p2";"(TC)5";"10";1124;1133;"AgU004295";1388;"HOIL1_HUMAN";"GO:0005829 // GO:0071797 // GO:0016874 // GO:0043130 // GO:0004842 // GO:0008270 // GO:0007166 // GO:0007249 // GO:0060546 // GO:0032088 // GO:2001238 // GO:0043123 // GO:0042346 // GO:0051092 // GO:0043161 // GO:0097039 // GO:0000209 // GO:0010803 // GO:0050852 // GO:0033209 // GO:0016032";"cell surface receptor signaling pathway (GO:0007166);I-kappaB kinase/NF-kappaB signaling (GO:0007249);negative regulation of necroptotic process (GO:0060546);negative regulation of NF-kappaB transcription factor activity (GO:0032088);positive regulation of extrinsic apoptotic signaling pathway (GO:2001238);positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123);positive regulation of NF-kappaB import into nucleus (GO:0042346);positive regulation of NF-kappaB transcription factor activity (GO:0051092);proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161);protein linear polyubiquitination (GO:0097039);protein polyubiquitination (GO:0000209);regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803);T cell receptor signaling pathway (GO:0050852);tumor necrosis factor-mediated signaling pathway (GO:0033209);viral process (GO:0016032);";"ligase activity (GO:0016874);ubiquitin binding (GO:0043130);ubiquitin-protein transferase activity (GO:0004842);zinc ion binding (GO:0008270);";"cytosol (GO:0005829);LUBAC complex (GO:0071797);";"3D-structure;Acetylation;Alternative splicing;Coiled coil;Complete proteome;Disease mutation;Host-virus interaction;Ligase;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger.;"
"AgU004366_v1.1";"1";"p3";"(CTC)6";"18";223;240;"AgU004366";1376;"RAGE_BOVIN";"GO:0016021 // GO:0006954";"inflammatory response (GO:0006954);";"No_GOMF";"integral component of membrane (GO:0016021);";"Complete proteome;Direct protein sequencing;Disulfide bond;Glycoprotein;Immunoglobulin domain;Inflammatory response;Membrane;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix.;"
"AgU004826_v1.1";"1";"p2";"(AT)7";"14";886;899;"AgU004826";1302;"FBX9_HUMAN";"GO:0005737 // GO:0019005 // GO:0000151 // GO:0004842 // GO:0045444 // GO:0045087 // GO:0016567 // GO:0032006 // GO:0031146";"fat cell differentiation (GO:0045444);innate immune response (GO:0045087);protein ubiquitination (GO:0016567);regulation of TOR signaling (GO:0032006);SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146);";"ubiquitin-protein transferase activity (GO:0004842);";"cytoplasm (GO:0005737);SCF ubiquitin ligase complex (GO:0019005);ubiquitin ligase complex (GO:0000151);";"Alternative splicing;Complete proteome;Cytoplasm;Phosphoprotein;Reference proteome;TPR repeat;Ubl conjugation pathway.;"
"AgU005175_v1.1";"1";"p2";"(AT)7";"14";304;317;"AgU005175";1264;"ID2_PONAB";"GO:0005813 // GO:0005737 // GO:0005829 // GO:0005654 // GO:0043234 // GO:0060612 // GO:0003166 // GO:0048469 // GO:0071285 // GO:0090398 // GO:0032922 // GO:0048557 // GO:0061031 // GO:0043153 // GO:0043353 // GO:0061030 // GO:0045475 // GO:0060749 // GO:0033598 // GO:0003149 // GO:0001656 // GO:0001779 // GO:0045578 // GO:0043392 // GO:0010629 // GO:2000178 // GO:0045665 // GO:0048715 // GO:0045668 // GO:0043433 // GO:0000122 // GO:0045892 // GO:0048663 // GO:0021772 // GO:0014003 // GO:0048541 // GO:0048711 // GO:0045777 // GO:0071158 // GO:0045648 // GO:0045600 // GO:0010628 // GO:0045651 // GO:0048661 // GO:0045893 // GO:0042752 // GO:2000045 // GO:0019216 // GO:0006351";"adipose tissue development (GO:0060612);bundle of His development (GO:0003166);cell maturation (GO:0048469);cellular response to lithium ion (GO:0071285);cellular senescence (GO:0090398);circadian regulation of gene expression (GO:0032922);embryonic digestive tract morphogenesis (GO:0048557);endodermal digestive tract morphogenesis (GO:0061031);entrainment of circadian clock by photoperiod (GO:0043153);enucleate erythrocyte differentiation (GO:0043353);epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030);locomotor rhythm (GO:0045475);mammary gland alveolus development (GO:0060749);mammary gland epithelial cell proliferation (GO:0033598);membranous septum morphogenesis (GO:0003149);metanephros development (GO:0001656);natural killer cell differentiation (GO:0001779);negative regulation of B cell differentiation (GO:0045578);negative regulation of DNA binding (GO:0043392);negative regulation of gene expression (GO:0010629);negative regulation of neural precursor cell proliferation (GO:2000178);negative regulation of neuron differentiation (GO:0045665);negative regulation of oligodendrocyte differentiation (GO:0048715);negative regulation of osteoblast differentiation (GO:0045668);negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);negative regulation of transcription, DNA-templated (GO:0045892);neuron fate commitment (GO:0048663);olfactory bulb development (GO:0021772);oligodendrocyte development (GO:0014003);Peyer's patch development (GO:0048541);positive regulation of astrocyte differentiation (GO:0048711);positive regulation of blood pressure (GO:0045777);positive regulation of cell cycle arrest (GO:0071158);positive regulation of erythrocyte differentiation (GO:0045648);positive regulation of fat cell differentiation (GO:0045600);positive regulation of gene expression (GO:0010628);positive regulation of macrophage differentiation (GO:0045651);positive regulation of smooth muscle cell proliferation (GO:0048661);positive regulation of transcription, DNA-templated (GO:0045893);regulation of circadian rhythm (GO:0042752);regulation of G1/S transition of mitotic cell cycle (GO:2000045);regulation of lipid metabolic process (GO:0019216);transcription, DNA-templated (GO:0006351);";"No_GOMF";"centrosome (GO:0005813);cytoplasm (GO:0005737);cytosol (GO:0005829);nucleoplasm (GO:0005654);protein complex (GO:0043234);";"Biological rhythms;Complete proteome;Cytoplasm;Developmental protein;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation.;"
"AgU005564_v1.1";"1";"p2";"(AG)5";"10";1082;1091;"AgU005564";1215;"TRIM5_ATEGE";"GO:0000932 // GO:0005634 // GO:0016874 // GO:0008329 // GO:0004842 // GO:0008270 // GO:0002218 // GO:0006914 // GO:0051607 // GO:0045087 // GO:0002221 // GO:0043123 // GO:0043410 // GO:0051092 // GO:0070534 // GO:0031664";"activation of innate immune response (GO:0002218);autophagy (GO:0006914);defense response to virus (GO:0051607);innate immune response (GO:0045087);pattern recognition receptor signaling pathway (GO:0002221);positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123);positive regulation of MAPK cascade (GO:0043410);positive regulation of NF-kappaB transcription factor activity (GO:0051092);protein K63-linked ubiquitination (GO:0070534);regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664);";"ligase activity (GO:0016874);signaling pattern recognition receptor activity (GO:0008329);ubiquitin-protein transferase activity (GO:0004842);zinc ion binding (GO:0008270);";"cytoplasmic mRNA processing body (GO:0000932);nucleus (GO:0005634);";"Acetylation;Antiviral defense;Autophagy;Coiled coil;Cytoplasm;Immunity;Innate immunity;Ligase;Metal-binding;Nucleus;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger.;"
"AgU005573_v1.1";"1";"p3";"(CCG)5";"15";193;207;"AgU005573";1215;"TNR1A_HUMAN";"GO:0009986 // GO:0005576 // GO:0005615 // GO:0000139 // GO:0005887 // GO:0045121 // GO:0005739 // GO:0005886 // GO:0043235 // GO:0043120 // GO:0005031 // GO:0007166 // GO:0071260 // GO:0019221 // GO:0071550 // GO:0042742 // GO:0090002 // GO:0008625 // GO:0007249 // GO:0006955 // GO:0006954 // GO:0008630 // GO:0007275 // GO:0050728 // GO:2000304 // GO:0043123 // GO:0050729 // GO:0045944 // GO:0042511 // GO:0006693 // GO:0042981 // GO:0042127 // GO:1903140 // GO:0010803 // GO:0032496 // GO:0033209 // GO:0016032";"cell surface receptor signaling pathway (GO:0007166);cellular response to mechanical stimulus (GO:0071260);cytokine-mediated signaling pathway (GO:0019221);death-inducing signaling complex assembly (GO:0071550);defense response to bacterium (GO:0042742);establishment of protein localization to plasma membrane (GO:0090002);extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625);I-kappaB kinase/NF-kappaB signaling (GO:0007249);immune response (GO:0006955);inflammatory response (GO:0006954);intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630);multicellular organismal development (GO:0007275);negative regulation of inflammatory response (GO:0050728);positive regulation of ceramide biosynthetic process (GO:2000304);positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123);positive regulation of inflammatory response (GO:0050729);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511);prostaglandin metabolic process (GO:0006693);regulation of apoptotic process (GO:0042981);regulation of cell proliferation (GO:0042127);regulation of establishment of endothelial barrier (GO:1903140);regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803);response to lipopolysaccharide (GO:0032496);tumor necrosis factor-mediated signaling pathway (GO:0033209);viral process (GO:0016032);";"tumor necrosis factor binding (GO:0043120);tumor necrosis factor-activated receptor activity (GO:0005031);";"cell surface (GO:0009986);extracellular region (GO:0005576);extracellular space (GO:0005615);Golgi membrane (GO:0000139);integral component of plasma membrane (GO:0005887);membrane raft (GO:0045121);mitochondrion (GO:0005739);plasma membrane (GO:0005886);receptor complex (GO:0043235);";"3D-structure;Alternative splicing;Amyloidosis;Apoptosis;Cell membrane;Cleavage on pair of basic residues;Complete proteome;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Golgi apparatus;Host-virus interaction;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix.;"
"AgU005575_v1.1";"1";"p2";"(GA)5";"10";115;124;"AgU005575";1215;"MEF2C_PONAB";"GO:0005737 // GO:0016607 // GO:0005634 // GO:0043234 // GO:0003677 // GO:0035198 // GO:0000977 // GO:0000981 // GO:0000983 // GO:0003700 // GO:0044212 // GO:0001077 // GO:0006915 // GO:0001782 // GO:0042100 // GO:0050853 // GO:0001568 // GO:0001974 // GO:0003211 // GO:0035051 // GO:0071277 // GO:0035690 // GO:0071498 // GO:0071222 // GO:0071374 // GO:0071560 // GO:0035984 // GO:0002062 // GO:0001958 // GO:2001013 // GO:0002467 // GO:0072102 // GO:0007507 // GO:0001947 // GO:0006959 // GO:0007611 // GO:0000165 // GO:0030318 // GO:0007521 // GO:0010629 // GO:0043524 // GO:0030279 // GO:0000122 // GO:0072160 // GO:0014033 // GO:0048666 // GO:0030182 // GO:0001649 // GO:0003151 // GO:0030220 // GO:0010694 // GO:0030890 // GO:2000987 // GO:0030501 // GO:2000727 // GO:0060045 // GO:0010628 // GO:2000111 // GO:0045663 // GO:0045666 // GO:0045669 // GO:0090073 // GO:2001016 // GO:0048643 // GO:0045944 // GO:0045893 // GO:0003138 // GO:0002634 // GO:0045652 // GO:0060025 // GO:0061333 // GO:0003139 // GO:0003185 // GO:0007519 // GO:0051145 // GO:0006366 // GO:0055012";"apoptotic process (GO:0006915);B cell homeostasis (GO:0001782);B cell proliferation (GO:0042100);B cell receptor signaling pathway (GO:0050853);blood vessel development (GO:0001568);blood vessel remodeling (GO:0001974);cardiac ventricle formation (GO:0003211);cardiocyte differentiation (GO:0035051);cellular response to calcium ion (GO:0071277);cellular response to drug (GO:0035690);cellular response to fluid shear stress (GO:0071498);cellular response to lipopolysaccharide (GO:0071222);cellular response to parathyroid hormone stimulus (GO:0071374);cellular response to transforming growth factor beta stimulus (GO:0071560);cellular response to trichostatin A (GO:0035984);chondrocyte differentiation (GO:0002062);endochondral ossification (GO:0001958);epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013);germinal center formation (GO:0002467);glomerulus morphogenesis (GO:0072102);heart development (GO:0007507);heart looping (GO:0001947);humoral immune response (GO:0006959);learning or memory (GO:0007611);MAPK cascade (GO:0000165);melanocyte differentiation (GO:0030318);muscle cell fate determination (GO:0007521);negative regulation of gene expression (GO:0010629);negative regulation of neuron apoptotic process (GO:0043524);negative regulation of ossification (GO:0030279);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);nephron tubule epithelial cell differentiation (GO:0072160);neural crest cell differentiation (GO:0014033);neuron development (GO:0048666);neuron differentiation (GO:0030182);osteoblast differentiation (GO:0001649);outflow tract morphogenesis (GO:0003151);platelet formation (GO:0030220);positive regulation of alkaline phosphatase activity (GO:0010694);positive regulation of B cell proliferation (GO:0030890);positive regulation of behavioral fear response (GO:2000987);positive regulation of bone mineralization (GO:0030501);positive regulation of cardiac muscle cell differentiation (GO:2000727);positive regulation of cardiac muscle cell proliferation (GO:0060045);positive regulation of gene expression (GO:0010628);positive regulation of macrophage apoptotic process (GO:2000111);positive regulation of myoblast differentiation (GO:0045663);positive regulation of neuron differentiation (GO:0045666);positive regulation of osteoblast differentiation (GO:0045669);positive regulation of protein homodimerization activity (GO:0090073);positive regulation of skeletal muscle cell differentiation (GO:2001016);positive regulation of skeletal muscle tissue development (GO:0048643);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of transcription, DNA-templated (GO:0045893);primary heart field specification (GO:0003138);regulation of germinal center formation (GO:0002634);regulation of megakaryocyte differentiation (GO:0045652);regulation of synaptic activity (GO:0060025);renal tubule morphogenesis (GO:0061333);secondary heart field specification (GO:0003139);sinoatrial valve morphogenesis (GO:0003185);skeletal muscle tissue development (GO:0007519);smooth muscle cell differentiation (GO:0051145);transcription from RNA polymerase II promoter (GO:0006366);ventricular cardiac muscle cell differentiation (GO:0055012);";"DNA binding (GO:0003677);miRNA binding (GO:0035198);RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977);RNA polymerase II transcription factor activity, sequence-specific DNA binding (GO:0000981);transcription factor activity, RNA polymerase II core promoter sequence-specific (GO:0000983);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription regulatory region DNA binding (GO:0044212);transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001077);";"cytoplasm (GO:0005737);nuclear speck (GO:0016607);nucleus (GO:0005634);protein complex (GO:0043234);";"Acetylation;Activator;Apoptosis;Complete proteome;Developmental protein;Differentiation;DNA-binding;Isopeptide bond;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation.;"
"AgU005648_v1.1";"1";"p3";"(GCT)7";"21";207;227;"AgU005648";1208;"PVRL2_HUMAN";"GO:0009986 // GO:0005913 // GO:0005911 // GO:0070062 // GO:0005925 // GO:0016021 // GO:0005887 // GO:0005886 // GO:0005915 // GO:0050839 // GO:0015026 // GO:0042802 // GO:0042803 // GO:0005102 // GO:0001618 // GO:0001675 // GO:0034332 // GO:0044406 // GO:0034329 // GO:0032990 // GO:0008037 // GO:0045216 // GO:0044782 // GO:0046814 // GO:0007010 // GO:0051654 // GO:0009566 // GO:0019064 // GO:0007157 // GO:0007156 // GO:0002891 // GO:0033005 // GO:0045954 // GO:0002860 // GO:0050776 // GO:0046596 // GO:0007165 // GO:0030382 // GO:0007286 // GO:0007289 // GO:0042271 // GO:0060370";"acrosome assembly (GO:0001675);adherens junction organization (GO:0034332);adhesion of symbiont to host (GO:0044406);cell junction assembly (GO:0034329);cell part morphogenesis (GO:0032990);cell recognition (GO:0008037);cell-cell junction organization (GO:0045216);cilium organization (GO:0044782);coreceptor-mediated virion attachment to host cell (GO:0046814);cytoskeleton organization (GO:0007010);establishment of mitochondrion localization (GO:0051654);fertilization (GO:0009566);fusion of virus membrane with host plasma membrane (GO:0019064);heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157);homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156);positive regulation of immunoglobulin mediated immune response (GO:0002891);positive regulation of mast cell activation (GO:0033005);positive regulation of natural killer cell mediated cytotoxicity (GO:0045954);positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860);regulation of immune response (GO:0050776);regulation of viral entry into host cell (GO:0046596);signal transduction (GO:0007165);sperm mitochondrion organization (GO:0030382);spermatid development (GO:0007286);spermatid nucleus differentiation (GO:0007289);susceptibility to natural killer cell mediated cytotoxicity (GO:0042271);susceptibility to T cell mediated cytotoxicity (GO:0060370);";"cell adhesion molecule binding (GO:0050839);coreceptor activity (GO:0015026);identical protein binding (GO:0042802);protein homodimerization activity (GO:0042803);receptor binding (GO:0005102);virus receptor activity (GO:0001618);";"cell surface (GO:0009986);cell-cell adherens junction (GO:0005913);cell-cell junction (GO:0005911);extracellular exosome (GO:0070062);focal adhesion (GO:0005925);integral component of membrane (GO:0016021);integral component of plasma membrane (GO:0005887);plasma membrane (GO:0005886);zonula adherens (GO:0005915);";"3D-structure;Alternative splicing;Cell adhesion;Cell membrane;Complete proteome;Disulfide bond;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Immunoglobulin domain;Membrane;Phosphoprotein;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix.;"
"AgU005740_v1.1";"1";"p2";"(GC)5";"10";248;257;"AgU005740";1196;"CD34_CANLF";"GO:0016324 // GO:0009925 // GO:0005737 // GO:0009897 // GO:0036053 // GO:0005887 // GO:0045171 // GO:0005764 // GO:0048471 // GO:0005886 // GO:0030246 // GO:0008283 // GO:0007160 // GO:0003094 // GO:0050900 // GO:0035759 // GO:0030195 // GO:1900035 // GO:1900038 // GO:1901215 // GO:0045019 // GO:0032720 // GO:0045766 // GO:0032733 // GO:0042482 // GO:0071636 // GO:2001214 // GO:0008217 // GO:0016337 // GO:0001894";"cell proliferation (GO:0008283);cell-matrix adhesion (GO:0007160);glomerular filtration (GO:0003094);leukocyte migration (GO:0050900);mesangial cell-matrix adhesion (GO:0035759);negative regulation of blood coagulation (GO:0030195);negative regulation of cellular response to heat (GO:1900035);negative regulation of cellular response to hypoxia (GO:1900038);negative regulation of neuron death (GO:1901215);negative regulation of nitric oxide biosynthetic process (GO:0045019);negative regulation of tumor necrosis factor production (GO:0032720);positive regulation of angiogenesis (GO:0045766);positive regulation of interleukin-10 production (GO:0032733);positive regulation of odontogenesis (GO:0042482);positive regulation of transforming growth factor beta production (GO:0071636);positive regulation of vasculogenesis (GO:2001214);regulation of blood pressure (GO:0008217);single organismal cell-cell adhesion (GO:0016337);tissue homeostasis (GO:0001894);";"carbohydrate binding (GO:0030246);";"apical plasma membrane (GO:0016324);basal plasma membrane (GO:0009925);cytoplasm (GO:0005737);external side of plasma membrane (GO:0009897);glomerular endothelium fenestra (GO:0036053);integral component of plasma membrane (GO:0005887);intercellular bridge (GO:0045171);lysosome (GO:0005764);perinuclear region of cytoplasm (GO:0048471);plasma membrane (GO:0005886);";"Alternative splicing;Cell adhesion;Complete proteome;Direct protein sequencing;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Signal;Transmembrane;Transmembrane helix.;"
"AgU006059_v1.1";"1";"p3";"(CAT)5";"15";397;411;"AgU006059";1160;"PSA1_HUMAN";"GO:0005813 // GO:0005737 // GO:0005829 // GO:0070062 // GO:0005654 // GO:0005634 // GO:0005844 // GO:0000502 // GO:0005839 // GO:0019773 // GO:0004175 // GO:0003723 // GO:0004298 // GO:0000186 // GO:0031145 // GO:0042590 // GO:0002479 // GO:0002474 // GO:0006915 // GO:0007411 // GO:0034641 // GO:0006977 // GO:0007173 // GO:0038095 // GO:0008543 // GO:0000082 // GO:0010467 // GO:0045087 // GO:0008286 // GO:0000165 // GO:0000278 // GO:0043066 // GO:0090090 // GO:0051436 // GO:0048011 // GO:0038061 // GO:0006595 // GO:0090263 // GO:0051437 // GO:0012501 // GO:0010499 // GO:0043161 // GO:0000209 // GO:0007265 // GO:0042981 // GO:0006521 // GO:0043488 // GO:0051439 // GO:0007264 // GO:0044281 // GO:0002223 // GO:0050852 // GO:0033209 // GO:0048010 // GO:0016032";"activation of MAPKK activity (GO:0000186);anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031145);antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590);antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479);antigen processing and presentation of peptide antigen via MHC class I (GO:0002474);apoptotic process (GO:0006915);axon guidance (GO:0007411);cellular nitrogen compound metabolic process (GO:0034641);DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977);epidermal growth factor receptor signaling pathway (GO:0007173);Fc-epsilon receptor signaling pathway (GO:0038095);fibroblast growth factor receptor signaling pathway (GO:0008543);G1/S transition of mitotic cell cycle (GO:0000082);gene expression (GO:0010467);innate immune response (GO:0045087);insulin receptor signaling pathway (GO:0008286);MAPK cascade (GO:0000165);mitotic cell cycle (GO:0000278);negative regulation of apoptotic process (GO:0043066);negative regulation of canonical Wnt signaling pathway (GO:0090090);negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436);neurotrophin TRK receptor signaling pathway (GO:0048011);NIK/NF-kappaB signaling (GO:0038061);polyamine metabolic process (GO:0006595);positive regulation of canonical Wnt signaling pathway (GO:0090263);positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437);programmed cell death (GO:0012501);proteasomal ubiquitin-independent protein catabolic process (GO:0010499);proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161);protein polyubiquitination (GO:0000209);Ras protein signal transduction (GO:0007265);regulation of apoptotic process (GO:0042981);regulation of cellular amino acid metabolic process (GO:0006521);regulation of mRNA stability (GO:0043488);regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439);small GTPase mediated signal transduction (GO:0007264);small molecule metabolic process (GO:0044281);stimulatory C-type lectin receptor signaling pathway (GO:0002223);T cell receptor signaling pathway (GO:0050852);tumor necrosis factor-mediated signaling pathway (GO:0033209);vascular endothelial growth factor receptor signaling pathway (GO:0048010);viral process (GO:0016032);";"endopeptidase activity (GO:0004175);RNA binding (GO:0003723);threonine-type endopeptidase activity (GO:0004298);";"centrosome (GO:0005813);cytoplasm (GO:0005737);cytosol (GO:0005829);extracellular exosome (GO:0070062);nucleoplasm (GO:0005654);nucleus (GO:0005634);polysome (GO:0005844);proteasome complex (GO:0000502);proteasome core complex (GO:0005839);proteasome core complex, alpha-subunit complex (GO:0019773);";"3D-structure;Acetylation;Alternative splicing;Complete proteome;Cytoplasm;Direct protein sequencing;Glycoprotein;Hydrolase;Immunity;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Protease;Proteasome;Reference proteome;Threonine protease;Ubl conjugation.;"
"AgU006102_v1.1";"1";"p2";"(GT)5";"10";807;816;"AgU006102";1150;"SEM3C_PONAB";"GO:0005576 // GO:0007411";"axon guidance (GO:0007411);";"No_GOMF";"extracellular region (GO:0005576);";"Complete proteome;Developmental protein;Differentiation;Disulfide bond;Glycoprotein;Immunoglobulin domain;Neurogenesis;Reference proteome;Secreted;Signal.;"
"AgU006175_v1.1";"1";"p2";"(GA)6";"12";227;238;"AgU006175";1145;"F6PLB9_CANLF";"GO:0032009 // GO:0005783 // GO:0005768 // GO:0016021 // GO:0005764 // GO:0005886 // GO:0043235 // GO:0003725 // GO:0003727 // GO:0035197 // GO:0004888 // GO:0071260 // GO:0051607 // GO:0007252 // GO:0045087 // GO:0002755 // GO:0032722 // GO:0045356 // GO:0045359 // GO:0045078 // GO:0032755 // GO:0045416 // GO:0042346 // GO:0001932 // GO:0034154";"cellular response to mechanical stimulus (GO:0071260);defense response to virus (GO:0051607);I-kappaB phosphorylation (GO:0007252);innate immune response (GO:0045087);MyD88-dependent toll-like receptor signaling pathway (GO:0002755);positive regulation of chemokine production (GO:0032722);positive regulation of interferon-alpha biosynthetic process (GO:0045356);positive regulation of interferon-beta biosynthetic process (GO:0045359);positive regulation of interferon-gamma biosynthetic process (GO:0045078);positive regulation of interleukin-6 production (GO:0032755);positive regulation of interleukin-8 biosynthetic process (GO:0045416);positive regulation of NF-kappaB import into nucleus (GO:0042346);regulation of protein phosphorylation (GO:0001932);toll-like receptor 7 signaling pathway (GO:0034154);";"double-stranded RNA binding (GO:0003725);single-stranded RNA binding (GO:0003727);siRNA binding (GO:0035197);transmembrane signaling receptor activity (GO:0004888);";"early phagosome (GO:0032009);endoplasmic reticulum (GO:0005783);endosome (GO:0005768);integral component of membrane (GO:0016021);lysosome (GO:0005764);plasma membrane (GO:0005886);receptor complex (GO:0043235);";"Complete proteome {ECO:0000313|Proteomes:UP000002254};Immunity {ECO:0000256|SAAS:SAAS00179803};Innate immunity {ECO:0000256|SAAS:SAAS00179803};Leucine-rich repeat {ECO:0000256|SAAS:SAAS00097173};Membrane {ECO:0000256|SAAS:SAAS00307852};Receptor {ECO:0000256|SAAS:SAAS00179802};Reference proteome {ECO:0000313|Proteomes:UP000002254};Repeat {ECO:0000256|SAAS:SAAS00097574};Transmembrane {ECO:0000256|SAAS:SAAS00307852};Transmembrane helix {ECO:0000256|SAAS:SAAS00307852}.;"
"AgU006223_v1.1";"1";"p2";"(TA)5";"10";507;516;"AgU006223";1142;"MP2K3_HUMAN";"GO:0005737 // GO:0005829 // GO:0016020 // GO:0005654 // GO:0005524 // GO:0004708 // GO:0019901 // GO:0004674 // GO:0004713 // GO:0000187 // GO:0060048 // GO:0006954 // GO:0045087 // GO:0002755 // GO:0002756 // GO:0045860 // GO:0045893 // GO:0042981 // GO:0042035 // GO:0007346 // GO:0007165 // GO:0023014 // GO:0051403 // GO:0031098 // GO:0034166 // GO:0034134 // GO:0034138 // GO:0034142 // GO:0034146 // GO:0034162 // GO:0002224 // GO:0038123 // GO:0038124 // GO:0035666";"activation of MAPK activity (GO:0000187);cardiac muscle contraction (GO:0060048);inflammatory response (GO:0006954);innate immune response (GO:0045087);MyD88-dependent toll-like receptor signaling pathway (GO:0002755);MyD88-independent toll-like receptor signaling pathway (GO:0002756);positive regulation of protein kinase activity (GO:0045860);positive regulation of transcription, DNA-templated (GO:0045893);regulation of apoptotic process (GO:0042981);regulation of cytokine biosynthetic process (GO:0042035);regulation of mitotic cell cycle (GO:0007346);signal transduction (GO:0007165);signal transduction by protein phosphorylation (GO:0023014);stress-activated MAPK cascade (GO:0051403);stress-activated protein kinase signaling cascade (GO:0031098);toll-like receptor 10 signaling pathway (GO:0034166);toll-like receptor 2 signaling pathway (GO:0034134);toll-like receptor 3 signaling pathway (GO:0034138);toll-like receptor 4 signaling pathway (GO:0034142);toll-like receptor 5 signaling pathway (GO:0034146);toll-like receptor 9 signaling pathway (GO:0034162);toll-like receptor signaling pathway (GO:0002224);toll-like receptor TLR1 (GO:0038123);toll-like receptor TLR6 (GO:0038124);TRIF-dependent toll-like receptor signaling pathway (GO:0035666);";"ATP binding (GO:0005524);MAP kinase kinase activity (GO:0004708);protein kinase binding (GO:0019901);protein serine/threonine kinase activity (GO:0004674);protein tyrosine kinase activity (GO:0004713);";"cytoplasm (GO:0005737);cytosol (GO:0005829);membrane (GO:0016020);nucleoplasm (GO:0005654);";"Acetylation;Alternative splicing;ATP-binding;Complete proteome;Disease mutation;Kinase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Tyrosine-protein kinase.;"
"AgU006292_v1.1";"1";"p2";"(AT)8";"16";503;518;"AgU006292";1131;"NPTN_MOUSE";"GO:0009986 // GO:0005829 // GO:0016021 // GO:0042734 // GO:0050839 // GO:0004714 // GO:0005105 // GO:0007156 // GO:0060291 // GO:0007204 // GO:0045743 // GO:0048170 // GO:0010976 // GO:0001934 // GO:0007169";"homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156);long-term synaptic potentiation (GO:0060291);positive regulation of cytosolic calcium ion concentration (GO:0007204);positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743);positive regulation of long-term neuronal synaptic plasticity (GO:0048170);positive regulation of neuron projection development (GO:0010976);positive regulation of protein phosphorylation (GO:0001934);transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169);";"cell adhesion molecule binding (GO:0050839);transmembrane receptor protein tyrosine kinase activity (GO:0004714);type 1 fibroblast growth factor receptor binding (GO:0005105);";"cell surface (GO:0009986);cytosol (GO:0005829);integral component of membrane (GO:0016021);presynaptic membrane (GO:0042734);";"Alternative splicing;Cell adhesion;Cell membrane;Complete proteome;Direct protein sequencing;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Neurogenesis;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix.;"
"AgU006300_v1.1";"1";"p2";"(CG)5";"10";544;553;"AgU006300";1130;"TRPM4_HUMAN";"GO:0005783 // GO:0005794 // GO:0016021 // GO:0005654 // GO:0005886 // GO:0005524 // GO:0005227 // GO:0005262 // GO:0002250 // GO:0070588 // GO:0061337 // GO:0002407 // GO:0034220 // GO:0090263 // GO:0008284 // GO:0016925 // GO:0042391 // GO:0002724 // GO:0055085 // GO:0042310";"adaptive immune response (GO:0002250);calcium ion transmembrane transport (GO:0070588);cardiac conduction (GO:0061337);dendritic cell chemotaxis (GO:0002407);ion transmembrane transport (GO:0034220);positive regulation of canonical Wnt signaling pathway (GO:0090263);positive regulation of cell proliferation (GO:0008284);protein sumoylation (GO:0016925);regulation of membrane potential (GO:0042391);regulation of T cell cytokine production (GO:0002724);transmembrane transport (GO:0055085);vasoconstriction (GO:0042310);";"ATP binding (GO:0005524);calcium activated cation channel activity (GO:0005227);calcium channel activity (GO:0005262);";"endoplasmic reticulum (GO:0005783);Golgi apparatus (GO:0005794);integral component of membrane (GO:0016021);nucleoplasm (GO:0005654);plasma membrane (GO:0005886);";"Adaptive immunity;Alternative splicing;ATP-binding;Calcium;Calmodulin-binding;Cell membrane;Coiled coil;Complete proteome;Disease mutation;Endoplasmic reticulum;Golgi apparatus;Immunity;Ion channel;Ion transport;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport;Ubl conjugation.;"
"AgU006317_v1.1";"1";"p2";"(TA)9";"18";797;814;"AgU006317";1129;"CXL10_CANLF";"GO:0009897 // GO:0005615 // GO:0008009 // GO:0048248 // GO:0008201 // GO:0071222 // GO:0070098 // GO:0006935 // GO:0051607 // GO:0042118 // GO:0007186 // GO:0006955 // GO:0006954 // GO:0045662 // GO:1901740 // GO:0030816 // GO:0043950 // GO:0002690 // GO:0090026 // GO:0051281 // GO:2000406 // GO:0042127 // GO:1901509 // GO:0010819 // GO:0032496 // GO:0010818";"cellular response to lipopolysaccharide (GO:0071222);chemokine-mediated signaling pathway (GO:0070098);chemotaxis (GO:0006935);defense response to virus (GO:0051607);endothelial cell activation (GO:0042118);G-protein coupled receptor signaling pathway (GO:0007186);immune response (GO:0006955);inflammatory response (GO:0006954);negative regulation of myoblast differentiation (GO:0045662);negative regulation of myoblast fusion (GO:1901740);positive regulation of cAMP metabolic process (GO:0030816);positive regulation of cAMP-mediated signaling (GO:0043950);positive regulation of leukocyte chemotaxis (GO:0002690);positive regulation of monocyte chemotaxis (GO:0090026);positive regulation of release of sequestered calcium ion into cytosol (GO:0051281);positive regulation of T cell migration (GO:2000406);regulation of cell proliferation (GO:0042127);regulation of endothelial tube morphogenesis (GO:1901509);regulation of T cell chemotaxis (GO:0010819);response to lipopolysaccharide (GO:0032496);T cell chemotaxis (GO:0010818);";"chemokine activity (GO:0008009);CXCR3 chemokine receptor binding (GO:0048248);heparin binding (GO:0008201);";"external side of plasma membrane (GO:0009897);extracellular space (GO:0005615);";"Chemotaxis;Citrullination;Complete proteome;Cytokine;Disulfide bond;Inflammatory response;Reference proteome;Secreted;Signal.;"
"AgU006325_v1.1";"1";"p2";"(TA)5";"10";102;111;"AgU006325";1125;"NPC1_HUMAN";"GO:0005783 // GO:0070062 // GO:0005576 // GO:0005794 // GO:0016021 // GO:0005887 // GO:0031902 // GO:0005765 // GO:0005764 // GO:0016020 // GO:0045121 // GO:0005635 // GO:0048471 // GO:0015485 // GO:0008158 // GO:0004872 // GO:0015248 // GO:0004888 // GO:0001618 // GO:0007628 // GO:0006914 // GO:0008206 // GO:0071404 // GO:0071383 // GO:0033344 // GO:0042632 // GO:0008203 // GO:0030301 // GO:0006897 // GO:0090150 // GO:0007041 // GO:0031579 // GO:0060548 // GO:0016242 // GO:2000189 // GO:0006486 // GO:0046686 // GO:0042493 // GO:0007165 // GO:0046718";"adult walking behavior (GO:0007628);autophagy (GO:0006914);bile acid metabolic process (GO:0008206);cellular response to low-density lipoprotein particle stimulus (GO:0071404);cellular response to steroid hormone stimulus (GO:0071383);cholesterol efflux (GO:0033344);cholesterol homeostasis (GO:0042632);cholesterol metabolic process (GO:0008203);cholesterol transport (GO:0030301);endocytosis (GO:0006897);establishment of protein localization to membrane (GO:0090150);lysosomal transport (GO:0007041);membrane raft organization (GO:0031579);negative regulation of cell death (GO:0060548);negative regulation of macroautophagy (GO:0016242);positive regulation of cholesterol homeostasis (GO:2000189);protein glycosylation (GO:0006486);response to cadmium ion (GO:0046686);response to drug (GO:0042493);signal transduction (GO:0007165);viral entry into host cell (GO:0046718);";"cholesterol binding (GO:0015485);hedgehog receptor activity (GO:0008158);receptor activity (GO:0004872);sterol transporter activity (GO:0015248);transmembrane signaling receptor activity (GO:0004888);virus receptor activity (GO:0001618);";"endoplasmic reticulum (GO:0005783);extracellular exosome (GO:0070062);extracellular region (GO:0005576);Golgi apparatus (GO:0005794);integral component of membrane (GO:0016021);integral component of plasma membrane (GO:0005887);late endosome membrane (GO:0031902);lysosomal membrane (GO:0005765);lysosome (GO:0005764);membrane (GO:0016020);membrane raft (GO:0045121);nuclear envelope (GO:0005635);perinuclear region of cytoplasm (GO:0048471);";"3D-structure;Alternative splicing;Cholesterol metabolism;Complete proteome;Disease mutation;Disulfide bond;Endosome;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Lipid metabolism;Lysosome;Membrane;Niemann-Pick disease;Polymorphism;Receptor;Reference proteome;Signal;Steroid metabolism;Sterol metabolism;Transmembrane;Transmembrane helix.;"
"AgU006325_v1.1";"2";"p2";"(CA)5";"10";539;548;"AgU006325";1125;"NPC1_HUMAN";"GO:0005783 // GO:0070062 // GO:0005576 // GO:0005794 // GO:0016021 // GO:0005887 // GO:0031902 // GO:0005765 // GO:0005764 // GO:0016020 // GO:0045121 // GO:0005635 // GO:0048471 // GO:0015485 // GO:0008158 // GO:0004872 // GO:0015248 // GO:0004888 // GO:0001618 // GO:0007628 // GO:0006914 // GO:0008206 // GO:0071404 // GO:0071383 // GO:0033344 // GO:0042632 // GO:0008203 // GO:0030301 // GO:0006897 // GO:0090150 // GO:0007041 // GO:0031579 // GO:0060548 // GO:0016242 // GO:2000189 // GO:0006486 // GO:0046686 // GO:0042493 // GO:0007165 // GO:0046718";"adult walking behavior (GO:0007628);autophagy (GO:0006914);bile acid metabolic process (GO:0008206);cellular response to low-density lipoprotein particle stimulus (GO:0071404);cellular response to steroid hormone stimulus (GO:0071383);cholesterol efflux (GO:0033344);cholesterol homeostasis (GO:0042632);cholesterol metabolic process (GO:0008203);cholesterol transport (GO:0030301);endocytosis (GO:0006897);establishment of protein localization to membrane (GO:0090150);lysosomal transport (GO:0007041);membrane raft organization (GO:0031579);negative regulation of cell death (GO:0060548);negative regulation of macroautophagy (GO:0016242);positive regulation of cholesterol homeostasis (GO:2000189);protein glycosylation (GO:0006486);response to cadmium ion (GO:0046686);response to drug (GO:0042493);signal transduction (GO:0007165);viral entry into host cell (GO:0046718);";"cholesterol binding (GO:0015485);hedgehog receptor activity (GO:0008158);receptor activity (GO:0004872);sterol transporter activity (GO:0015248);transmembrane signaling receptor activity (GO:0004888);virus receptor activity (GO:0001618);";"endoplasmic reticulum (GO:0005783);extracellular exosome (GO:0070062);extracellular region (GO:0005576);Golgi apparatus (GO:0005794);integral component of membrane (GO:0016021);integral component of plasma membrane (GO:0005887);late endosome membrane (GO:0031902);lysosomal membrane (GO:0005765);lysosome (GO:0005764);membrane (GO:0016020);membrane raft (GO:0045121);nuclear envelope (GO:0005635);perinuclear region of cytoplasm (GO:0048471);";"3D-structure;Alternative splicing;Cholesterol metabolism;Complete proteome;Disease mutation;Disulfide bond;Endosome;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Lipid metabolism;Lysosome;Membrane;Niemann-Pick disease;Polymorphism;Receptor;Reference proteome;Signal;Steroid metabolism;Sterol metabolism;Transmembrane;Transmembrane helix.;"
"AgU006358_v1.1";"1";"p2";"(GA)5";"10";215;224;"AgU006358";1125;"PTMS_HUMAN";"GO:0005634 // GO:0006260 // GO:0002376";"DNA replication (GO:0006260);immune system process (GO:0002376);";"No_GOMF";"nucleus (GO:0005634);";"Acetylation;Complete proteome;Direct protein sequencing;Immunity;Phosphoprotein;Reference proteome.;"
"AgU006358_v1.1";"2";"p3";"(GGC)5";"15";900;914;"AgU006358";1125;"PTMS_HUMAN";"GO:0005634 // GO:0006260 // GO:0002376";"DNA replication (GO:0006260);immune system process (GO:0002376);";"No_GOMF";"nucleus (GO:0005634);";"Acetylation;Complete proteome;Direct protein sequencing;Immunity;Phosphoprotein;Reference proteome.;"
"AgU006421_v1.1";"1";"p2";"(AG)8";"16";311;326;"AgU006421";1115;"CLC2D_HUMAN";"GO:0009986 // GO:0005783 // GO:0005887 // GO:0016020 // GO:0005886 // GO:0030246 // GO:0004888 // GO:0007166 // GO:0050776";"cell surface receptor signaling pathway (GO:0007166);regulation of immune response (GO:0050776);";"carbohydrate binding (GO:0030246);transmembrane signaling receptor activity (GO:0004888);";"cell surface (GO:0009986);endoplasmic reticulum (GO:0005783);integral component of plasma membrane (GO:0005887);membrane (GO:0016020);plasma membrane (GO:0005886);";"3D-structure;Alternative splicing;Cell membrane;Complete proteome;Disulfide bond;Endoplasmic reticulum;Glycoprotein;Lectin;Membrane;Polymorphism;Receptor;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix.;"
"AgU007141_v1.1";"1";"p3";"(GCT)5";"15";341;355;"AgU007141";1045;"ROBO4_HUMAN";"GO:0070062 // GO:0016021 // GO:0004872 // GO:0001525 // GO:0030154 // GO:0030334";"angiogenesis (GO:0001525);cell differentiation (GO:0030154);regulation of cell migration (GO:0030334);";"receptor activity (GO:0004872);";"extracellular exosome (GO:0070062);integral component of membrane (GO:0016021);";"Alternative splicing;Angiogenesis;Complete proteome;Developmental protein;Differentiation;Disulfide bond;Glycoprotein;Immunoglobulin domain;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal.;"
"AgU007556_v1.1";"1";"p2";"(AG)6";"12";107;118;"AgU007556";1018;"BST2_HUMAN";"GO:0031225 // GO:0016324 // GO:0009986 // GO:0005737 // GO:0070062 // GO:0005794 // GO:0005887 // GO:0005770 // GO:0016020 // GO:0045121 // GO:0005771 // GO:0005886 // GO:0008191 // GO:0044822 // GO:0042803 // GO:0004871 // GO:0042113 // GO:0008283 // GO:0007267 // GO:0019221 // GO:0051607 // GO:0006959 // GO:0045087 // GO:0007275 // GO:0030308 // GO:0030336 // GO:0010951 // GO:1901253 // GO:0002737 // GO:0045071 // GO:0043123 // GO:0032956 // GO:0035455 // GO:0035456 // GO:0034341 // GO:0009615 // GO:0060337";"B cell activation (GO:0042113);cell proliferation (GO:0008283);cell-cell signaling (GO:0007267);cytokine-mediated signaling pathway (GO:0019221);defense response to virus (GO:0051607);humoral immune response (GO:0006959);innate immune response (GO:0045087);multicellular organismal development (GO:0007275);negative regulation of cell growth (GO:0030308);negative regulation of cell migration (GO:0030336);negative regulation of endopeptidase activity (GO:0010951);negative regulation of intracellular transport of viral material (GO:1901253);negative regulation of plasmacytoid dendritic cell cytokine production (GO:0002737);negative regulation of viral genome replication (GO:0045071);positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123);regulation of actin cytoskeleton organization (GO:0032956);response to interferon-alpha (GO:0035455);response to interferon-beta (GO:0035456);response to interferon-gamma (GO:0034341);response to virus (GO:0009615);type I interferon signaling pathway (GO:0060337);";"metalloendopeptidase inhibitor activity (GO:0008191);poly(A) RNA binding (GO:0044822);protein homodimerization activity (GO:0042803);signal transducer activity (GO:0004871);";"anchored component of membrane (GO:0031225);apical plasma membrane (GO:0016324);cell surface (GO:0009986);cytoplasm (GO:0005737);extracellular exosome (GO:0070062);Golgi apparatus (GO:0005794);integral component of plasma membrane (GO:0005887);late endosome (GO:0005770);membrane (GO:0016020);membrane raft (GO:0045121);multivesicular body (GO:0005771);plasma membrane (GO:0005886);";"3D-structure;Alternative initiation;Antiviral defense;B-cell activation;Cell membrane;Coiled coil;Complete proteome;Cytoplasm;Disulfide bond;Endosome;Glycoprotein;Golgi apparatus;GPI-anchor;Immunity;Innate immunity;Isopeptide bond;Lipoprotein;Membrane;Polymorphism;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix;Ubl conjugation.;"
"AgU007808_v1.1";"1";"p2";"(TC)5";"10";678;687;"AgU007808";997;"AKIP1_HUMAN";"GO:0005654 // GO:0034446";"substrate adhesion-dependent cell spreading (GO:0034446);";"No_GOMF";"nucleoplasm (GO:0005654);";"Alternative splicing;Complete proteome;Nucleus;Polymorphism;Proto-oncogene;Reference proteome.;"
"AgU007843_v1.1";"1";"p2";"(CA)5";"10";332;341;"AgU007843";995;"SMAD3_RAT";"GO:0005737 // GO:0000790 // GO:0005637 // GO:0005654 // GO:0005634 // GO:0005886 // GO:0043234 // GO:0043235 // GO:0071141 // GO:0071144 // GO:0005667 // GO:0031490 // GO:0000987 // GO:0003677 // GO:0019899 // GO:0000978 // GO:0043565 // GO:0046332 // GO:0000988 // GO:0000983 // GO:0003700 // GO:0008134 // GO:0030618 // GO:0008270 // GO:0097296 // GO:0007050 // GO:0045216 // GO:0048589 // GO:0048701 // GO:0048617 // GO:0009880 // GO:0007492 // GO:0019049 // GO:0097191 // GO:0001947 // GO:0006955 // GO:0002520 // GO:0001701 // GO:0070306 // GO:0001889 // GO:0001707 // GO:0043066 // GO:0030308 // GO:0008285 // GO:0050728 // GO:0045930 // GO:0045668 // GO:0033689 // GO:0042177 // GO:0001933 // GO:0000122 // GO:0061045 // GO:0038092 // GO:0002076 // GO:0048340 // GO:0060039 // GO:0010694 // GO:0030501 // GO:0090263 // GO:0035413 // GO:0030335 // GO:0032332 // GO:0010718 // GO:1901203 // GO:0051894 // GO:0032731 // GO:0050927 // GO:0051496 // GO:0042993 // GO:0045944 // GO:0032916 // GO:0050821 // GO:0051098 // GO:0050678 // GO:0050776 // GO:0016202 // GO:0017015 // GO:0032909 // GO:0001666 // GO:0023019 // GO:0007183 // GO:0060395 // GO:0001756 // GO:0042110 // GO:0030878 // GO:0006351 // GO:0060290 // GO:0007179 // GO:0006810 // GO:0001657";"activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296);cell cycle arrest (GO:0007050);cell-cell junction organization (GO:0045216);developmental growth (GO:0048589);embryonic cranial skeleton morphogenesis (GO:0048701);embryonic foregut morphogenesis (GO:0048617);embryonic pattern specification (GO:0009880);endoderm development (GO:0007492);evasion or tolerance of host defenses by virus (GO:0019049);extrinsic apoptotic signaling pathway (GO:0097191);heart looping (GO:0001947);immune response (GO:0006955);immune system development (GO:0002520);in utero embryonic development (GO:0001701);lens fiber cell differentiation (GO:0070306);liver development (GO:0001889);mesoderm formation (GO:0001707);negative regulation of apoptotic process (GO:0043066);negative regulation of cell growth (GO:0030308);negative regulation of cell proliferation (GO:0008285);negative regulation of inflammatory response (GO:0050728);negative regulation of mitotic cell cycle (GO:0045930);negative regulation of osteoblast differentiation (GO:0045668);negative regulation of osteoblast proliferation (GO:0033689);negative regulation of protein catabolic process (GO:0042177);negative regulation of protein phosphorylation (GO:0001933);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);negative regulation of wound healing (GO:0061045);nodal signaling pathway (GO:0038092);osteoblast development (GO:0002076);paraxial mesoderm morphogenesis (GO:0048340);pericardium development (GO:0060039);positive regulation of alkaline phosphatase activity (GO:0010694);positive regulation of bone mineralization (GO:0030501);positive regulation of canonical Wnt signaling pathway (GO:0090263);positive regulation of catenin import into nucleus (GO:0035413);positive regulation of cell migration (GO:0030335);positive regulation of chondrocyte differentiation (GO:0032332);positive regulation of epithelial to mesenchymal transition (GO:0010718);positive regulation of extracellular matrix assembly (GO:1901203);positive regulation of focal adhesion assembly (GO:0051894);positive regulation of interleukin-1 beta production (GO:0032731);positive regulation of positive chemotaxis (GO:0050927);positive regulation of stress fiber assembly (GO:0051496);positive regulation of transcription factor import into nucleus (GO:0042993);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of transforming growth factor beta3 production (GO:0032916);protein stabilization (GO:0050821);regulation of binding (GO:0051098);regulation of epithelial cell proliferation (GO:0050678);regulation of immune response (GO:0050776);regulation of striated muscle tissue development (GO:0016202);regulation of transforming growth factor beta receptor signaling pathway (GO:0017015);regulation of transforming growth factor beta2 production (GO:0032909);response to hypoxia (GO:0001666);signal transduction involved in regulation of gene expression (GO:0023019);SMAD protein complex assembly (GO:0007183);SMAD protein signal transduction (GO:0060395);somitogenesis (GO:0001756);T cell activation (GO:0042110);thyroid gland development (GO:0030878);transcription, DNA-templated (GO:0006351);transdifferentiation (GO:0060290);transforming growth factor beta receptor signaling pathway (GO:0007179);transport (GO:0006810);ureteric bud development (GO:0001657);";"chromatin DNA binding (GO:0031490);core promoter proximal region sequence-specific DNA binding (GO:0000987);DNA binding (GO:0003677);enzyme binding (GO:0019899);RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978);sequence-specific DNA binding (GO:0043565);SMAD binding (GO:0046332);transcription factor activity, protein binding (GO:0000988);transcription factor activity, RNA polymerase II core promoter sequence-specific (GO:0000983);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription factor binding (GO:0008134);transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity (GO:0030618);zinc ion binding (GO:0008270);";"cytoplasm (GO:0005737);nuclear chromatin (GO:0000790);nuclear inner membrane (GO:0005637);nucleoplasm (GO:0005654);nucleus (GO:0005634);plasma membrane (GO:0005886);protein complex (GO:0043234);receptor complex (GO:0043235);SMAD protein complex (GO:0071141);SMAD2-SMAD3 protein complex (GO:0071144);transcription factor complex (GO:0005667);";"Acetylation;ADP-ribosylation;Complete proteome;Cytoplasm;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc.;"
"AgU007845_v1.1";"1";"p4";"(CATT)6";"24";463;486;"AgU007845";993;"TNR12_HUMAN";"GO:0009986 // GO:0016021 // GO:0005886 // GO:0001726 // GO:0001525 // GO:0097191 // GO:0043065 // GO:0045773 // GO:2001238 // GO:0045765 // GO:0061041 // GO:0006931 // GO:0033209";"angiogenesis (GO:0001525);extrinsic apoptotic signaling pathway (GO:0097191);positive regulation of apoptotic process (GO:0043065);positive regulation of axon extension (GO:0045773);positive regulation of extrinsic apoptotic signaling pathway (GO:2001238);regulation of angiogenesis (GO:0045765);regulation of wound healing (GO:0061041);substrate-dependent cell migration, cell attachment to substrate (GO:0006931);tumor necrosis factor-mediated signaling pathway (GO:0033209);";"No_GOMF";"cell surface (GO:0009986);integral component of membrane (GO:0016021);plasma membrane (GO:0005886);ruffle (GO:0001726);";"3D-structure;Alternative splicing;Angiogenesis;Apoptosis;Cell adhesion;Complete proteome;Developmental protein;Differentiation;Disulfide bond;Membrane;Receptor;Reference proteome;Signal;Transmembrane;Transmembrane helix.;"
"AgU008174_v1.1";"1";"p3";"(CCT)5";"15";147;161;"AgU008174";971;"CD2B2_MOUSE";"GO:0005737 // GO:0016607 // GO:0005654 // GO:0005634 // GO:0005682 // GO:0043021 // GO:0000398 // GO:0010923";"mRNA splicing, via spliceosome (GO:0000398);negative regulation of phosphatase activity (GO:0010923);";"ribonucleoprotein complex binding (GO:0043021);";"cytoplasm (GO:0005737);nuclear speck (GO:0016607);nucleoplasm (GO:0005654);nucleus (GO:0005634);U5 snRNP (GO:0005682);";"Acetylation;Complete proteome;Cytoplasm;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome.;"
"AgU008391_v1.1";"1";"p2";"(CA)20";"40";338;377;"AgU008391";957;"TNR1A_HUMAN";"GO:0009986 // GO:0005576 // GO:0005615 // GO:0000139 // GO:0005887 // GO:0045121 // GO:0005739 // GO:0005886 // GO:0043235 // GO:0043120 // GO:0005031 // GO:0007166 // GO:0071260 // GO:0019221 // GO:0071550 // GO:0042742 // GO:0090002 // GO:0008625 // GO:0007249 // GO:0006955 // GO:0006954 // GO:0008630 // GO:0007275 // GO:0050728 // GO:2000304 // GO:0043123 // GO:0050729 // GO:0045944 // GO:0042511 // GO:0006693 // GO:0042981 // GO:0042127 // GO:1903140 // GO:0010803 // GO:0032496 // GO:0033209 // GO:0016032";"cell surface receptor signaling pathway (GO:0007166);cellular response to mechanical stimulus (GO:0071260);cytokine-mediated signaling pathway (GO:0019221);death-inducing signaling complex assembly (GO:0071550);defense response to bacterium (GO:0042742);establishment of protein localization to plasma membrane (GO:0090002);extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625);I-kappaB kinase/NF-kappaB signaling (GO:0007249);immune response (GO:0006955);inflammatory response (GO:0006954);intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630);multicellular organismal development (GO:0007275);negative regulation of inflammatory response (GO:0050728);positive regulation of ceramide biosynthetic process (GO:2000304);positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123);positive regulation of inflammatory response (GO:0050729);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511);prostaglandin metabolic process (GO:0006693);regulation of apoptotic process (GO:0042981);regulation of cell proliferation (GO:0042127);regulation of establishment of endothelial barrier (GO:1903140);regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803);response to lipopolysaccharide (GO:0032496);tumor necrosis factor-mediated signaling pathway (GO:0033209);viral process (GO:0016032);";"tumor necrosis factor binding (GO:0043120);tumor necrosis factor-activated receptor activity (GO:0005031);";"cell surface (GO:0009986);extracellular region (GO:0005576);extracellular space (GO:0005615);Golgi membrane (GO:0000139);integral component of plasma membrane (GO:0005887);membrane raft (GO:0045121);mitochondrion (GO:0005739);plasma membrane (GO:0005886);receptor complex (GO:0043235);";"3D-structure;Alternative splicing;Amyloidosis;Apoptosis;Cell membrane;Cleavage on pair of basic residues;Complete proteome;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Golgi apparatus;Host-virus interaction;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix.;"
"AgU009399_v1.1";"1";"p2";"(CA)5";"10";665;674;"AgU009399";888;"UFO_MOUSE";"GO:0009986 // GO:0070062 // GO:0005615 // GO:0044228 // GO:0016021 // GO:0005622 // GO:0005886 // GO:0005524 // GO:0001786 // GO:0046982 // GO:0004713 // GO:0004714 // GO:0043277 // GO:0001974 // GO:0048469 // GO:0031668 // GO:0035457 // GO:0071222 // GO:0097028 // GO:0007167 // GO:0034101 // GO:0021885 // GO:0006954 // GO:0045087 // GO:0001779 // GO:0043066 // GO:2000669 // GO:0032689 // GO:0051250 // GO:0043524 // GO:0032720 // GO:0001764 // GO:0042698 // GO:0018108 // GO:0006909 // GO:0030168 // GO:0001961 // GO:0032825 // GO:0048549 // GO:0051897 // GO:0043491 // GO:0032940 // GO:0007283 // GO:0034446 // GO:0060068 // GO:0046718";"apoptotic cell clearance (GO:0043277);blood vessel remodeling (GO:0001974);cell maturation (GO:0048469);cellular response to extracellular stimulus (GO:0031668);cellular response to interferon-alpha (GO:0035457);cellular response to lipopolysaccharide (GO:0071222);dendritic cell differentiation (GO:0097028);enzyme linked receptor protein signaling pathway (GO:0007167);erythrocyte homeostasis (GO:0034101);forebrain cell migration (GO:0021885);inflammatory response (GO:0006954);innate immune response (GO:0045087);natural killer cell differentiation (GO:0001779);negative regulation of apoptotic process (GO:0043066);negative regulation of dendritic cell apoptotic process (GO:2000669);negative regulation of interferon-gamma production (GO:0032689);negative regulation of lymphocyte activation (GO:0051250);negative regulation of neuron apoptotic process (GO:0043524);negative regulation of tumor necrosis factor production (GO:0032720);neuron migration (GO:0001764);ovulation cycle (GO:0042698);peptidyl-tyrosine phosphorylation (GO:0018108);phagocytosis (GO:0006909);platelet activation (GO:0030168);positive regulation of cytokine-mediated signaling pathway (GO:0001961);positive regulation of natural killer cell differentiation (GO:0032825);positive regulation of pinocytosis (GO:0048549);positive regulation of protein kinase B signaling (GO:0051897);protein kinase B signaling (GO:0043491);secretion by cell (GO:0032940);spermatogenesis (GO:0007283);substrate adhesion-dependent cell spreading (GO:0034446);vagina development (GO:0060068);viral entry into host cell (GO:0046718);";"ATP binding (GO:0005524);phosphatidylserine binding (GO:0001786);protein heterodimerization activity (GO:0046982);protein tyrosine kinase activity (GO:0004713);transmembrane receptor protein tyrosine kinase activity (GO:0004714);";"cell surface (GO:0009986);extracellular exosome (GO:0070062);extracellular space (GO:0005615);host cell surface (GO:0044228);integral component of membrane (GO:0016021);intracellular (GO:0005622);plasma membrane (GO:0005886);";"ATP-binding;Cell membrane;Complete proteome;Differentiation;Disulfide bond;Glycoprotein;Immunity;Immunoglobulin domain;Innate immunity;Kinase;Membrane;Nucleotide-binding;Oncogene;Phosphoprotein;Receptor;Reference proteome;Repeat;Signal;Transferase;Transmembrane;Transmembrane helix;Tyrosine-protein kinase;Ubl conjugation.;"
"AgU009504_v1.1";"1";"p3";"(TGC)5";"15";440;454;"AgU009504";879;"EP300_HUMAN";"GO:0000785 // GO:0005737 // GO:0000123 // GO:0005654 // GO:0005634 // GO:0032993 // GO:0005667 // GO:0016407 // GO:0033613 // GO:0050681 // GO:0003823 // GO:0008013 // GO:0003682 // GO:0031490 // GO:0001047 // GO:0003684 // GO:0003677 // GO:0004402 // GO:0004468 // GO:0035257 // GO:0097157 // GO:0008022 // GO:0001102 // GO:0000978 // GO:0000979 // GO:0003713 // GO:0008134 // GO:0001228 // GO:0016746 // GO:0008270 // GO:0006915 // GO:0030183 // GO:0071320 // GO:0071549 // GO:0035690 // GO:0071333 // GO:0034605 // GO:0070301 // GO:0071456 // GO:0071389 // GO:1990090 // GO:0071300 // GO:0035984 // GO:0034644 // GO:0006325 // GO:0007623 // GO:0048565 // GO:0006281 // GO:0045444 // GO:0000086 // GO:0007507 // GO:0043969 // GO:0043966 // GO:0043967 // GO:0045087 // GO:0018393 // GO:0006475 // GO:0042771 // GO:0001889 // GO:0030324 // GO:0035855 // GO:0007613 // GO:0000278 // GO:0018076 // GO:0043154 // GO:2000629 // GO:0000122 // GO:0007399 // GO:0007219 // GO:0006289 // GO:0009887 // GO:0030220 // GO:0043923 // GO:0045773 // GO:0010942 // GO:0045793 // GO:0032967 // GO:0043388 // GO:0010560 // GO:0035066 // GO:0014737 // GO:0032092 // GO:0033160 // GO:0001934 // GO:0050714 // GO:0045862 // GO:0060298 // GO:0051091 // GO:0045944 // GO:0006990 // GO:0045727 // GO:0032481 // GO:0006473 // GO:0043491 // GO:0050821 // GO:0065004 // GO:0060765 // GO:0060177 // GO:0051726 // GO:1900034 // GO:0061418 // GO:0006355 // GO:0090043 // GO:0051592 // GO:0032025 // GO:0043627 // GO:0045471 // GO:0070542 // GO:0001666 // GO:0034612 // GO:0007519 // GO:0001756 // GO:0002223 // GO:0006283 // GO:0016032";"apoptotic process (GO:0006915);B cell differentiation (GO:0030183);cellular response to cAMP (GO:0071320);cellular response to dexamethasone stimulus (GO:0071549);cellular response to drug (GO:0035690);cellular response to glucose stimulus (GO:0071333);cellular response to heat (GO:0034605);cellular response to hydrogen peroxide (GO:0070301);cellular response to hypoxia (GO:0071456);cellular response to mineralocorticoid stimulus (GO:0071389);cellular response to nerve growth factor stimulus (GO:1990090);cellular response to retinoic acid (GO:0071300);cellular response to trichostatin A (GO:0035984);cellular response to UV (GO:0034644);chromatin organization (GO:0006325);circadian rhythm (GO:0007623);digestive tract development (GO:0048565);DNA repair (GO:0006281);fat cell differentiation (GO:0045444);G2/M transition of mitotic cell cycle (GO:0000086);heart development (GO:0007507);histone H2B acetylation (GO:0043969);histone H3 acetylation (GO:0043966);histone H4 acetylation (GO:0043967);innate immune response (GO:0045087);internal peptidyl-lysine acetylation (GO:0018393);internal protein amino acid acetylation (GO:0006475);intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771);liver development (GO:0001889);lung development (GO:0030324);megakaryocyte development (GO:0035855);memory (GO:0007613);mitotic cell cycle (GO:0000278);N-terminal peptidyl-lysine acetylation (GO:0018076);negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154);negative regulation of miRNA metabolic process (GO:2000629);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);nervous system development (GO:0007399);Notch signaling pathway (GO:0007219);nucleotide-excision repair (GO:0006289);organ morphogenesis (GO:0009887);platelet formation (GO:0030220);positive regulation by host of viral transcription (GO:0043923);positive regulation of axon extension (GO:0045773);positive regulation of cell death (GO:0010942);positive regulation of cell size (GO:0045793);positive regulation of collagen biosynthetic process (GO:0032967);positive regulation of DNA binding (GO:0043388);positive regulation of glycoprotein biosynthetic process (GO:0010560);positive regulation of histone acetylation (GO:0035066);positive regulation of muscle atrophy (GO:0014737);positive regulation of protein binding (GO:0032092);positive regulation of protein import into nucleus, translocation (GO:0033160);positive regulation of protein phosphorylation (GO:0001934);positive regulation of protein secretion (GO:0050714);positive regulation of proteolysis (GO:0045862);positive regulation of sarcomere organization (GO:0060298);positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990);positive regulation of translation (GO:0045727);positive regulation of type I interferon production (GO:0032481);protein acetylation (GO:0006473);protein kinase B signaling (GO:0043491);protein stabilization (GO:0050821);protein-DNA complex assembly (GO:0065004);regulation of androgen receptor signaling pathway (GO:0060765);regulation of angiotensin metabolic process (GO:0060177);regulation of cell cycle (GO:0051726);regulation of cellular response to heat (GO:1900034);regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418);regulation of transcription, DNA-templated (GO:0006355);regulation of tubulin deacetylation (GO:0090043);response to calcium ion (GO:0051592);response to cobalt ion (GO:0032025);response to estrogen (GO:0043627);response to ethanol (GO:0045471);response to fatty acid (GO:0070542);response to hypoxia (GO:0001666);response to tumor necrosis factor (GO:0034612);skeletal muscle tissue development (GO:0007519);somitogenesis (GO:0001756);stimulatory C-type lectin receptor signaling pathway (GO:0002223);transcription-coupled nucleotide-excision repair (GO:0006283);viral process (GO:0016032);";"acetyltransferase activity (GO:0016407);activating transcription factor binding (GO:0033613);androgen receptor binding (GO:0050681);antigen binding (GO:0003823);beta-catenin binding (GO:0008013);chromatin binding (GO:0003682);chromatin DNA binding (GO:0031490);core promoter binding (GO:0001047);damaged DNA binding (GO:0003684);DNA binding (GO:0003677);histone acetyltransferase activity (GO:0004402);lysine N-acetyltransferase activity, acting on acetyl phosphate as donor (GO:0004468);nuclear hormone receptor binding (GO:0035257);pre-mRNA intronic binding (GO:0097157);protein C-terminus binding (GO:0008022);RNA polymerase II activating transcription factor binding (GO:0001102);RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978);RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979);transcription coactivator activity (GO:0003713);transcription factor binding (GO:0008134);transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding (GO:0001228);transferase activity, transferring acyl groups (GO:0016746);zinc ion binding (GO:0008270);";"chromatin (GO:0000785);cytoplasm (GO:0005737);histone acetyltransferase complex (GO:0000123);nucleoplasm (GO:0005654);nucleus (GO:0005634);protein-DNA complex (GO:0032993);transcription factor complex (GO:0005667);";"3D-structure;Acetylation;Acyltransferase;Biological rhythms;Bromodomain;Cell cycle;Chromosomal rearrangement;Citrullination;Complete proteome;Cytoplasm;Direct protein sequencing;Disease mutation;Host-virus interaction;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger.;"
"AgU009791_v1.1";"1";"p2";"(AT)5";"10";127;136;"AgU009791";859;"Q7Z5E4_HUMAN";"No_GOcodes";"No_GOBP";"No_GOMF";"No_GOCC";"No_keywords"
"AgU010008_v1.1";"1";"p2";"(CA)8";"16";318;333;"AgU010008";850;"STA5A_HUMAN";"GO:0005737 // GO:0005829 // GO:0005654 // GO:0000979 // GO:0004871 // GO:0003700 // GO:0006103 // GO:0000255 // GO:0097011 // GO:0006101 // GO:0006600 // GO:0046449 // GO:0046543 // GO:0046544 // GO:0060742 // GO:0006631 // GO:0007565 // GO:0006549 // GO:0007259 // GO:0060397 // GO:0007595 // GO:0019915 // GO:0001553 // GO:0061180 // GO:0001779 // GO:0045647 // GO:0033026 // GO:0006107 // GO:0018108 // GO:0048541 // GO:0042104 // GO:0045579 // GO:0045588 // GO:0050729 // GO:0045086 // GO:0060376 // GO:0070668 // GO:0045931 // GO:0040018 // GO:0032825 // GO:0045954 // GO:0045944 // GO:0038161 // GO:0060740 // GO:0030856 // GO:0040014 // GO:0019218 // GO:0006357 // GO:0006105 // GO:0033077 // GO:0043029 // GO:0019530 // GO:0006351 // GO:0006573";"2-oxoglutarate metabolic process (GO:0006103);allantoin metabolic process (GO:0000255);cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011);citrate metabolic process (GO:0006101);creatine metabolic process (GO:0006600);creatinine metabolic process (GO:0046449);development of secondary female sexual characteristics (GO:0046543);development of secondary male sexual characteristics (GO:0046544);epithelial cell differentiation involved in prostate gland development (GO:0060742);fatty acid metabolic process (GO:0006631);female pregnancy (GO:0007565);isoleucine metabolic process (GO:0006549);JAK-STAT cascade (GO:0007259);JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397);lactation (GO:0007595);lipid storage (GO:0019915);luteinization (GO:0001553);mammary gland epithelium development (GO:0061180);natural killer cell differentiation (GO:0001779);negative regulation of erythrocyte differentiation (GO:0045647);negative regulation of mast cell apoptotic process (GO:0033026);oxaloacetate metabolic process (GO:0006107);peptidyl-tyrosine phosphorylation (GO:0018108);Peyer's patch development (GO:0048541);positive regulation of activated T cell proliferation (GO:0042104);positive regulation of B cell differentiation (GO:0045579);positive regulation of gamma-delta T cell differentiation (GO:0045588);positive regulation of inflammatory response (GO:0050729);positive regulation of interleukin-2 biosynthetic process (GO:0045086);positive regulation of mast cell differentiation (GO:0060376);positive regulation of mast cell proliferation (GO:0070668);positive regulation of mitotic cell cycle (GO:0045931);positive regulation of multicellular organism growth (GO:0040018);positive regulation of natural killer cell differentiation (GO:0032825);positive regulation of natural killer cell mediated cytotoxicity (GO:0045954);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);prolactin signaling pathway (GO:0038161);prostate gland epithelium morphogenesis (GO:0060740);regulation of epithelial cell differentiation (GO:0030856);regulation of multicellular organism growth (GO:0040014);regulation of steroid metabolic process (GO:0019218);regulation of transcription from RNA polymerase II promoter (GO:0006357);succinate metabolic process (GO:0006105);T cell differentiation in thymus (GO:0033077);T cell homeostasis (GO:0043029);taurine metabolic process (GO:0019530);transcription, DNA-templated (GO:0006351);valine metabolic process (GO:0006573);";"RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979);signal transducer activity (GO:0004871);transcription factor activity, sequence-specific DNA binding (GO:0003700);";"cytoplasm (GO:0005737);cytosol (GO:0005829);nucleoplasm (GO:0005654);";"Activator;Alternative splicing;Complete proteome;Cytoplasm;DNA-binding;Lactation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;SH2 domain;Transcription;Transcription regulation;Ubl conjugation.;"
"AgU010547_v1.1";"1";"p2";"(AT)6";"12";455;466;"AgU010547";818;"WASL_MOUSE";"GO:0030478 // GO:0005737 // GO:0016023 // GO:0005829 // GO:0070062 // GO:0000139 // GO:0030027 // GO:0005634 // GO:0030036 // GO:0045010 // GO:0051301 // GO:0034629 // GO:0006900 // GO:0007067 // GO:2000402 // GO:1903526 // GO:2000370 // GO:0051491 // GO:0032880 // GO:0006355 // GO:0009617 // GO:0051653 // GO:0006351 // GO:0016050 // GO:0030050";"actin cytoskeleton organization (GO:0030036);actin nucleation (GO:0045010);cell division (GO:0051301);cellular protein complex localization (GO:0034629);membrane budding (GO:0006900);mitotic nuclear division (GO:0007067);negative regulation of lymphocyte migration (GO:2000402);negative regulation of membrane tubulation (GO:1903526);positive regulation of clathrin-mediated endocytosis (GO:2000370);positive regulation of filopodium assembly (GO:0051491);regulation of protein localization (GO:0032880);regulation of transcription, DNA-templated (GO:0006355);response to bacterium (GO:0009617);spindle localization (GO:0051653);transcription, DNA-templated (GO:0006351);vesicle organization (GO:0016050);vesicle transport along actin filament (GO:0030050);";"No_GOMF";"actin cap (GO:0030478);cytoplasm (GO:0005737);cytoplasmic membrane-bounded vesicle (GO:0016023);cytosol (GO:0005829);extracellular exosome (GO:0070062);Golgi membrane (GO:0000139);lamellipodium (GO:0030027);nucleus (GO:0005634);";"3D-structure;Acetylation;Actin-binding;Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoskeleton;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation.;"
"AgU010559_v1.1";"1";"p2";"(AT)6";"12";250;261;"AgU010559";821;"CCL20_BOVIN";"GO:0005615 // GO:0048020 // GO:0008009 // GO:0071346 // GO:0071347 // GO:0071356 // GO:0070098 // GO:0007186 // GO:0006954 // GO:0048247 // GO:0002548 // GO:0030593 // GO:0070374 // GO:0043547 // GO:2000406";"cellular response to interferon-gamma (GO:0071346);cellular response to interleukin-1 (GO:0071347);cellular response to tumor necrosis factor (GO:0071356);chemokine-mediated signaling pathway (GO:0070098);G-protein coupled receptor signaling pathway (GO:0007186);inflammatory response (GO:0006954);lymphocyte chemotaxis (GO:0048247);monocyte chemotaxis (GO:0002548);neutrophil chemotaxis (GO:0030593);positive regulation of ERK1 and ERK2 cascade (GO:0070374);positive regulation of GTPase activity (GO:0043547);positive regulation of T cell migration (GO:2000406);";"CCR chemokine receptor binding (GO:0048020);chemokine activity (GO:0008009);";"extracellular space (GO:0005615);";"Chemotaxis;Complete proteome;Cytokine;Disulfide bond;Inflammatory response;Reference proteome;Secreted;Signal.;"
"AgU010620_v1.1";"1";"p2";"(TG)5";"10";309;318;"AgU010620";819;"AACS_RAT";"GO:0005829 // GO:0030729 // GO:0005524 // GO:0047760 // GO:0060612 // GO:0071397 // GO:0071333 // GO:0071394 // GO:0006631 // GO:0001889 // GO:0032024 // GO:0042493 // GO:0045471 // GO:0007584 // GO:0034201 // GO:0014070 // GO:0010243 // GO:0014074 // GO:0042594 // GO:0050872";"adipose tissue development (GO:0060612);cellular response to cholesterol (GO:0071397);cellular response to glucose stimulus (GO:0071333);cellular response to testosterone stimulus (GO:0071394);fatty acid metabolic process (GO:0006631);liver development (GO:0001889);positive regulation of insulin secretion (GO:0032024);response to drug (GO:0042493);response to ethanol (GO:0045471);response to nutrient (GO:0007584);response to oleic acid (GO:0034201);response to organic cyclic compound (GO:0014070);response to organonitrogen compound (GO:0010243);response to purine-containing compound (GO:0014074);response to starvation (GO:0042594);white fat cell differentiation (GO:0050872);";"acetoacetate-CoA ligase activity (GO:0030729);ATP binding (GO:0005524);butyrate-CoA ligase activity (GO:0047760);";"cytosol (GO:0005829);";"ATP-binding;Complete proteome;Cytoplasm;Direct protein sequencing;Fatty acid metabolism;Ligase;Lipid metabolism;Nucleotide-binding;Reference proteome.;"
"AgU011733_v1.1";"1";"p2";"(CA)5";"10";418;427;"AgU011733";762;"UB2L6_HUMAN";"GO:0005829 // GO:0005654 // GO:0042296 // GO:0004842 // GO:0006464 // GO:0019221 // GO:0006281 // GO:0045087 // GO:0032020 // GO:0019941 // GO:0032480 // GO:0019985";"cellular protein modification process (GO:0006464);cytokine-mediated signaling pathway (GO:0019221);DNA repair (GO:0006281);innate immune response (GO:0045087);ISG15-protein conjugation (GO:0032020);modification-dependent protein catabolic process (GO:0019941);negative regulation of type I interferon production (GO:0032480);translesion synthesis (GO:0019985);";"ISG15 transferase activity (GO:0042296);ubiquitin-protein transferase activity (GO:0004842);";"cytosol (GO:0005829);nucleoplasm (GO:0005654);";"3D-structure;Alternative splicing;Complete proteome;Direct protein sequencing;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway.;"
"AgU011784_v1.1";"1";"p2";"(GC)5";"10";419;428;"AgU011784";760;"ZN580_MOUSE";"GO:0005634 // GO:0046872 // GO:0000977 // GO:0070301 // GO:0006935 // GO:0006954 // GO:0051272 // GO:0010595 // GO:0001938 // GO:0010628 // GO:0032757 // GO:0002690 // GO:0006357 // GO:0006351";"cellular response to hydrogen peroxide (GO:0070301);chemotaxis (GO:0006935);inflammatory response (GO:0006954);positive regulation of cellular component movement (GO:0051272);positive regulation of endothelial cell migration (GO:0010595);positive regulation of endothelial cell proliferation (GO:0001938);positive regulation of gene expression (GO:0010628);positive regulation of interleukin-8 production (GO:0032757);positive regulation of leukocyte chemotaxis (GO:0002690);regulation of transcription from RNA polymerase II promoter (GO:0006357);transcription, DNA-templated (GO:0006351);";"metal ion binding (GO:0046872);RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977);";"nucleus (GO:0005634);";"Chemotaxis;Complete proteome;DNA-binding;Inflammatory response;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger.;"
"AgU013299_v1.1";"1";"p2";"(AC)5";"10";546;555;"AgU013299";694;"RN125_MACFA";"GO:0016874 // GO:0008270 // GO:0002250 // GO:0016567";"adaptive immune response (GO:0002250);protein ubiquitination (GO:0016567);";"ligase activity (GO:0016874);zinc ion binding (GO:0008270);";"No_GOCC";"Adaptive immunity;Immunity;Ligase;Lipoprotein;Metal-binding;Myristate;Ubl conjugation pathway;Zinc;Zinc-finger.;"
"AgU013484_v1.1";"1";"p2";"(TC)5";"10";389;398;"AgU013484";686;"DYHC1_HUMAN";"GO:0005813 // GO:0005868 // GO:0005829 // GO:0070062 // GO:0030175 // GO:0016020 // GO:0005874 // GO:0005524 // GO:0016887 // GO:0003777 // GO:0044822 // GO:0019886 // GO:0033962 // GO:0051293 // GO:0000086 // GO:0007018 // GO:0000278 // GO:0007052 // GO:0006996 // GO:0034063 // GO:0006810";"antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886);cytoplasmic mRNA processing body assembly (GO:0033962);establishment of spindle localization (GO:0051293);G2/M transition of mitotic cell cycle (GO:0000086);microtubule-based movement (GO:0007018);mitotic cell cycle (GO:0000278);mitotic spindle organization (GO:0007052);organelle organization (GO:0006996);stress granule assembly (GO:0034063);transport (GO:0006810);";"ATP binding (GO:0005524);ATPase activity (GO:0016887);microtubule motor activity (GO:0003777);poly(A) RNA binding (GO:0044822);";"centrosome (GO:0005813);cytoplasmic dynein complex (GO:0005868);cytosol (GO:0005829);extracellular exosome (GO:0070062);filopodium (GO:0030175);membrane (GO:0016020);microtubule (GO:0005874);";"3D-structure;Acetylation;ATP-binding;Charcot-Marie-Tooth disease;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Dynein;Mental retardation;Microtubule;Motor protein;Neurodegeneration;Neuropathy;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transport.;"
"AgU013617_v1.1";"1";"p2";"(TC)5";"10";295;304;"AgU013617";680;"MARH7_HUMAN";"GO:0016874 // GO:0008270 // GO:0042130 // GO:0016567 // GO:0002643";"negative regulation of T cell proliferation (GO:0042130);protein ubiquitination (GO:0016567);regulation of tolerance induction (GO:0002643);";"ligase activity (GO:0016874);zinc ion binding (GO:0008270);";"No_GOCC";"Acetylation;Alternative splicing;Complete proteome;Ligase;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation pathway;Zinc;Zinc-finger.;"
"AgU013753_v1.1";"1";"p3";"(TTC)5";"15";484;498;"AgU013753";675;"MYH10_MOUSE";"GO:0015629 // GO:0042641 // GO:0030424 // GO:0005903 // GO:0005938 // GO:0032154 // GO:0005737 // GO:0005829 // GO:0043197 // GO:0070062 // GO:0030426 // GO:0030027 // GO:0030496 // GO:0005739 // GO:0016459 // GO:0016460 // GO:0097513 // GO:0043005 // GO:0043025 // GO:0005634 // GO:0001725 // GO:0051015 // GO:0030898 // GO:0043531 // GO:0005524 // GO:0000146 // GO:0030036 // GO:0030048 // GO:0031032 // GO:0007512 // GO:0035904 // GO:0007411 // GO:0007409 // GO:0007420 // GO:0055003 // GO:0003279 // GO:0007155 // GO:0008283 // GO:0021680 // GO:0060976 // GO:0006887 // GO:0021592 // GO:0007507 // GO:0001701 // GO:0021670 // GO:0000281 // GO:0030239 // GO:0050885 // GO:0001764 // GO:0031175 // GO:0007097 // GO:0001778 // GO:0008360 // GO:0060041 // GO:0006930 // GO:0021678 // GO:0055015";"actin cytoskeleton organization (GO:0030036);actin filament-based movement (GO:0030048);actomyosin structure organization (GO:0031032);adult heart development (GO:0007512);aorta development (GO:0035904);axon guidance (GO:0007411);axonogenesis (GO:0007409);brain development (GO:0007420);cardiac myofibril assembly (GO:0055003);cardiac septum development (GO:0003279);cell adhesion (GO:0007155);cell proliferation (GO:0008283);cerebellar Purkinje cell layer development (GO:0021680);coronary vasculature development (GO:0060976);exocytosis (GO:0006887);fourth ventricle development (GO:0021592);heart development (GO:0007507);in utero embryonic development (GO:0001701);lateral ventricle development (GO:0021670);mitotic cytokinesis (GO:0000281);myofibril assembly (GO:0030239);neuromuscular process controlling balance (GO:0050885);neuron migration (GO:0001764);neuron projection development (GO:0031175);nuclear migration (GO:0007097);plasma membrane repair (GO:0001778);regulation of cell shape (GO:0008360);retina development in camera-type eye (GO:0060041);substrate-dependent cell migration, cell extension (GO:0006930);third ventricle development (GO:0021678);ventricular cardiac muscle cell development (GO:0055015);";"actin filament binding (GO:0051015);actin-dependent ATPase activity (GO:0030898);ADP binding (GO:0043531);ATP binding (GO:0005524);microfilament motor activity (GO:0000146);";"actin cytoskeleton (GO:0015629);actomyosin (GO:0042641);axon (GO:0030424);brush border (GO:0005903);cell cortex (GO:0005938);cleavage furrow (GO:0032154);cytoplasm (GO:0005737);cytosol (GO:0005829);dendritic spine (GO:0043197);extracellular exosome (GO:0070062);growth cone (GO:0030426);lamellipodium (GO:0030027);midbody (GO:0030496);mitochondrion (GO:0005739);myosin complex (GO:0016459);myosin II complex (GO:0016460);myosin II filament (GO:0097513);neuron projection (GO:0043005);neuronal cell body (GO:0043025);nucleus (GO:0005634);stress fiber (GO:0001725);";"Acetylation;Actin-binding;ATP-binding;Calmodulin-binding;Cell adhesion;Cell projection;Cell shape;Coiled coil;Complete proteome;Motor protein;Myosin;Nucleotide-binding;Phosphoprotein;Reference proteome.;"
"AgU013922_v1.1";"1";"p2";"(GT)5";"10";310;319;"AgU013922";669;"ICAM3_PANTR";"GO:0016021 // GO:0016337";"single organismal cell-cell adhesion (GO:0016337);";"No_GOMF";"integral component of membrane (GO:0016021);";"Cell adhesion;Complete proteome;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix.;"
"AgU014161_v1.1";"1";"p2";"(CT)5";"10";304;313;"AgU014161";660;"CSPG2_BOVIN";"GO:0005578 // GO:0005509 // GO:0030246 // GO:0005540 // GO:0007155";"cell adhesion (GO:0007155);";"calcium ion binding (GO:0005509);carbohydrate binding (GO:0030246);hyaluronic acid binding (GO:0005540);";"proteinaceous extracellular matrix (GO:0005578);";"Alternative splicing;Calcium;Complete proteome;Direct protein sequencing;Disulfide bond;EGF-like domain;Extracellular matrix;Glycoprotein;Hyaluronic acid;Immunoglobulin domain;Lectin;Phosphoprotein;Proteoglycan;Reference proteome;Repeat;Secreted;Signal;Sushi.;"
"AgU014501_v1.1";"1";"p2";"(GA)5";"10";300;309;"AgU014501";647;"NKAP_HUMAN";"GO:0005737 // GO:0005654 // GO:0003682 // GO:0031490 // GO:0044822 // GO:0030851 // GO:0071425 // GO:0000122 // GO:0045892 // GO:0007219 // GO:0046638 // GO:1903955 // GO:0019827 // GO:0033077 // GO:0006351";"granulocyte differentiation (GO:0030851);hematopoietic stem cell proliferation (GO:0071425);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);negative regulation of transcription, DNA-templated (GO:0045892);Notch signaling pathway (GO:0007219);positive regulation of alpha-beta T cell differentiation (GO:0046638);positive regulation of protein targeting to mitochondrion (GO:1903955);stem cell population maintenance (GO:0019827);T cell differentiation in thymus (GO:0033077);transcription, DNA-templated (GO:0006351);";"chromatin binding (GO:0003682);chromatin DNA binding (GO:0031490);poly(A) RNA binding (GO:0044822);";"cytoplasm (GO:0005737);nucleoplasm (GO:0005654);";"Acetylation;Complete proteome;Notch signaling pathway;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation.;"
"AgU014501_v1.1";"2";"p3";"(AGA)6";"18";445;462;"AgU014501";647;"NKAP_HUMAN";"GO:0005737 // GO:0005654 // GO:0003682 // GO:0031490 // GO:0044822 // GO:0030851 // GO:0071425 // GO:0000122 // GO:0045892 // GO:0007219 // GO:0046638 // GO:1903955 // GO:0019827 // GO:0033077 // GO:0006351";"granulocyte differentiation (GO:0030851);hematopoietic stem cell proliferation (GO:0071425);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);negative regulation of transcription, DNA-templated (GO:0045892);Notch signaling pathway (GO:0007219);positive regulation of alpha-beta T cell differentiation (GO:0046638);positive regulation of protein targeting to mitochondrion (GO:1903955);stem cell population maintenance (GO:0019827);T cell differentiation in thymus (GO:0033077);transcription, DNA-templated (GO:0006351);";"chromatin binding (GO:0003682);chromatin DNA binding (GO:0031490);poly(A) RNA binding (GO:0044822);";"cytoplasm (GO:0005737);nucleoplasm (GO:0005654);";"Acetylation;Complete proteome;Notch signaling pathway;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation.;"
"AgU032052_v1.1";"1";"p2";"(AT)6";"12";1875;1886;"AgU032052";3120;"SKAP2_HUMAN";"GO:0005737 // GO:0005829 // GO:0005654 // GO:0005886 // GO:0005070 // GO:0042113 // GO:0002757 // GO:0009967 // GO:0006461 // GO:0007165";"B cell activation (GO:0042113);immune response-activating signal transduction (GO:0002757);positive regulation of signal transduction (GO:0009967);protein complex assembly (GO:0006461);signal transduction (GO:0007165);";"SH3/SH2 adaptor activity (GO:0005070);";"cytoplasm (GO:0005737);cytosol (GO:0005829);nucleoplasm (GO:0005654);plasma membrane (GO:0005886);";"3D-structure;B-cell activation;Complete proteome;Cytoplasm;Phosphoprotein;Polymorphism;Reference proteome;SH3 domain.;"
"AgU032202_v1.1";"1";"p2";"(AG)5";"10";799;808;"AgU032202";1225;"LEG3_CANLF";"GO:0005737 // GO:0005576 // GO:0005681 // GO:0030246 // GO:0030154 // GO:0045087 // GO:0006397 // GO:0008380";"cell differentiation (GO:0030154);innate immune response (GO:0045087);mRNA processing (GO:0006397);RNA splicing (GO:0008380);";"carbohydrate binding (GO:0030246);";"cytoplasm (GO:0005737);extracellular region (GO:0005576);spliceosomal complex (GO:0005681);";"Acetylation;Complete proteome;Cytoplasm;Differentiation;Direct protein sequencing;Disulfide bond;IgE-binding protein;Immunity;Innate immunity;Lectin;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome;Repeat;Secreted;Spliceosome.;"
"AgU032055_v1.1";"1";"p2";"(TA)5";"10";524;533;"AgU032055";2840;"TXNIP_HUMAN";"GO:0005737 // GO:0005829 // GO:0005758 // GO:0005634 // GO:0004857 // GO:0031625 // GO:0007049 // GO:0071228 // GO:0045087 // GO:0030216 // GO:0051782 // GO:0000122 // GO:0035872 // GO:0048008 // GO:0043065 // GO:0006606 // GO:0042127 // GO:0051592 // GO:0042493 // GO:0032355 // GO:0009749 // GO:0042542 // GO:0009612 // GO:0032570 // GO:0006351";"cell cycle (GO:0007049);cellular response to tumor cell (GO:0071228);innate immune response (GO:0045087);keratinocyte differentiation (GO:0030216);negative regulation of cell division (GO:0051782);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872);platelet-derived growth factor receptor signaling pathway (GO:0048008);positive regulation of apoptotic process (GO:0043065);protein import into nucleus (GO:0006606);regulation of cell proliferation (GO:0042127);response to calcium ion (GO:0051592);response to drug (GO:0042493);response to estradiol (GO:0032355);response to glucose (GO:0009749);response to hydrogen peroxide (GO:0042542);response to mechanical stimulus (GO:0009612);response to progesterone (GO:0032570);transcription, DNA-templated (GO:0006351);";"enzyme inhibitor activity (GO:0004857);ubiquitin protein ligase binding (GO:0031625);";"cytoplasm (GO:0005737);cytosol (GO:0005829);mitochondrial intermembrane space (GO:0005758);nucleus (GO:0005634);";"3D-structure;Alternative splicing;Cell cycle;Complete proteome;Cytoplasm;Disulfide bond;Isopeptide bond;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation.;"
"AgU032268_v1.1";"1";"p2";"(AC)21";"42";553;594;"AgU032268";1505;"CD59_PIG";"GO:0031362 // GO:0009986 // GO:0070062 // GO:0005615 // GO:0005925 // GO:0005886 // GO:0001848 // GO:0007166 // GO:0045087 // GO:0030449";"cell surface receptor signaling pathway (GO:0007166);innate immune response (GO:0045087);regulation of complement activation (GO:0030449);";"complement binding (GO:0001848);";"anchored component of external side of plasma membrane (GO:0031362);cell surface (GO:0009986);extracellular exosome (GO:0070062);extracellular space (GO:0005615);focal adhesion (GO:0005925);plasma membrane (GO:0005886);";"Cell membrane;Complete proteome;Direct protein sequencing;Disulfide bond;Glycoprotein;GPI-anchor;Lipoprotein;Membrane;Reference proteome;Signal.;"
"AgU025816_v1.1";"1";"p3";"(GGA)6";"18";126;143;"AgU025816";321;"HS90A_HUMAN";"GO:0005737 // GO:0005829 // GO:0071682 // GO:0070062 // GO:0005576 // GO:0043202 // GO:0042470 // GO:0016020 // GO:0043209 // GO:0005654 // GO:0005634 // GO:0005886 // GO:0032587 // GO:0005524 // GO:0016887 // GO:0051020 // GO:0042802 // GO:0023026 // GO:0030235 // GO:0000166 // GO:0044822 // GO:0042803 // GO:0030911 // GO:0007411 // GO:0034605 // GO:0061684 // GO:0051131 // GO:0038096 // GO:0000086 // GO:0045087 // GO:0006839 // GO:0000278 // GO:0046209 // GO:0006996 // GO:0045429 // GO:0045040 // GO:0042026 // GO:0006898 // GO:1900034 // GO:0050999 // GO:0046677 // GO:0009409 // GO:0009408 // GO:0006986 // GO:0007165 // GO:0044281 // GO:0048010";"axon guidance (GO:0007411);cellular response to heat (GO:0034605);chaperone-mediated autophagy (GO:0061684);chaperone-mediated protein complex assembly (GO:0051131);Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096);G2/M transition of mitotic cell cycle (GO:0000086);innate immune response (GO:0045087);mitochondrial transport (GO:0006839);mitotic cell cycle (GO:0000278);nitric oxide metabolic process (GO:0046209);organelle organization (GO:0006996);positive regulation of nitric oxide biosynthetic process (GO:0045429);protein import into mitochondrial outer membrane (GO:0045040);protein refolding (GO:0042026);receptor-mediated endocytosis (GO:0006898);regulation of cellular response to heat (GO:1900034);regulation of nitric-oxide synthase activity (GO:0050999);response to antibiotic (GO:0046677);response to cold (GO:0009409);response to heat (GO:0009408);response to unfolded protein (GO:0006986);signal transduction (GO:0007165);small molecule metabolic process (GO:0044281);vascular endothelial growth factor receptor signaling pathway (GO:0048010);";"ATP binding (GO:0005524);ATPase activity (GO:0016887);GTPase binding (GO:0051020);identical protein binding (GO:0042802);MHC class II protein complex binding (GO:0023026);nitric-oxide synthase regulator activity (GO:0030235);nucleotide binding (GO:0000166);poly(A) RNA binding (GO:0044822);protein homodimerization activity (GO:0042803);TPR domain binding (GO:0030911);";"cytoplasm (GO:0005737);cytosol (GO:0005829);endocytic vesicle lumen (GO:0071682);extracellular exosome (GO:0070062);extracellular region (GO:0005576);lysosomal lumen (GO:0043202);melanosome (GO:0042470);membrane (GO:0016020);myelin sheath (GO:0043209);nucleoplasm (GO:0005654);nucleus (GO:0005634);plasma membrane (GO:0005886);ruffle membrane (GO:0032587);";"3D-structure;Acetylation;Alternative splicing;ATP-binding;Cell membrane;Chaperone;Complete proteome;Cytoplasm;Direct protein sequencing;Membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;S-nitrosylation;Stress response;Ubl conjugation.;"
"AgU032568_v1.1";"1";"p3";"(CCT)6";"18";365;382;"AgU032568";1568;"KIF3B_HUMAN";"GO:0005813 // GO:0097542 // GO:0005829 // GO:0070062 // GO:0030990 // GO:0016939 // GO:0016020 // GO:0005874 // GO:0015630 // GO:0030496 // GO:0005873 // GO:0072372 // GO:0005819 // GO:0005524 // GO:0008574 // GO:0003777 // GO:0017048 // GO:0008089 // GO:0019886 // GO:0007596 // GO:0007368 // GO:0061024 // GO:0007018 // GO:0007100 // GO:0090307 // GO:0007052 // GO:0006996 // GO:0072383 // GO:0032467";"anterograde axon cargo transport (GO:0008089);antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886);blood coagulation (GO:0007596);determination of left/right symmetry (GO:0007368);membrane organization (GO:0061024);microtubule-based movement (GO:0007018);mitotic centrosome separation (GO:0007100);mitotic spindle assembly (GO:0090307);mitotic spindle organization (GO:0007052);organelle organization (GO:0006996);plus-end-directed vesicle transport along microtubule (GO:0072383);positive regulation of cytokinesis (GO:0032467);";"ATP binding (GO:0005524);ATP-dependent microtubule motor activity, plus-end-directed (GO:0008574);microtubule motor activity (GO:0003777);Rho GTPase binding (GO:0017048);";"centrosome (GO:0005813);ciliary tip (GO:0097542);cytosol (GO:0005829);extracellular exosome (GO:0070062);intraciliary transport particle (GO:0030990);kinesin II complex (GO:0016939);membrane (GO:0016020);microtubule (GO:0005874);microtubule cytoskeleton (GO:0015630);midbody (GO:0030496);plus-end kinesin complex (GO:0005873);primary cilium (GO:0072372);spindle (GO:0005819);";"3D-structure;Acetylation;Alternative splicing;ATP-binding;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Microtubule;Motor protein;Nucleotide-binding;Reference proteome.;"
"AgU032760_v1.1";"1";"p3";"(AGA)6";"18";122;139;"AgU032760";426;"CHD7_HUMAN";"GO:0005730 // GO:0005634 // GO:0005524 // GO:0003682 // GO:0004386 // GO:0000978 // GO:0007512 // GO:0007628 // GO:0048844 // GO:0008015 // GO:0007417 // GO:0016568 // GO:0050890 // GO:0021545 // GO:0035116 // GO:0060429 // GO:0060324 // GO:0030540 // GO:0048806 // GO:0003007 // GO:0001701 // GO:0042472 // GO:0060173 // GO:0043584 // GO:0042048 // GO:0021772 // GO:0021553 // GO:0060021 // GO:0040018 // GO:0060123 // GO:0050767 // GO:0006355 // GO:0060041 // GO:0006364 // GO:0048752 // GO:0007605 // GO:0001501 // GO:0030217 // GO:0006351";"adult heart development (GO:0007512);adult walking behavior (GO:0007628);artery morphogenesis (GO:0048844);blood circulation (GO:0008015);central nervous system development (GO:0007417);chromatin modification (GO:0016568);cognition (GO:0050890);cranial nerve development (GO:0021545);embryonic hindlimb morphogenesis (GO:0035116);epithelium development (GO:0060429);face development (GO:0060324);female genitalia development (GO:0030540);genitalia development (GO:0048806);heart morphogenesis (GO:0003007);in utero embryonic development (GO:0001701);inner ear morphogenesis (GO:0042472);limb development (GO:0060173);nose development (GO:0043584);olfactory behavior (GO:0042048);olfactory bulb development (GO:0021772);olfactory nerve development (GO:0021553);palate development (GO:0060021);positive regulation of multicellular organism growth (GO:0040018);regulation of growth hormone secretion (GO:0060123);regulation of neurogenesis (GO:0050767);regulation of transcription, DNA-templated (GO:0006355);retina development in camera-type eye (GO:0060041);rRNA processing (GO:0006364);semicircular canal morphogenesis (GO:0048752);sensory perception of sound (GO:0007605);skeletal system development (GO:0001501);T cell differentiation (GO:0030217);transcription, DNA-templated (GO:0006351);";"ATP binding (GO:0005524);chromatin binding (GO:0003682);helicase activity (GO:0004386);RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978);";"nucleolus (GO:0005730);nucleus (GO:0005634);";"3D-structure;Alternative splicing;ATP-binding;Chromatin regulator;Coiled coil;Complete proteome;Disease mutation;DNA-binding;Helicase;Hydrolase;Hypogonadotropic hypogonadism;Kallmann syndrome;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;rRNA processing;Transcription;Transcription regulation.;"
"4741325_length_871_cvg_4.5_tip_1";"1";"p2";"(CA)5";"10";760;769;"4741325";871;"GCSAM_HUMAN";"GO:0005737 // GO:0005886 // GO:0003779 // GO:0045159 // GO:0019901 // GO:2000402 // GO:0050855";"negative regulation of lymphocyte migration (GO:2000402);regulation of B cell receptor signaling pathway (GO:0050855);";"actin binding (GO:0003779);myosin II binding (GO:0045159);protein kinase binding (GO:0019901);";"cytoplasm (GO:0005737);plasma membrane (GO:0005886);";"Alternative splicing;Cell membrane;Complete proteome;Cytoplasm;Membrane;Phosphoprotein;Reference proteome.;"
"4744327_length_942_cvg_8.2_tip_1";"1";"p2";"(AG)5";"10";120;129;"4744327";942;"IFIH1_HUMAN";"GO:0005829 // GO:0005634 // GO:0005524 // GO:0003677 // GO:0003725 // GO:0004386 // GO:0043021 // GO:0003727 // GO:0008270 // GO:0039528 // GO:0009597 // GO:0045087 // GO:0039530 // GO:0032480 // GO:0032727 // GO:0032728 // GO:0016925 // GO:0034344 // GO:0009615 // GO:0016032";"cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528);detection of virus (GO:0009597);innate immune response (GO:0045087);MDA-5 signaling pathway (GO:0039530);negative regulation of type I interferon production (GO:0032480);positive regulation of interferon-alpha production (GO:0032727);positive regulation of interferon-beta production (GO:0032728);protein sumoylation (GO:0016925);regulation of type III interferon production (GO:0034344);response to virus (GO:0009615);viral process (GO:0016032);";"ATP binding (GO:0005524);DNA binding (GO:0003677);double-stranded RNA binding (GO:0003725);helicase activity (GO:0004386);ribonucleoprotein complex binding (GO:0043021);single-stranded RNA binding (GO:0003727);zinc ion binding (GO:0008270);";"cytosol (GO:0005829);nucleus (GO:0005634);";"3D-structure;Aicardi-Goutieres syndrome;Alternative splicing;Antiviral defense;ATP-binding;Complete proteome;Cytoplasm;Diabetes mellitus;Disease mutation;Helicase;Host-virus interaction;Hydrolase;Immunity;Innate immunity;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;RNA-binding;Ubl conjugation;Zinc.;"
"4744731_length_953_cvg_17.8_tip_0";"1";"p2";"(GA)6";"12";219;230;"4744731";953;"CD20_CANLF";"GO:0016021 // GO:0005886 // GO:0042113";"B cell activation (GO:0042113);";"No_GOMF";"integral component of membrane (GO:0016021);plasma membrane (GO:0005886);";"B-cell activation;Cell membrane;Complete proteome;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix.;"
"4744731_length_953_cvg_17.8_tip_0";"2";"p3";"(TTC)5";"15";466;480;"4744731";953;"CD20_CANLF";"GO:0016021 // GO:0005886 // GO:0042113";"B cell activation (GO:0042113);";"No_GOMF";"integral component of membrane (GO:0016021);plasma membrane (GO:0005886);";"B-cell activation;Cell membrane;Complete proteome;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix.;"
"4746463_length_1006_cvg_3.8_tip_1";"1";"p3";"(GGC)6";"18";102;119;"4746463";1006;"EGR2_PIG";"GO:0005737 // GO:0005634 // GO:0003682 // GO:0016874 // GO:0046872 // GO:0000978 // GO:0003700 // GO:0044212 // GO:0001077 // GO:0035284 // GO:0071320 // GO:0071371 // GO:0021612 // GO:0045444 // GO:0008045 // GO:0042552 // GO:0043066 // GO:0045893 // GO:0006611 // GO:0016925 // GO:0048168 // GO:0030278 // GO:0021660 // GO:0021666 // GO:0007622 // GO:0014037 // GO:0035914";"brain segmentation (GO:0035284);cellular response to cAMP (GO:0071320);cellular response to gonadotropin stimulus (GO:0071371);facial nerve structural organization (GO:0021612);fat cell differentiation (GO:0045444);motor neuron axon guidance (GO:0008045);myelination (GO:0042552);negative regulation of apoptotic process (GO:0043066);positive regulation of transcription, DNA-templated (GO:0045893);protein export from nucleus (GO:0006611);protein sumoylation (GO:0016925);regulation of neuronal synaptic plasticity (GO:0048168);regulation of ossification (GO:0030278);rhombomere 3 formation (GO:0021660);rhombomere 5 formation (GO:0021666);rhythmic behavior (GO:0007622);Schwann cell differentiation (GO:0014037);skeletal muscle cell differentiation (GO:0035914);";"chromatin binding (GO:0003682);ligase activity (GO:0016874);metal ion binding (GO:0046872);RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978);transcription factor activity, sequence-specific DNA binding (GO:0003700);transcription regulatory region DNA binding (GO:0044212);transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001077);";"cytoplasm (GO:0005737);nucleus (GO:0005634);";"Activator;Complete proteome;DNA-binding;Ligase;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger.;"
"4750219_length_1140_cvg_4.7_tip_1";"1";"p2";"(CT)5";"10";568;577;"4750219";1140;"SNAI1_HUMAN";"GO:0005737 // GO:0005634 // GO:0019900 // GO:0046872 // GO:0000977 // GO:0001078 // GO:0060536 // GO:0016477 // GO:0001837 // GO:0031069 // GO:0060972 // GO:0001707 // GO:0060806 // GO:0043518 // GO:1902230 // GO:0000122 // GO:0010957 // GO:0061314 // GO:0001649 // GO:0060021 // GO:0030335 // GO:0010718 // GO:0045893 // GO:2000810 // GO:0060707";"cartilage morphogenesis (GO:0060536);cell migration (GO:0016477);epithelial to mesenchymal transition (GO:0001837);hair follicle morphogenesis (GO:0031069);left/right pattern formation (GO:0060972);mesoderm formation (GO:0001707);negative regulation of cell differentiation involved in embryonic placenta development (GO:0060806);negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518);negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);negative regulation of vitamin D biosynthetic process (GO:0010957);Notch signaling involved in heart development (GO:0061314);osteoblast differentiation (GO:0001649);palate development (GO:0060021);positive regulation of cell migration (GO:0030335);positive regulation of epithelial to mesenchymal transition (GO:0010718);positive regulation of transcription, DNA-templated (GO:0045893);regulation of bicellular tight junction assembly (GO:2000810);trophoblast giant cell differentiation (GO:0060707);";"kinase binding (GO:0019900);metal ion binding (GO:0046872);RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977);transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001078);";"cytoplasm (GO:0005737);nucleus (GO:0005634);";"3D-structure;ADP-ribosylation;Complete proteome;Cytoplasm;Developmental protein;DNA-binding;Glycoprotein;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger.;"
"4750387_length_1146_cvg_5.5_tip_1";"1";"p3";"(AAG)5";"15";530;544;"4750387";1146;"DAB2P_HUMAN";"GO:1990597 // GO:0030424 // GO:0044300 // GO:0044301 // GO:0005737 // GO:0005829 // GO:0030425 // GO:0030139 // GO:0070062 // GO:0031235 // GO:0043025 // GO:0032809 // GO:1990032 // GO:0005886 // GO:0071889 // GO:0005123 // GO:0005096 // GO:0042802 // GO:0019900 // GO:0031434 // GO:0031435 // GO:0043548 // GO:0036312 // GO:0032266 // GO:0070273 // GO:0032403 // GO:0042803 // GO:0019901 // GO:0051721 // GO:0017124 // GO:0035591 // GO:0043184 // GO:0007257 // GO:0000186 // GO:0000185 // GO:0006987 // GO:0001525 // GO:0007411 // GO:0007049 // GO:0021814 // GO:0044257 // GO:0071364 // GO:0071347 // GO:0071222 // GO:0071356 // GO:0035924 // GO:0072577 // GO:0007173 // GO:0008625 // GO:0038095 // GO:0008543 // GO:0007252 // GO:0006954 // GO:0045087 // GO:0008286 // GO:0070059 // GO:0021819 // GO:0000165 // GO:0016525 // GO:0090090 // GO:0035414 // GO:0008285 // GO:2000599 // GO:0010596 // GO:0042059 // GO:0010633 // GO:0050680 // GO:0010719 // GO:0070373 // GO:0048147 // GO:0070317 // GO:0034260 // GO:0043124 // GO:0043407 // GO:0032088 // GO:0043553 // GO:0014067 // GO:0001933 // GO:0071901 // GO:0046580 // GO:0034144 // GO:0000122 // GO:0045892 // GO:0030948 // GO:1900747 // GO:0048812 // GO:0048011 // GO:0043065 // GO:2001235 // GO:0071158 // GO:1900006 // GO:0043547 // GO:1903896 // GO:0046330 // GO:0043507 // GO:0043410 // GO:2001224 // GO:0010976 // GO:1901800 // GO:0045732 // GO:0071902 // GO:0090129 // GO:0045944 // GO:0007265 // GO:0038026 // GO:0040008 // GO:0043087 // GO:0043122 // GO:1900744 // GO:0043254 // GO:0043497 // GO:0007264 // GO:0006927 // GO:0035148 // GO:0048010 // GO:0036324";"activation of JUN kinase activity (GO:0007257);activation of MAPKK activity (GO:0000186);activation of MAPKKK activity (GO:0000185);activation of signaling protein activity involved in unfolded protein response (GO:0006987);angiogenesis (GO:0001525);axon guidance (GO:0007411);cell cycle (GO:0007049);cell motility involved in cerebral cortex radial glia guided migration (GO:0021814);cellular protein catabolic process (GO:0044257);cellular response to epidermal growth factor stimulus (GO:0071364);cellular response to interleukin-1 (GO:0071347);cellular response to lipopolysaccharide (GO:0071222);cellular response to tumor necrosis factor (GO:0071356);cellular response to vascular endothelial growth factor stimulus (GO:0035924);endothelial cell apoptotic process (GO:0072577);epidermal growth factor receptor signaling pathway (GO:0007173);extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625);Fc-epsilon receptor signaling pathway (GO:0038095);fibroblast growth factor receptor signaling pathway (GO:0008543);I-kappaB phosphorylation (GO:0007252);inflammatory response (GO:0006954);innate immune response (GO:0045087);insulin receptor signaling pathway (GO:0008286);intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059);layer formation in cerebral cortex (GO:0021819);MAPK cascade (GO:0000165);negative regulation of angiogenesis (GO:0016525);negative regulation of canonical Wnt signaling pathway (GO:0090090);negative regulation of catenin import into nucleus (GO:0035414);negative regulation of cell proliferation (GO:0008285);negative regulation of cyclin catabolic process (GO:2000599);negative regulation of endothelial cell migration (GO:0010596);negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059);negative regulation of epithelial cell migration (GO:0010633);negative regulation of epithelial cell proliferation (GO:0050680);negative regulation of epithelial to mesenchymal transition (GO:0010719);negative regulation of ERK1 and ERK2 cascade (GO:0070373);negative regulation of fibroblast proliferation (GO:0048147);negative regulation of G0 to G1 transition (GO:0070317);negative regulation of GTPase activity (GO:0034260);negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124);negative regulation of MAP kinase activity (GO:0043407);negative regulation of NF-kappaB transcription factor activity (GO:0032088);negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553);negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067);negative regulation of protein phosphorylation (GO:0001933);negative regulation of protein serine/threonine kinase activity (GO:0071901);negative regulation of Ras protein signal transduction (GO:0046580);negative regulation of toll-like receptor 4 signaling pathway (GO:0034144);negative regulation of transcription from RNA polymerase II promoter (GO:0000122);negative regulation of transcription, DNA-templated (GO:0045892);negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948);negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747);neuron projection morphogenesis (GO:0048812);neurotrophin TRK receptor signaling pathway (GO:0048011);positive regulation of apoptotic process (GO:0043065);positive regulation of apoptotic signaling pathway (GO:2001235);positive regulation of cell cycle arrest (GO:0071158);positive regulation of dendrite development (GO:1900006);positive regulation of GTPase activity (GO:0043547);positive regulation of IRE1-mediated unfolded protein response (GO:1903896);positive regulation of JNK cascade (GO:0046330);positive regulation of JUN kinase activity (GO:0043507);positive regulation of MAPK cascade (GO:0043410);positive regulation of neuron migration (GO:2001224);positive regulation of neuron projection development (GO:0010976);positive regulation of proteasomal protein catabolic process (GO:1901800);positive regulation of protein catabolic process (GO:0045732);positive regulation of protein serine/threonine kinase activity (GO:0071902);positive regulation of synapse maturation (GO:0090129);positive regulation of transcription from RNA polymerase II promoter (GO:0045944);Ras protein signal transduction (GO:0007265);reelin-mediated signaling pathway (GO:0038026);regulation of growth (GO:0040008);regulation of GTPase activity (GO:0043087);regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122);regulation of p38MAPK cascade (GO:1900744);regulation of protein complex assembly (GO:0043254);regulation of protein heterodimerization activity (GO:0043497);small GTPase mediated signal transduction (GO:0007264);transformed cell apoptotic process (GO:0006927);tube formation (GO:0035148);vascular endothelial growth factor receptor signaling pathway (GO:0048010);vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324);";"14-3-3 protein binding (GO:0071889);death receptor binding (GO:0005123);GTPase activator activity (GO:0005096);identical protein binding (GO:0042802);kinase binding (GO:0019900);mitogen-activated protein kinase kinase binding (GO:0031434);mitogen-activated protein kinase kinase kinase binding (GO:0031435);phosphatidylinositol 3-kinase binding (GO:0043548);phosphatidylinositol 3-kinase regulatory subunit binding (GO:0036312);phosphatidylinositol-3-phosphate binding (GO:0032266);phosphatidylinositol-4-phosphate binding (GO:0070273);protein complex binding (GO:0032403);protein homodimerization activity (GO:0042803);protein kinase binding (GO:0019901);protein phosphatase 2A binding (GO:0051721);SH3 domain binding (GO:0017124);signaling adaptor activity (GO:0035591);vascular endothelial growth factor receptor 2 binding (GO:0043184);";"AIP1-IRE1 complex (GO:1990597);axon (GO:0030424);cerebellar mossy fiber (GO:0044300);climbing fiber (GO:0044301);cytoplasm (GO:0005737);cytosol (GO:0005829);dendrite (GO:0030425);endocytic vesicle (GO:0030139);extracellular exosome (GO:0070062);intrinsic component of the cytoplasmic side of the plasma membrane (GO:0031235);neuronal cell body (GO:0043025);neuronal cell body membrane (GO:0032809);parallel fiber (GO:1990032);plasma membrane (GO:0005886);";"Alternative splicing;Angiogenesis;Apoptosis;Cell cycle;Cell membrane;Cell projection;Chromosomal rearrangement;Coiled coil;Complete proteome;Cytoplasm;Developmental protein;Growth regulation;GTPase activation;Immunity;Inflammatory response;Innate immunity;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Stress response;Tumor suppressor;Unfolded protein response.;"
"4750419_length_1148_cvg_8.7_tip_1";"1";"p2";"(CA)5";"10";901;910;"4750419";1148;"GAB2_HUMAN";"GO:0005737 // GO:0005829 // GO:0005886 // GO:0005547 // GO:0043325 // GO:0005068 // GO:0038095 // GO:0045087 // GO:0030316 // GO:0048015 // GO:0008284 // GO:0043306 // GO:0007169";"Fc-epsilon receptor signaling pathway (GO:0038095);innate immune response (GO:0045087);osteoclast differentiation (GO:0030316);phosphatidylinositol-mediated signaling (GO:0048015);positive regulation of cell proliferation (GO:0008284);positive regulation of mast cell degranulation (GO:0043306);transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169);";"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547);phosphatidylinositol-3,4-bisphosphate binding (GO:0043325);transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068);";"cytoplasm (GO:0005737);cytosol (GO:0005829);plasma membrane (GO:0005886);";"3D-structure;Alternative splicing;Cell membrane;Complete proteome;Cytoplasm;Membrane;Phosphoprotein;Polymorphism;Reference proteome.;"
"4750933_length_1171_cvg_8.8_tip_1";"1";"p2";"(TC)5";"10";945;954;"4750933";1171;"DYH7_HUMAN";"GO:0005858 // GO:0005929 // GO:0005737 // GO:0036156 // GO:0005874 // GO:0005524 // GO:0016887 // GO:0005509 // GO:0003777 // GO:0003341 // GO:0001539 // GO:0036159";"cilium movement (GO:0003341);cilium or flagellum-dependent cell motility (GO:0001539);inner dynein arm assembly (GO:0036159);";"ATP binding (GO:0005524);ATPase activity (GO:0016887);calcium ion binding (GO:0005509);microtubule motor activity (GO:0003777);";"axonemal dynein complex (GO:0005858);cilium (GO:0005929);cytoplasm (GO:0005737);inner dynein arm (GO:0036156);microtubule (GO:0005874);";"Alternative splicing;ATP-binding;Cell projection;Cilium;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Dynein;Microtubule;Motor protein;Nucleotide-binding;Polymorphism;Reference proteome;Repeat.;"
"4751237_length_1187_cvg_6.3_tip_1";"1";"p2";"(GA)5";"10";192;201;"4751237";1187;"SRC_HUMAN";"GO:0005884 // GO:0005901 // GO:0005737 // GO:0005829 // GO:0070062 // GO:0031234 // GO:0005770 // GO:0005764 // GO:0005743 // GO:0005739 // GO:0005634 // GO:0048471 // GO:0005886 // GO:0032587 // GO:0005524 // GO:0019899 // GO:0046875 // GO:0070851 // GO:0020037 // GO:0051427 // GO:0005178 // GO:0044325 // GO:0016301 // GO:0019900 // GO:0004715 // GO:0051219 // GO:0004672 // GO:0004713 // GO:0005102 // GO:0097110 // GO:0042169 // GO:0005070 // GO:0086098 // GO:0007411 // GO:0007596 // GO:0045453 // GO:0060444 // GO:0007155 // GO:0007049 // GO:0030154 // GO:0071498 // GO:0071375 // GO:0036120 // GO:0071393 // GO:0034614 // GO:0048013 // GO:0007173 // GO:0038096 // GO:0008543 // GO:0030900 // GO:0045087 // GO:0007229 // GO:0035556 // GO:0050900 // GO:0061024 // GO:2000811 // GO:0043066 // GO:0043154 // GO:2001237 // GO:0051895 // GO:2001243 // GO:0051902 // GO:0032463 // GO:0048011 // GO:0048477 // GO:0036035 // GO:0038083 // GO:0018108 // GO:0030168 // GO:0090263 // GO:0010634 // GO:0070374 // GO:0033625 // GO:2000394 // GO:0050731 // GO:0071803 // GO:0051897 // GO:0071902 // GO:0050847 // GO:0046777 // GO:0031648 // GO:0007265 // GO:0045124 // GO:2001286 // GO:0051726 // GO:0060491 // GO:0042127 // GO:0022407 // GO:2000641 // GO:0010632 // GO:0033146 // GO:0071801 // GO:0043393 // GO:0043114 // GO:0070555 // GO:0007172 // GO:0007165 // GO:0007264 // GO:0002223 // GO:0043149 // GO:0034446 // GO:0031295 // GO:0007179 // GO:0060065 // GO:0048010 // GO:0016032";"angiotensin-activated signaling pathway involved in heart process (GO:0086098);axon guidance (GO:0007411);blood coagulation (GO:0007596);bone resorption (GO:0045453);branching involved in mammary gland duct morphogenesis (GO:0060444);cell adhesion (GO:0007155);cell cycle (GO:0007049);cell differentiation (GO:0030154);cellular response to fluid shear stress (GO:0071498);cellular response to peptide hormone stimulus (GO:0071375);cellular response to platelet-derived growth factor stimulus (GO:0036120);cellular response to progesterone stimulus (GO:0071393);cellular response to reactive oxygen species (GO:0034614);ephrin receptor signaling pathway (GO:0048013);epidermal growth factor receptor signaling pathway (GO:0007173);Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096);fibroblast growth factor receptor signaling pathway (GO:0008543);forebrain development (GO:0030900);innate immune response (GO:0045087);integrin-mediated signaling pathway (GO:0007229);intracellular signal transduction (GO:0035556);leukocyte migration (GO:0050900);membrane organization (GO:0061024);negative regulation of anoikis (GO:2000811);negative regulation of apoptotic process (GO:0043066);negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154);negative regulation of extrinsic apoptotic signaling pathway (GO:2001237);negative regulation of focal adhesion assembly (GO:0051895);negative regulation of intrinsic apoptotic signaling pathway (GO:2001243);negative regulation of mitochondrial depolarization (GO:0051902);negative regulation of protein homooligomerization (GO:0032463);neurotrophin TRK receptor signaling pathway (GO:0048011);oogenesis (GO:0048477);osteoclast development (GO:0036035);peptidyl-tyrosine autophosphorylation (GO:0038083);peptidyl-tyrosine phosphorylation (GO:0018108);platelet activation (GO:0030168);positive regulation of canonical Wnt signaling pathway (GO:0090263);positive regulation of epithelial cell migration (GO:0010634);positive regulation of ERK1 and ERK2 cascade (GO:0070374);positive regulation of integrin activation (GO:0033625);positive regulation of lamellipodium morphogenesis (GO:2000394);positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731);positive regulation of podosome assembly (GO:0071803);positive regulation of protein kinase B signaling (GO:0051897);positive regulation of protein serine/threonine kinase activity (GO:0071902);progesterone receptor signaling pathway (GO:0050847);protein autophosphorylation (GO:0046777);protein destabilization (GO:0031648);Ras protein signal transduction (GO:0007265);regulation of bone resorption (GO:0045124);regulation of caveolin-mediated endocytosis (GO:2001286);regulation of cell cycle (GO:0051726);regulation of cell projection assembly (GO:0060491);regulation of cell proliferation (GO:0042127);regulation of cell-cell adhesion (GO:0022407);regulation of early endosome to late endosome transport (GO:2000641);regulation of epithelial cell migration (GO:0010632);regulation of intracellular estrogen receptor signaling pathway (GO:0033146);regulation of podosome assembly (GO:0071801);regulation of protein binding (GO:0043393);regulation of vascular permeability (GO:0043114);response to interleukin-1 (GO:0070555);signal complex assembly (GO:0007172);signal transduction (GO:0007165);small GTPase mediated signal transduction (GO:0007264);stimulatory C-type lectin receptor signaling pathway (GO:0002223);stress fiber assembly (GO:0043149);substrate adhesion-dependent cell spreading (GO:0034446);T cell costimulation (GO:0031295);transforming growth factor beta receptor signaling pathway (GO:0007179);uterus development (GO:0060065);vascular endothelial growth factor receptor signaling pathway (GO:0048010);viral process (GO:0016032);";"ATP binding (GO:0005524);enzyme binding (GO:0019899);ephrin receptor binding (GO:0046875);growth factor receptor binding (GO:0070851);heme binding (GO:0020037);hormone receptor binding (GO:0051427);integrin binding (GO:0005178);ion channel binding (GO:0044325);kinase activity (GO:0016301);kinase binding (GO:0019900);non-membrane spanning protein tyrosine kinase activity (GO:0004715);phosphoprotein binding (GO:0051219);protein kinase activity (GO:0004672);protein tyrosine kinase activity (GO:0004713);receptor binding (GO:0005102);scaffold protein binding (GO:0097110);SH2 domain binding (GO:0042169);SH3/SH2 adaptor activity (GO:0005070);";"actin filament (GO:0005884);caveola (GO:0005901);cytoplasm (GO:0005737);cytosol (GO:0005829);extracellular exosome (GO:0070062);extrinsic component of cytoplasmic side of plasma membrane (GO:0031234);late endosome (GO:0005770);lysosome (GO:0005764);mitochondrial inner membrane (GO:0005743);mitochondrion (GO:0005739);nucleus (GO:0005634);perinuclear region of cytoplasm (GO:0048471);plasma membrane (GO:0005886);ruffle membrane (GO:0032587);";"3D-structure;Alternative splicing;ATP-binding;Cell adhesion;Cell cycle;Cell membrane;Complete proteome;Cytoplasm;Cytoskeleton;Host-virus interaction;Immunity;Kinase;Lipoprotein;Membrane;Mitochondrion;Mitochondrion inner membrane;Myristate;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;SH2 domain;SH3 domain;Transferase;Tyrosine-protein kinase;Ubl conjugation.;"
"4751391_length_1195_cvg_12.9_tip_0";"1";"p2";"(TC)5";"10";704;713;"4751391";1195;"MEFV_MOUSE";"GO:0005737 // GO:0030027 // GO:0005874 // GO:0005875 // GO:0005634 // GO:0001726 // GO:0003779 // GO:0008270 // GO:0006954 // GO:0045087 // GO:0050728 // GO:0032691 // GO:0032695 // GO:0071641 // GO:2001056";"inflammatory response (GO:0006954);innate immune response (GO:0045087);negative regulation of inflammatory response (GO:0050728);negative regulation of interleukin-1 beta production (GO:0032691);negative regulation of interleukin-12 production (GO:0032695);negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641);positive regulation of cysteine-type endopeptidase activity (GO:2001056);";"actin binding (GO:0003779);zinc ion binding (GO:0008270);";"cytoplasm (GO:0005737);lamellipodium (GO:0030027);microtubule (GO:0005874);microtubule associated complex (GO:0005875);nucleus (GO:0005634);ruffle (GO:0001726);";"Actin-binding;Cell projection;Coiled coil;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Immunity;Inflammatory response;Innate immunity;Metal-binding;Microtubule;Nucleus;Reference proteome;Zinc;Zinc-finger.;"
"4753675_length_1332_cvg_9.9_tip_1";"1";"p2";"(TC)6";"12";418;429;"4753675";1332;"E2AK3_HUMAN";"GO:0005737 // GO:0005783 // GO:0005789 // GO:0030176 // GO:0016020 // GO:0005524 // GO:0019899 // GO:0004694 // GO:0042802 // GO:0042803 // GO:0004672 // GO:0019903 // GO:0004674 // GO:0006919 // GO:0001525 // GO:0030282 // GO:0019722 // GO:0044267 // GO:0042149 // GO:0002063 // GO:0036492 // GO:0031018 // GO:0007029 // GO:0030968 // GO:0006983 // GO:0045444 // GO:0030073 // GO:0048009 // GO:0070059 // GO:0007595 // GO:0043066 // GO:0031642 // GO:0017148 // GO:0032057 // GO:0001503 // GO:0018105 // GO:0036499 // GO:1902237 // GO:0010628 // GO:0032092 // GO:1900182 // GO:0045943 // GO:0010575 // GO:0046777 // GO:0051260 // GO:0006468 // GO:0060734 // GO:1902235 // GO:0019217 // GO:0010998 // GO:0034976 // GO:0001501 // GO:0032933 // GO:0006412";"activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919);angiogenesis (GO:0001525);bone mineralization (GO:0030282);calcium-mediated signaling (GO:0019722);cellular protein metabolic process (GO:0044267);cellular response to glucose starvation (GO:0042149);chondrocyte development (GO:0002063);eiF2alpha phosphorylation in response to endoplasmic reticulum stress (GO:0036492);endocrine pancreas development (GO:0031018);endoplasmic reticulum organization (GO:0007029);endoplasmic reticulum unfolded protein response (GO:0030968);ER overload response (GO:0006983);fat cell differentiation (GO:0045444);insulin secretion (GO:0030073);insulin-like growth factor receptor signaling pathway (GO:0048009);intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059);lactation (GO:0007595);negative regulation of apoptotic process (GO:0043066);negative regulation of myelination (GO:0031642);negative regulation of translation (GO:0017148);negative regulation of translational initiation in response to stress (GO:0032057);ossification (GO:0001503);peptidyl-serine phosphorylation (GO:0018105);PERK-mediated unfolded protein response (GO:0036499);positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237);positive regulation of gene expression (GO:0010628);positive regulation of protein binding (GO:0032092);positive regulation of protein localization to nucleus (GO:1900182);positive regulation of transcription from RNA polymerase I promoter (GO:0045943);positive regulation of vascular endothelial growth factor production (GO:0010575);protein autophosphorylation (GO:0046777);protein homooligomerization (GO:0051260);protein phosphorylation (GO:0006468);regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734);regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235);regulation of fatty acid metabolic process (GO:0019217);regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998);response to endoplasmic reticulum stress (GO:0034976);skeletal system development (GO:0001501);SREBP signaling pathway (GO:0032933);translation (GO:0006412);";"ATP binding (GO:0005524);enzyme binding (GO:0019899);eukaryotic translation initiation factor 2alpha kinase activity (GO:0004694);identical protein binding (GO:0042802);protein homodimerization activity (GO:0042803);protein kinase activity (GO:0004672);protein phosphatase binding (GO:0019903);protein serine/threonine kinase activity (GO:0004674);";"cytoplasm (GO:0005737);endoplasmic reticulum (GO:0005783);endoplasmic reticulum membrane (GO:0005789);integral component of endoplasmic reticulum membrane (GO:0030176);membrane (GO:0016020);";"3D-structure;ADP-ribosylation;ATP-binding;Complete proteome;Diabetes mellitus;Disease mutation;Endoplasmic reticulum;Glycoprotein;Kinase;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Signal;Stress response;Transferase;Translation regulation;Transmembrane;Transmembrane helix;Unfolded protein response.;"
"4754597_length_1401_cvg_5.7_tip_1";"1";"p2";"(GA)5";"10";477;486;"4754597";1401;"MYOM1_MOUSE";"GO:0005856 // GO:0031430 // GO:0032982 // GO:0030017 // GO:0042802 // GO:0042803 // GO:0005200 // GO:0098779 // GO:0006936 // GO:0002230";"mitophagy in response to mitochondrial depolarization (GO:0098779);muscle contraction (GO:0006936);positive regulation of defense response to virus by host (GO:0002230);";"identical protein binding (GO:0042802);protein homodimerization activity (GO:0042803);structural constituent of cytoskeleton (GO:0005200);";"cytoskeleton (GO:0005856);M band (GO:0031430);myosin filament (GO:0032982);sarcomere (GO:0030017);";"3D-structure;Alternative splicing;Complete proteome;Cytoplasm;Immunoglobulin domain;Muscle protein;Phosphoprotein;Reference proteome;Repeat;Thick filament.;"
"4755571_length_1487_cvg_10.6_tip_1";"1";"p2";"(AG)5";"10";1029;1038;"4755571";1487;"AGRA3_HUMAN";"GO:0009897 // GO:0016021 // GO:0004930 // GO:0007166 // GO:0007186";"cell surface receptor signaling pathway (GO:0007166);G-protein coupled receptor signaling pathway (GO:0007186);";"G-protein coupled receptor activity (GO:0004930);";"external side of plasma membrane (GO:0009897);integral component of membrane (GO:0016021);";"Alternative splicing;Complete proteome;Disulfide bond;G-protein coupled receptor;Glycoprotein;Immunoglobulin domain;Leucine-rich repeat;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transducer;Transmembrane;Transmembrane helix.;"
"4756187_length_1545_cvg_8.7_tip_1";"1";"p2";"(CA)7";"14";319;332;"4756187";1545;"TNR9_HUMAN";"GO:0009897 // GO:0005615 // GO:0005887 // GO:0004872 // GO:0005031 // GO:0006915 // GO:0008625 // GO:0006955 // GO:0006954 // GO:0007275 // GO:0008285 // GO:2001180 // GO:2001183 // GO:0070207 // GO:0042981 // GO:0032496 // GO:0033209";"apoptotic process (GO:0006915);extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625);immune response (GO:0006955);inflammatory response (GO:0006954);multicellular organismal development (GO:0007275);negative regulation of cell proliferation (GO:0008285);negative regulation of interleukin-10 secretion (GO:2001180);negative regulation of interleukin-12 secretion (GO:2001183);protein homotrimerization (GO:0070207);regulation of apoptotic process (GO:0042981);response to lipopolysaccharide (GO:0032496);tumor necrosis factor-mediated signaling pathway (GO:0033209);";"receptor activity (GO:0004872);tumor necrosis factor-activated receptor activity (GO:0005031);";"external side of plasma membrane (GO:0009897);extracellular space (GO:0005615);integral component of plasma membrane (GO:0005887);";"Complete proteome;Direct protein sequencing;Disulfide bond;Glycoprotein;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix.;"
